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GENERAL INTRODUCTION AND OUTLINE OF THE THESIS 
 
Identification of patients at risk of developing coronary artery disease 
events is one of the most challenging issues in clinical cardiology. The risk 
of acute coronary events in subjects without known coronary artery 
disease is related to the presence of cardiovascular risk factors. Several 
scoring tools that include demographic and clinical characteristics have 
been developed and are frequently used in clinical practice to predict the 
10-year risk of hard coronary events. These tools allow stratification of 
patients into low-, intermediate, and high-risk categories, in order to 
determine the need and intensity of risk-modifying interventions.1-3 
However, traditional risk assessment may still fail to identify a 
considerable proportion of patients with future coronary events, since it 
provides a statistical probability of having coronary artery disease rather 
than a direct individual assessment.4 Indeed, it has been observed that as 
much as 20% of acute coronary events can occur in the absence of major 
cardiovascular risk factors.5 
The potential value of additional risk assessment with stress testing (i.e. 
electrocardiographic exercise test, stress echocardiography or myocardial 
perfusion imaging) to improve the identification of patients at risk of 
coronary events has been extensively evaluated.6,7 More recently, direct 
visualization of subclinical atherosclerosis, by coronary artery calcium 
score (CACS) assessment with electron-beam computed tomography 
(EBCT) or multi-slice computed tomography (MSCT), and MSCT coronary 
angiography, has emerged as an extremely rapidly developing non-
invasive imaging modality to refine traditional risk assessment. These 
imaging techniques may be a practical approach since they provide a 
direct non-invasive estimate of atherosclerotic plaque burden in the 
coronary arteries (Figure 1).8 The application of these imaging modalities 
may be particularly useful among patients with history of atrial fibrillation, 
since coronary artery disease is considered to be highly prevalent in 
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Figure 1. Panel A. Evaluation of CACS by MSCT reveals the presence of 
coronary calcium in the left anterior descending coronary artery. Panel B. Curved 
multi-planar reconstructions showing three distinct plaque characteristics 
observed on MSCT with non-calcified plaque (arrow, left panel), mixed plaque 
(arrow, mid-panel), and calcified plaque (arrow, right panel).  
 
Conventional echocardiography as well as novel echocardiographic 
techniques, such as speckle-tracking echocardiography, may be of value 
as well for the identification of patients with obstructive coronary artery 
disease. Comprehensive echocardiographic assessment of cardiac and 
ascending aorta calcifications, which have been related to coronary artery 
disease and cardiovascular events,10,11 may be a simple, non-invasive, and 
widely available technique to predict the presence of extensive coronary 
calcium and obstructive coronary artery disease (Figure 2).  
Speckle-tracking echocardiography, a novel non-invasive imaging modality 
able to quantify myocardial motion and deformation in a region-by-region 
analysis, may detect the presence of subclinical impairment of myocardial 
function, which could represent a marker of obstructive coronary artery 
disease (Figure 3).12 
Advanced echocardiographic imaging techniques may be of incremental 
diagnostic and prognostic value among patients with clinically overt 
cardiac diseases; contrast-enhanced echocardiography, real-time three-
dimensional echocardiography (RT3DE) and speckle-tracking imaging 
have indeed demonstrated their incremental value over conventional 
echocardiography for the assessment of global and regional left 
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ventricular function and for a better understand of cardiac mechanics.13-15 
The use of contrast agents allows for the evaluation of cardiac flow 
dynamics, which are closely related to myocardial motion and 
deformation, 16,17 and of myocardial blood flow.18 
 
 
Figure 2. Example of a 50-year-old male with calcified posterior mitral annulus 
and aortic valve and 3-vessel coronary artery disease. Panel A shows the 
parasternal long-axis view of the left ventricle with calcification of the aortic valve 
(arrows) and the posterior annulus of the mitral valve (arrow). Panel B shows the 
apical long-axis view of the left ventricle and calcified posterior mitral annulus 
(arrow). Panel C shows the right coronary artery with a significant lesion of the 
mid segment (arrow) and panel D shows the left coronary system with significant 
lesions in the circumflex coronary artery and first diagonal branch of the left 
anterior descending coronary artery (arrows).  
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Figure 3. Speckle-tracking echocardiography provides a direct measure of 
myocardial deformation and can therefore be used to detect subtle abnormalities 
in LV systolic and diastolic function. Global longitudinal strain and strain rate 
curves obtained by speckle-tracking analysis from an apical 4-chamber view are 
shown in panel A and B, respectively. 
 
Coronary artery calcium scoring and multi-sl ice computed 
tomography coronary angiography 
EBCT and MSCT have been previously validated as sensitive techniques for 
the detection of coronary calcium, a marker of coronary atherosclerosis.19 
EBCT was introduced in the early 1980s specifically for cardiac imaging. 
The use of non-mechanical X-ray source allows for prospective ECG-
triggered image acquisition with high temporal resolution (50–100 ms), 
thereby limiting respiratory and cardiac motion artifacts. Coronary 
calcifications are defined as hyper-attenuating lesions >130 Hounsfield 
units with an area of three or more adjacent pixels (at least 1 mm2).20 To 
quantify the extent of coronary calcium, a score has been developed by 
Agatston et al.21 To express the extent of detected coronary calcium, 
CACS is commonly classified into four categories: 0, 1–99, 100–399, and 
≥400, indicating no calcific deposits, mild, moderate, and severe coronary 
calcifications, respectively.22 Several studies have recently demonstrated 
that CACS obtained using newer generation MSCT scanners (with higher 
number of detectors and faster X-ray gantry rotation time) are 
comparable to those obtained with EBCT.23 
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Main disadvantages of calcium scoring are the lack of information on the 
degree of coronary stenosis and the inability to identify non-calcified 
plaques. The introduction of MSCT coronary angiography has overcome 
these limitations, allowing direct non-invasive anatomic assessment of the 
coronary arteries. For diagnosis, numerous studies support the use of 
MSCT coronary angiography for rule out of the presence of coronary 
artery disease with a high accuracy;24,25 a differentiation can also be made 
between non-calcified plaques having low attenuation, calcified plaques 
with high attenuation, and mixed plaques with both non-calcified and 
calcified elements (Figure 1).26 Furthermore, plaque remodelling, a marker 
of vulnerability, can also be appreciated.26 These advantages have led to 
an increased use of MSCT as a gatekeeper for further diagnostic testing. 
In addition, early identification of coronary artery disease with MSCT 
coronary angiography may be useful for risk stratification.27 
 
Echocardiographic assessment of cardiac and ascending aorta 
calcifications 
Previous studies have consistently demonstrated that mitral annular 
calcium and aortic valve sclerosis are not simple passive degenerative 
disorders influenced by mechanical stress, but active inflammatory 
processes with histopathologic features similar to atherosclerosis.28 Large 
population cohort studies have also shown that aortic valve sclerosis and 
mitral annular calcium are associated with increased cardiovascular 
morbidity and mortality.10,11 Because it is unlikely that aortic valve 
sclerosis and mitral annular calcium directly lead to adverse cardiovascular 
outcomes, their relation with coronary atherosclerosis most likely explains 
these observations. Accordingly, echocardiographic recognition of cardiac 
and ascending aorta calcium could be helpful to optimize the identification 
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Echocardiographic assessment of myocardial deformation 
Speckle-tracking echocardiography has been introduced in the last years 
for the assessment of myocardial deformation; it allows an angle-
independent analysis of myocardial strain (and strain rate) in multiple 
directions (radial, longitudinal and circumferential), through the detection 
and tracking of the unique myocardial ultrasound patterns frame by 
frame. The in-plane frame-to-frame displacement of each pattern over 
time is used to derive strain.29 Using this technique, regional and global 
myocardial contractility can be studied, as well as more complex cardiac 
mechanics, such as the systolic twisting motion of the left ventricle along 
its longitudinal axis, which results from the opposite rotation of the left 
ventricular apex compared with the base. Left ventricular twist has 
emerged as an important, sensitive parameter of left ventricular systolic 
function.30 
 
Real-time three-dimensional echocardiography 
Over the last few decades, advances in ultrasound and computer 
technologies have enabled on-line real-time display of three-dimensional 
(3D) images of the heart. Several studies have demonstrated superior 
accuracy and reproducibility of RT3DE over standard two-dimensional 
echocardiography for quantification of left ventricular size and function.31 
In addition, the 3D tracking of endocardial motion of volumetric segments 
refines the analysis of regional left ventricular function and allows the 
assessment of temporal sequence of regional myocardial contraction, 
thus providing quantitative data of left ventricular dyssynchrony.31 In 
patients with acute myocardial infarction (AMI), the presence of 
significant left ventricular dyssynchrony has been associated with adverse 
left ventricular remodelling and functional impairment at follow-up. 
 
Contrast-enhanced echocardiography 
Transthoracic echocardiography (and in particular RT3DE) is not able to 
provide diagnostically useful images in a non-negligible proportion of 
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patients, mainly because of obesity and lung disease. The use of echo-
contrast agents solves these issues, providing cardiac chamber 
opacification and improving endocardial border definition, thereby 




Figure 4. Panel A. Example of fair-quality echocardiogram during nonenhanced 
RT3DE. Panel B. Optimal LV chamber opacification and improved endocardial 
border definition during contrast-enhanced RT3DE in the same patient. The 3 
apical views are shown with the 4-chamber view as a reference view in the top 
right and the 2- and 3-chamber views in the bottom left and bottom right, 
respectively. Top left: short-axis view.  
 
Besides improving the assessment of left ventricular function, echo-
contrast agents may also be used to assess myocardial perfusion and to 
investigate left ventricular hydrodynamics. During early left ventricular 
filling, the blood flow forms an intraventricular rotational body of fluid, 
which is critical in optimizing the blood flow during systole.17 Knowledge 
of abnormalities involving left ventricular hydrodynamics may be useful, 
since it provides direct information regarding the ultimate goal of left 
ventricular performance, i.e. optimal blood flow. 
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OBJECTIVES AND OUTLINE OF THE THESIS 
 
The objectives of the thesis were to investigate the incremental value in 
clinical practice of different non-invasive imaging techniques in patients 
with suspected coronary artery disease and in patients with acute 
myocardial infarction (AMI).  
In Part I, the use of non-invasive imaging modalities for diagnosis and risk 
stratification of patients with suspected coronary artery disease will be 
introduced. An overview of the prognostic value of CACS assessment is 
provided in Chapter 2; in addition, potential other applications of CACS 
assessment and the limitations of the technique are discussed. The 
incremental value of CACS and MSCT coronary angiography and the 
relation between coronary atherosclerosis and presence of abnormal 
stress testing are subsequently investigated in the general population 
(Chapters 3-4) and among patients with paroxysmal or persistent AF 
(Chapters 5-6). The clinical usefulness of comprehensive 
echocardiographic assessment of the burden of cardiac and ascending 
aorta calcium to predict coronary artery calcium and presence and 
severity of obstructive coronary artery disease is evaluated in Chapter 7 
while in Chapter 8 the relation between obstructive coronary artery 
disease and subclinical left ventricular systolic dysfunction, as assessed 
by speckle-tracking echocardiography, is investigated. 
Part I I  will discuss the diagnostic and prognostic value of novel 
echocardiographic techniques in patients with AMI. The incremental value 
of contrast-enhanced RT3DE early after AMI was investigated in Chapter 
9. The left ventricular hydrodynamics early after AMI and their relation to 
left ventricular diastolic function and infarct size are evaluated in 
Chapter 10, while the effects of AMI on left ventricular torsional 
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Identification of patients at risk of future coronary artery disease (CAD) 
events traditionally relies on scoring tools that take demographic and 
clinical characteristics into account (e.g., the Framingham risk score in the 
United States and the Heart Score in Europe). Although these scoring 
tools have been shown to have a good predictive value, they may still fail 
to recognize a proportion of patients with coronary atherosclerosis at risk 
for future CAD events. In order to improve risk stratification, direct 
visualization of subclinical atherosclerosis has been advocated. Electron-
beam computed tomography and multislice computed tomography 
provide a direct estimation of coronary calcium, a marker of coronary 
atherosclerosis. A large amount of data is available supporting the clinical 
value of the noninvasive assessment of coronary artery calcium score 
(CACS) with these techniques and its incremental prognostic information 
over traditional risk stratification. Aim of this review is to provide an 
overview of the literature regarding the prognostic value of CACS 
assessment. In addition, potential other applications of CACS assessment 


















Identification of patients at risk of developing coronary artery disease 
(CAD) events is one of the most challenging issues in clinical cardiology. 
Indeed, in a large proportion of individuals, the initial presentation of CAD 
is acute myocardial infarction (AMI) or sudden cardiac death.1 The risk of 
CAD events in subjects without known CAD is related to the presence of 
coronary risk factors (i.e., age, gender, diabetes mellitus, systolic blood 
pressure, total cholesterol and high-density lipoprotein cholesterol level, 
and smoking history).1 For this reason, scoring tools that take 
demographic and clinical characteristics into account (e.g., the 
Framingham risk score (FRS) in the United States and the Heart Score in 
Europe) have been developed and are frequently used in clinical practice 
to predict the 10-year risk of hard CAD events.2,3 Accordingly, these 
algorithms allow stratification of individuals into low-, intermediate- and 
high-risk categories, in order to determine the need and intensity of risk-
modifying interventions. However, these scoring tools have several 
limitations that reduce their ability to provide accurate risk stratification.4 
In particular, cardiovascular risk may not be adequately recognized in 
certain subset of patients including young individuals and nondiabetic 
women below the age of 70 years.4-7 In addition, a variation in CAD 
severity for each level of risk factor exposure has been observed, likely 
related to the duration of exposure, genetic susceptibility and other 
biochemical and environmental risk factors.8,9 
Several biomarkers and noninvasive imaging techniques have been 
advocated to refine the traditional risk assessment of CAD events. Among 
the available noninvasive imaging techniques, coronary artery calcium 
score (CACS) assessment with electron-beam computed tomography 
(EBCT) or multislice computed tomography (MSCT) may represent a 
practical approach since it provides a direct noninvasive estimate of 
atherosclerotic plaque burden in the coronary arteries. The aim of this 
review is to provide an overview of the literature regarding the prognostic 
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value of CACS assessment. In addition, potential other applications of 
CACS assessment as well as the limitations of the technique are 
discussed. 
 
EBCT AND MSCT FOR CORONARY ARTERY CALCIUM ASSESSMENT 
 
EBCT and MSCT have been previously validated as sensitive techniques for 
the detection of coronary calcium, a marker of coronary atherosclerosis.10 
EBCT was introduced in the early 1980s specifically for cardiac imaging. 
The use of nonmechanical X-ray source allows for prospective ECG-
triggered image acquisition with high temporal resolution (50–100 ms), 
thereby limiting respiratory and cardiac motion artifacts. Usually, 30–40 
nonoverlapping slices of 3 mm thickness are obtained during a single 20- 
to 30-second breath hold to include the whole heart and the entire 
coronary artery tree.11 Coronary calcifications are defined as hyper-
attenuating lesions >130 Hounsfield units with an area of three or more 
adjacent pixels (at least 1 mm2).11 To quantify the extent of coronary 
calcium, a score has been developed by Agatston et al.12 Using 3-mm slice 
thickness images, the CACS is defined as the product of the area of 
calcification per coronary segment and a factor rated 1 through 4 
determined by the maximum calcium CT density within that segment. To 
express the extent of detected coronary calcium, CACS is commonly 
classified into four categories: 0, 1–99, 100–399, and ≥400, indicating no 
calcific deposits, mild, moderate, and severe coronary calcifications, 
respectively.13 The presence of coronary calcifications and the extent of 
CACS has been found to be also gender- and age-related; in particular, a 
rapid increase in CACS is present in men after age 45 and in women after 
age 55.14 These data have been used to derive nomogram tables, in order 
to compare CACS of asymptomatic subjects with the expected normal 
values (Table 1).14 A CACS ≥75th percentile for age- and gender-matched 
individuals is usually considered as an indicator of elevated coronary 
calcium burden.15-17 Several studies have recently demonstrated that 
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CACS obtained using newer generation MSCT scanners (with higher 
number of detectors and faster X-ray gantry rotation time) are 
comparable to those obtained with EBCT.18-20 However, it should be 
acknowledged that MSCT has still lower interscan and interreader 
reproducibility than EBCT.21 Examples of patients with and without 
coronary calcium, as detected by MSCT, are shown in Figure 1. 
 
Table 1. Coronary artery calcium scores (CACS) by percentile, gender and age in a large 
asymptomatic population (N° = 21265) screened with electron-beam computed 
tomography. Adapted from Wong et al.14 with permission. 
Asymptomatic Women (N° = 6027) 
Age (years)  ≤40 41-45 46-50 51-55 
N° of subjects  331 407 855 1213 




















Age (years) 56-60 61-65 66-70 71-75 >75 
N° of subjects 1091 770 626 437 297 
























Asymptomatic Men (N° = 15238) 
Age (years) ≤35 36-40 41-45 46-50 51-55 
N° of subjects 466 1011 1873 2503 2915 
























Age (years) 56-60 61-65 66-70 71-75 >75 
N° of subjects 2385 1765 1212 679 429 
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Figure 1. Panel A. 47-year-old asymptomatic female at intermediate risk for 
future coronary artery disease (CAD) events. Coronary artery calcium score 
(CACS) assessment by MSCT reveals the absence of coronary calcium. Panel B. 
55-year-old asymptomatic male patient at intermediate risk for future CAD 
events. Evaluation of CACS by MSCT reveals the presence of coronary calcium in 
the left anterior descending coronary artery. Total CACS was >400. 
 
CORONARY ARTERY CALCIFICATIONS AND ATHEROSCLEROSIS 
 
Calcifications of the coronary arteries are strictly related to the process 
of atherosclerotic plaque formation and evolution.22 Previous studies have 
consistently demonstrated that vascular deposition of mineral calcium is 
not simply a passive precipitation of calcium phosphate crystals in 
damaged tissues.23,24 Instead, it is an organized and regulated process 
similar to bone formation that typically occurs in areas of atherosclerotic 
lipid accumulation.23,24 Consequently, the presence of calcific deposits in 
coronary arteries is considered to be pathognomonic of coronary 
atherosclerosis. In addition, histopathological and intravascular ultrasound 
studies found a good correlation between CACS measured using EBCT and 
the volume of coronary artery atherosclerosis, leading to the concept 
that CACS may be considered a surrogate of total atherosclerotic plaque 
burden.10,25-27 In this regard, however, two main drawbacks of CACS 
assessment should be acknowledged. Firstly, a large part of the total 
plaque volume is due to noncalcified tissue, which is not detected. As a 
result, CACS may underestimate total coronary atherosclerotic plaque 
burden, particularly in younger individuals.10 Secondly, the relation of 
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coronary calcification and the presence of significant stenosis is more 
variable.22 Even though a positive relation exists between the amount of 
CACS and the likelihood of significant luminal narrowing, obstructive 
plaques can occur at sites with limited calcium, while extensive calcific 
deposits without stenosis can be observed.28-32 
 
RISK STRATIFICATION OF ASYMPTOMATIC SUBJECTS 
 
Numerous studies have previously demonstrated the ability of CACS to 
predict cardiac events in asymptomatic subjects, with significant 
incremental value over conventional risk factor assessment. In a 
retrospective study of 5635 asymptomatic adults at low-intermediate 
risk (mean age 51±9 years), Kondos et al.17 observed that CACS >170 
measured with EBCT was associated with a relative risk of cardiac events 
of 7.2 (95% CI 2.0–26.2), after a mean follow-up of 37 months. The 
prognostic information obtained from CACS assessment was incremental 
to conventional risk stratification. Similar findings were reported by Shaw 
and colleagues in a retrospective analysis of 10,377 asymptomatic 
patients (40% women), with a mean of 5 years follow-up after EBCT 
evaluation.33 CACS was an independent predictor of death after 
adjustment for Framingham risk factors (p <0.001), with an increase of 
risk that was proportional to the increase of CACS (risk-factor adjusted 
relative risk of 1.6, 1.7, 2.5, and 4 for CACS 11–100, 101–400, 401–
1000, and >1000, respectively). The incremental value of CACS to FRS 
was illustrated by a significant increase of the area under the ROC curves, 
from 0.72 for FRS to 0.78 with the addition of CACS (p <0.001). Further 
follow-up in a large cohort of 25,253 asymptomatic subjects confirmed 
these data, showing increasing mortality rates after a mean follow-up of 
6.8 years with increasing baseline CACS (Figure 2).34 
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Figure 2. Cumulative survival by coronary artery calcium score (CACS) after 
adjustment for coronary risk factors (age, hypercholesterolemia, diabetes 
mellitus, smoking, hypertension, and family history of premature coronary heart 
disease). Increasing CACS was associated with increased risk of all-cause 
mortality. DM: diabetes mellitus; HTN: hypertension. Adapted from Budoff et al.34 
with permission. 
 
Prospective studies have confirmed these observations reinforcing the 
concept that CACS assessment may be of clinical value to refine 
traditional risk stratification.35–37 In a prospective observational 
population-based study, Greenland et al.35 used EBCT to screen 1029 
asymptomatic nondiabetic subjects older than 45 years with at least one 
coronary risk factor. After a median follow-up of 7 years, a CACS >300 
predicted the risk of AMI or cardiac death (hazard ratio 3.9; 95% CI 2.1–
7.3; p <0.001) compared with a CACS of zero. Across FRS categories, 
CACS was predictive of risk among subjects with intermediate and high 
FRS, but not among subjects with low FRS. Figure 3 shows the predicted 
7-year event rates (AMI or cardiac death) across FRS and CACS 
categories. 
 




Figure 3. Predicted 7-year event rates for categories of FRS and CACS. Pairwise 
analyses compared the highest CACS level (>300) with each of the lower levels of 
CACS within each FRS group. A statistically significant difference between CACS 
>300 and each of the other three CACS groups was observed for FRS >10% (p 
<0.001) and between CACS >300 and CACS zero for FRS <10% (p = 0.01). From 
Greenland et al.35 with permission. 
 
More recently, in the St. Francis Heart Study,36 screening for CAD by EBCT 
was performed in 4903 asymptomatic individuals. In the subgroup of 
1357 subjects in whom risk factors were measured, CACS was superior in 
the prediction of CAD events (cardiac death, AMI, surgical, or 
percutaneous coronary revascularization procedures) after a mean follow-
up of 4.3 years as compared to the FRS. Area under the ROC curve for 
CACS was 0.79 as compared to 0.68 for FRS (p <0.001). In addition, 
CACS significantly improved the risk stratification based on FRS (p 
<0.001 for trend). 
On the basis of these previous studies, a consensus document from the 
American College of Cardiology Foundation (ACCF) and the American 
Heart Association (AHA) has been recently published, providing 
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recommendations on the use of CACS assessment for risk stratification of 
asymptomatic subjects.38 In particular, individuals at intermediate FRS risk 
are considered to represent potential candidates for evaluation of CACS. 
In this group, the presence of CACS ≥400 would allow reclassification of 
individuals to a higher risk category, thereby altering clinical decision-
making. Conversely, CACS screening is not recommended in subjects at 
either low or high FRS. In patients at low risk, the presence of a high CACS 
would not elevate the individual's risk above the threshold to initiate 
medical therapy. Conversely, in the latter category, a high risk of CAD 
events is a priori anticipated on the basis of the high-risk profile, and 
aggressive medical therapy is already required. Moreover, Blaha et al.39 
recently showed that, after a mean follow-up of 5.6 years, asymptomatic 
subjects at high risk (in particular diabetic patients and smokers) even in 
the absence of coronary calcifications, experience more CAD events, as 
compared to patients at low risk. Accordingly, the ACCF/AHA consensus 
document does not support the concept that absence of CACS would 
lower the risk status of individuals with high FRS. 
Of note, in opposition to ACCF/AHA consensus document, the US 
Preventive Services Task Force (USPSTF) did not recommend the use of 
CACS for risk stratification of asymptomatic subjects.40 In particular, the 
USPSTF pointed out that only poor- to fair-quality evidence indicates that 
higher CACS predicts CAD events independent of Framingham risk 
factors, on the basis of a systematic review of eight cohort studies. 
However, it is important to remark that USPSTF did not include in its 
analysis the results of important large prospective, population-based 
studies clearly demonstrating the incremental prognostic value of CACS 
over conventional risk factor assessment.36,37 Inclusion of these studies 
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RISK STRATIFICATION OF SYMPTOMATIC PATIENTS 
 
Most of the available data regarding the clinical value of CACS assessment 
have been obtained in asymptomatic individuals. However, several studies 
have shown the utility of CACS for risk stratification also in symptomatic 
subjects. In a prospective, multicenter study of 491 symptomatic 
patients (mean age 55±12 years) who underwent both invasive coronary 
angiography and EBCT, Detrano and colleagues observed a strong 
association between CACS and the occurrence of CAD events.41 Patients 
with CACS higher than the median value (75.3) had a six times higher 
probability of CAD events after a mean follow-up of 30±13 months, as 
compared to patients with CACS below the median value. Interestingly, at 
multivariate analysis, log CACS, but not the number of significantly 
diseased segments at invasive coronary angiography, was selected as an 
independent predictor of CAD events, suggesting that global plaque 
burden rather than the degree of stenosis mainly determines the 
prognosis of CAD. 
Keelan et al.42 further confirmed these preliminary observations. A total of 
288 symptomatic subjects who underwent invasive angiography and 
EBCT were followed-up for 6.9 years. Univariate analysis showed that 
CACS ≥100 was significantly related to the occurrence of hard CAD 
events (unadjusted relative risk 3.2, 95% CI 1.17–8.71; p = 0.023). At 
multivariate analysis, besides increasing age, CACS was the most powerful 
predictor of future hard CAD events. Conversely, none of the 
conventional coronary risk factors (except age) nor angiographic stenosis 
was related to the occurrence of CAD events, supporting the results of 
Detrano and collegues. In another study, Georgiu et al.43 screened, by 
EBCT, 192 patients admitted in the emergency department because of 
chest pain. A graded relation between increasing CACS values and the 
incidence of cardiovascular events after a mean follow-up of 50±10 
months was observed. In particular, the annualized event rate was 0.6% 
for the patients without coronary calcium as compared with 13.9% per 
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year for the patients with CACS >400 (p <0.001). At multivariate 
analysis, CACS and age- and gender-matched calcium percentiles were 
the strongest predictors of future events. 
The results of these studies demonstrate that CACS assessment also in 
symptomatic subjects may provide valuable prognostic information. 
 
SELECTION OF PATIENTS REQUIRING TREATMENT 
 
On the basis of the prognostic data previously described, CACS has been 
proposed to refine medical decision-making. Indeed, the National 
Cholesterol Education Program's Adult Treatment Panel III guidelines state 
that the presence of a high CACS (defined as CACS at or above the 75th 
percentile for age and gender) in subjects at intermediate risk of CAD 
events identifies advanced coronary atherosclerosis.44 In these patients, 
more intensive lipid-lowering therapy is recommended in order to achieve 
a low-density lipoprotein cholesterol target of less than 100 mg/dl.44 
However, thus far, only few data on the outcome of medical therapy 
based on CACS are available. In the St. Francis Heart Study,45 1005 
asymptomatic subjects (mean age 59±6 years) with CACS at or above 
the 80th percentile for age and gender were randomized to receive 
atorvastatin 20 mg daily, vitamin C 1 g daily, and vitamin E (alpha-
tocopherol) 1000 U daily or placebo. All subjects received aspirin 81 mg 
daily. Mean duration of treatment was 4.3 years. Treatment significantly 
reduced total cholesterol by 26.5–30.4% (p <0.0001), low-density 
lipoprotein cholesterol by 39% (p <0.001), and triglycerides by 11% (p = 
0.02). Nevertheless, no significant reduction in atherosclerotic 
cardiovascular disease event rate was achieved by treatment. 
Interestingly, however, subanalysis revealed that treatment did reduce 
event rates in individuals with baseline CACS >400 (8.7% vs. 15.0%, 42% 
reduction, p <0.046). 
More recently, McCullough and Chinnaiyan systematically reviewed five 
prospective randomized trials evaluating the change in CACS as a 
Coronary	  Artery	  Calcium	  Scoring	  in	  Cardiovascular	  Risk	  Assessment	   37	  
	  
surrogate endpoint for treatment effect in patients at risk for or with CAD 
and could not demonstrate any consistent treatment effect on CACS 
progression at 1 year of follow-up.46 Further randomized studies are 
therefore needed to clarify whether clinical management based on CACS 
may positively impact outcome. 
 
SELECTION OF FURTHER DIAGNOSTIC TESTS 
 
CACS provides a relatively simple method for early identification of 
atherosclerosis. Accordingly, the technique may be used to identify 
patients that may benefit from further evaluation by means of functional 
testing. In comparative studies between CACS and myocardial perfusion 
imaging a relationship has been observed between the presence and 
extent of calcifications and the presence of ischemia.47–62 In one of the 
first comparative studies by He et al.47 in predominantly asymptomatic 
individuals, abnormal perfusion was observed in 0% of individuals with a 
CACS <10, in 2.6% of individuals with a CACS 11–100, in 11.3% of 
individuals with a CACS 101–400, and in 46% of individuals with a CACS 
>400. Similar increases in the prevalence of ischemia with increasingly 
higher CACS have been observed in other studies.48–52,54–61 Importantly, a 
CACS above 400 has consistently been shown to imply a high likelihood of 
ischemia. Accordingly, further evaluation by means of myocardial 
perfusion imaging in patients with CACS exceeding 400 has been deemed 
appropriate.63 Since a CACS >400 is observed in only approximately 10% 
of asymptomatic individuals,34 only a small proportion of patients referred 
for CACS will need further evaluation with ischemia testing. Conversely, in 
asymptomatic individuals with a CACS <100, further testing using 
myocardial perfusion imaging may not be needed as the prevalence of 
ischemia in patients with a CACS <100 is generally very low (< 
10%).47,48,50,58,63,64 
Although this notion may be valid for the general asymptomatic 
population, some studies have reported a higher prevalence of ischemia in 
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patients with low CACS. Most likely, the observed discrepancies may 
reflect differences in study populations.49,54,56,60 In a large study in 
asymptomatic patients with diabetes, a higher prevalence of myocardial 
perfusion defects (18%) was observed in patients with a low CACS 
between 11 and 100.53 In a further evaluation by Scholte et al.60 in 
asymptomatic diabetics, the prevalence of ischemia in patients with a low 
CACS <100 was 21%. These observations indicate that CACS should be 
treated with caution in patients with diabetes, as a low CACS may not 
invariably rule out the presence of ischemia. 
Also in symptomatic patients, a higher prevalence of ischemia (exceeding 
10%) has been observed in individuals with a low CACS <100; 
furthermore, the increased prevalence of ischemia has been linked to the 
severity of symptoms and the pretest likelihood of CAD.55,57–59 As 
compared to patients with minor symptoms or a low pretest likelihood, a 
higher proportion of patients with more severe symptoms or a higher 
pretest likelihood appear to have ischemia despite low CACS.58 In 
symptomatic patients therefore, CACS may only serve as a reliable 
gatekeeper for myocardial perfusion imaging in patients with relatively 
minor symptoms and a low pretest likelihood for CAD. 
 
EVALUATION OF TREATMENT 
 
Serial assessment of CACS has been previously proposed to evaluate the 
efficacy of treatment with lipid-lowering drugs. Callister and colleagues 
retrospectively studied 149 asymptomatic patients (age range 32–75 
years, 61% men) who underwent two consecutive EBCT examinations for 
CACS evaluation at least 12 months apart.65 Patients treated with HMG-
CoA reductase inhibitors with a final low-density lipoprotein cholesterol 
level of less than 120 mg/dl had a significant reduction in CACS (mean 
change −7±23%; p = 0.01) whereas a significant increase in CACS 
(mean change +25±22%, p <0.001) was observed in treated patients 
with a final low-density lipoprotein cholesterol level of at least 120 mg/dl. 
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An even larger increase in CACS was observed in untreated patients who 
had a final low-density lipoprotein cholesterol level of at least 120 mg/dl; 
in these subjects, a mean change of +52±36% in CACS was observed at 
follow-up (p <0.001). 
Similar results were observed by Budoff et al.66 and Achenbach et al.67 
Budoff et al.66 studied 299 asymptomatic subjects (mean age 58±10 
years, 76% men) who underwent baseline EBCT for CACS evaluation and 
follow-up assessment after a minimum of 12 months. The observed mean 
change in CACS in the study population was 33.2±9.2% per year. The 
increase in CACS among patients receiving statin therapy was significantly 
lower, as compared to nontreated patients (15±8% per year vs. 
39±12% per year; p <0.001) (Figure 4). 
 
 
Figure 4. Effect of statin therapy on the progression of coronary calcifications in 
299 asymptomatic subjects with high cholesterol levels. The progression of 
coronary calcifications in the study population was 33.2±9.2% per year (right). 
The progression of coronary calcifications among patients receiving statins (left) 
was significantly lower, as compared to nontreated patients (middle). From Budoff 
et al.66 with permission. 
 
Achenbach et al.67 studied 66 asymptomatic subjects with low-density 
lipoprotein cholesterol level higher than 130 mg/dl, no lipid-lowering 
treatment and a prior EBCT scan with evidence of coronary calcium (CACS 
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≥20). A second EBCT scan was performed after a mean interval of 14 
months (untreated period) and a third EBCT scan was repeated after 12 
months of therapy with cerivastatin (treatment period). During the 
untreated period, the median annual relative increase in CACS was 
significantly higher (25%) as compared to the median annual relative 
increase in CACS during the treatment period (8.8%, p <0.001). 
Assessment of CACS progression during statin treatment may be also 
useful to improve the identification of patients at risk of future CAD 
events. Raggi and colleagues [68] studied 495 asymptomatic subjects 
(57±8 years) in whom an initial EBCT study had revealed evidence of 
coronary calcium (CACS ≥30). After the baseline EBCT study, statin 
therapy was started and, after a mean interval of 1.9±1 years, the EBCT 
examination was repeated. During a mean follow-up of 3.2±0.7 years, 
AMI was observed in 41 patients. Interestingly, CACS progression was 
significantly higher among patients experiencing AMI as compared to 
event-free subjects (42±23% per year vs. 17±25% per year; p <0.001). 
At multivariate analysis, besides CACS at follow-up, CACS progression 
>15% per year was the most powerful predictor of future AMI (p 
<0.001). 
However, more recent randomized trials failed to confirm these 
preliminary results. In particular, the St. Francis Heart Study failed to 
demonstrate that atorvastatin 20 mg daily (together with vitamin C 1 g 
daily, and vitamin E 1000 U daily) was able to reduce the progression of 
coronary calcifications in 1005 asymptomatic subjects.45 Similarly, the 
BELLES study showed that intensive statin therapy (i.e., atorvastatin 80 
mg daily) compared to moderate statin therapy (i.e., pravastatin 40 mg 
daily) did not reduce the progression of coronary calcifications in 615 
hyperlipidemic, postmenopausal women.69 Consequently, on the basis of 
these contradictory data, serial CACS scanning to evaluate the efficacy of 
treatment with lipid-lowering drugs and the progression of coronary 
calcification cannot be currently advised. 
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LIMITATIONS OF CALCIUM SCORING 
 
Despite the large amount of data supporting its value as noninvasive 
marker of coronary atherosclerosis and its clinical utility, some limitations 
of CACS assessment need to be acknowledged. CACS assessment does 
not provide information on the degree of coronary stenosis. Previous 
studies showed that the specificity for obstructive CAD is about 40%.70 
Accordingly, in symptomatic patients, in whom the clinical goal is to 
determine the cause of symptoms and thus assess the presence of 
lesions potentially requiring revascularization, the value of CACS 
assessment may be limited. Moreover, CACS assessment only visualizes 
calcified plaques, and consequently patients with exclusively noncalcified 
plaques are not identified. This issue appears to be relevant especially in 
the setting of diabetes mellitus and (acute) chest pain syndromes.71–75 
Scholte et al.71 for instance, using MSCT coronary angiography, showed 
that in asymptomatic patients with type 2 diabetes a nonnegligible 
proportion of coronary plaques (41%) are noncalcified. Among patients 
with acute and long-term chest pain syndrome, Rubinshtein and 
colleagues showed that a low or zero CACS was not able to exclude the 
presence of obstructive CAD.72 Use of MSCT coronary angiography 
revealed single-vessel CAD in all patients with zero CACS, while 
multivessel CAD was identified in 50% of patients with low CACS (defined 
as CACS <100).72 More recently, Gottlieb et al.75 observed that a 
nonnegligible proportion (19%) of patients with zero CACS clinically 
referred for conventional angiography had indeed ≥1 obstructive coronary 
lesion; of note, 12.5% of patients with zero CACS underwent coronary 
revascularization within 30 days. Similar results were reported by 
Henneman et al.73 and Marwan et al.74 In these studies, a high prevalence 
of obstructive CAD in the absence of coronary calcifications was observed 
among patients with acute coronary syndromes. 
 




Figure 5. Panel A. Coronary artery calcium score (CACS) has a significant 
incremental prognostic value (depicted by χ2 value on the y-axis) over age and 
gender (#). Obstructive CAD (50% stenosis) on multislice computed tomography 
coronary angiography (MSCTA) and plaque burden (i.e., number of diseased 
segments or segments with obstructive CAD on MSCTA) have a further 
incremental prognostic value over age, gender, and CACS (*). Panel B. CACS has 
a significant incremental prognostic value (depicted by χ2 value on the y-axis) 
over age and gender (#). MSCTA plaque composition has a further incremental 
prognostic value over age, gender, and CACS (*). Adapted from van Werkhoven et 
al.76 with permission. 
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On the basis of these data, noninvasive assessment of coronary 
atherosclerosis by means of MSCT coronary angiography may further 
improve identification of high-risk patients. Recently, van Werkhoven et 
al.76 demonstrated indeed that evidence of obstructive CAD as well as the 
number of diseased segments, obstructive segments, and noncalcified 
plaques at MSCT coronary angiography have significant incremental 





A large amount of data supports the use of CACS assessment to improve 
risk stratification as compared to conventional risk assessment. CACS 
may be particularly valuable in asymptomatic individuals at intermediate 
risk. In these patients, the information provided by CACS assessment 
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Background. Non-invasive assessment of subclinical atherosclerosis by 
means of coronary artery calcium scoring (CACS) and multi-slice 
computed tomography (MSCT) coronary angiography could improve 
patients’ risk stratification. However, data relating observations on 
CACS and MSCT coronary angiography to traditional risk assessment are 
scarce. 
Methods and Results. In 314 consecutive outpatients (54±13 years, 
56% males) without known CAD, CACS and 64-slice MSCT coronary 
angiography were performed. According to the Framingham risk score 
(FRS), 51% of patients were at low, 24% at intermediate and 25% at high 
risk, respectively. MSCT angiograms showing atherosclerosis were 
classified as showing obstructive (≥50% luminal narrowing) CAD or not. 
Both CACS and MSCT coronary angiography showed a high prevalence of 
normal coronary arteries in low FRS patients (70% and 61%, 
respectively). An increase in the prevalence of CACS >400 (4% low vs 
19% intermediate vs 36% high), CAD (39% low vs 79% intermediate vs 
91% high), and obstructive CAD (15% low vs 43% intermediate vs 58% 
high) was observed across the FRS categories (p <0.0001 for all 
comparisons). 
Conclusions. A strong positive relationship exists between FRS and the 
prevalence and extent of atherosclerosis. Especially in intermediate FRS 
patients, CACS and MSCT coronary angiography provide useful 
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Identification of patients at risk of developing coronary artery disease 
(CAD) events is one of the most challenging issues in clinical cardiology. 
For this purpose, several scoring tools that take demographic and clinical 
characteristics into account have been developed. These tools allow 
stratification of patients into low-, intermediate-, and high-risk categories, 
in order to determine the intensity of risk-modifying interventions.1-3 
Among them, the Framingham risk score (FRS) is one of the most 
frequently used;1,4 it considers traditional risk factors (age, gender, 
diabetes mellitus, systolic blood pressure, total cholesterol and HDL 
cholesterol level, and smoking history) to predict the 10-year risk of hard 
CAD events. However, traditional risk assessment may still fail to identify 
a considerable proportion of patients with future CAD events, since it 
provides a statistical probability of having CAD rather than a direct 
individual assessment.5 Indeed, it has been observed that as much as 20% 
of CAD events can occur in the absence of major cardiovascular risk 
factors.6 
To improve risk stratification, direct visualization of subclinical 
atherosclerosis has been advocated. Indeed, previous studies have shown 
that non-invasive assessment of the coronary artery calcium score 
(CACS), by means of electron-beam computed tomography (EBCT) or 
multi-slice computed tomography (MSCT) provides prognostic 
information that is incremental to traditional risk stratification.7 Recently, 
more detailed visualization of the coronary arteries has become possible 
with the introduction of MSCT coronary angiography.8-10 Possibly, MSCT 
coronary angiography could also improve patients’ risk stratification 
similar to CACS. However, data relating observations on CACS and MSCT 
coronary angiography to traditional risk assessment are scarce. Aim of 
the present study therefore was to evaluate the prevalence of CAD 
across the FRS categories using CACS and MSCT coronary angiography. In 
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addition, differences in CACS and MSCT coronary angiography findings 





The study population consisted of 314 consecutive outpatients clinically 
referred to MSCT for coronary evaluation, due to an increased risk profile 
and/or stable chest pain complaints. Patients with typical angina, known 
history of CAD and/or contraindications to MSCT were not included in the 
study, as well as patients who were not in sinus rhythm during the MSCT 
examination. History of CAD was defined as the presence of previous 
acute coronary syndrome, percutaneous or surgical coronary 
revascularization, and/or one or more angiographically documented 
coronary artery stenosis ≥50% luminal diameter.11 Contraindications for 
MSCT were: (1) known allergy to iodinated contrast agent, (2) renal 
failure (defined as glomerular filtration rate <30 ml/min), and (3) 
pregnancy. 
For each patient, the presence of coronary risk factors (diabetes mellitus, 
systemic hypertension, hypercholesterolemia, positive family history, 
cigarette smoking, and obesity) and the presence of chest pain 
complaints (atypical angina and non-cardiac chest pain), both defined in 
accordance to previously published guidelines,4,12-15 were recorded. The 
Framingham 10-year risk of hard CAD events was also calculated as 
previously described in the National Cholesterol Education Program’s 
Adult Treatment Panel III report.4 In accordance with the FRS, the study 
population was then categorized as at low (<10%), intermediate (10-
20%), and high risk (>20%).4 In addition, patients were further divided as 
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MSCT Data Acquisition 
MSCT coronary angiography was performed with a 64-slice MSCT scanner 
(Aquilion 64, Toshiba Medical Systems, Japan). The heart rate and blood 
pressure were monitored before the examination in each patient. In the 
absence of contraindications, patients with a heart rate ≥65 beats/minute 
were administered oral ß-blockers (metoprolol, 50 or 100 mg, single dose, 
1 hour before the examination). 
First, a prospective coronary calcium scan without contrast was 
performed, followed by 64-slice MSCT coronary angiography, performed 
according to protocols previously described.16 Data were subsequently 
transferred to dedicated workstations for post-processing and evaluation 
(Advantage, GE Healthcare, USA and Vitrea 2, Vital Images, USA). 
 
MSCT Data Analysis 
The MSCT data analysis was performed by two experienced observers 
who had no knowledge of the patient’s medical history and symptom 
status; disagreement was solved by consensus or evaluation by a third 
observer. 
 
Coronary artery calcium score 
Coronary artery calcium was identified as a dense area in the coronary 
artery >130 Hounsfield units. A total CACS was recorded for each patient. 
In accordance with the value of total CACS, patients were subsequently 
categorized as having no calcium (total score = 0) or low (total score = 1-
100), moderate (total score = 101-400), and severe (total score > 400) 
CACS.17 
 
MSCT coronary angiography 
MSCT coronary angiograms were evaluated for the presence of 
obstructive CAD (≥50% luminal narrowing) on a patient and vessel level. 
For this purpose, both the original axial dataset as well as curved multi-
planar reconstructions were used. Each vessel was evaluated for the 
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presence of any atherosclerotic plaque, defined as structures >1 mm² 
within and/or adjacent to the coronary artery lumen, which could be 
clearly distinguished from the vessel lumen and the surrounding 
pericardial tissue, as described previously.9 Subsequently, the vessels 
were further classified as 1. completely normal, 2. having non-obstructive 
CAD when atherosclerotic lesions <50% of luminal diameter were present, 
or 3. having obstructive CAD when atherosclerotic lesions ≥50% of 
luminal diameter were present. 
The prevalence of CAD (including obstructive and non-obstructive CAD), 
obstructive CAD, the presence of obstructive CAD in one vessel (single-
vessel disease) or two or three vessels (multi-vessel disease), and 
location in the left main (LM) and/or proximal left anterior descending 
(LAD) coronary artery were evaluated. Multi-vessel disease and LM and/or 
proximal LAD disease were considered to represent high-risk features. 
 
Statistical Analysis 
Continuous variables are expressed as mean (standard deviation) or as 
median (25th to 75th percentile range), when not normally distributed. 
Categorical variables are expressed as absolute numbers (percentages). 
The differences in continuous variables were assessed using the Student t 
test when normally distributed and the Mann-Whitney test when not 
normally distributed. Chi-square test for greater than two-by-two and 
Fisher exact for two-by-two contingency tables were computed to test 
for differences in categorical variables. A P value <0.05 was considered 
statistically significant. Statistical analyses were performed using SPSS 





Baseline characteristics of the study population are shown in Table 1. The 
mean age was 54±13 years, and 177 (56%) patients were male. A total 
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of 152 (48%) patients were asymptomatic, while 82 (26%) patients had 
history of atypical angina and 80 (26%) patients had a history of non-
cardiac chest pain. The FRS was low, intermediate, and high, respectively, 
in 159 (51%), 77 (24%), and 78 (25%) patients. 
 
MSCT Calcium Scoring and Coronary Angiography 
Table 2 and Figures 1 and 2 depict the results of calcium scoring and 
MSCT coronary angiography in the overall population and among 
asymptomatic and symptomatic patients. 
 
Table 1. Baseline characteristics of the study population 
Variable n = 314 
Age (years) 54±13 
Gender (male/female) 177/137 
Diabetes mellitus 69 (22%) 
Hypertension 
- Systolic blood pressure (mmHg) 





- Total cholesterol (mmol/l) 




Family history of coronary artery disease 123 (39%) 
Smoking history 88 (28%) 
Overweight 
Obesity 




≥ 3 risk factors 84 (27%) 
Chest pain complaints 
- Asymptomatic 
- Atypical angina 













Data are expressed as means±SD and n (%). 
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Data are expressed as median (25th to 75th percentile range), and n (%).  P = ns for all 
comparisons between asymptomatic vs. symptomatic subjects. CAD: coronary artery 
disease. 
 
Coronary artery calcium score 
As shown in Table 2, the median CACS was 1 (25th to 75th percentile 
range 0-159). No calcium was observed in 157 (50%), while CACS was 
low in 63 (20%) patients, moderate in 44 (14%), and severe in 50 (16%) 
patients. 
The median CACS did not differ between asymptomatic and symptomatic 
patients and the prevalence of no calcium and minimal, mild, moderate, 
and severe coronary calcifications was not statistically different between 
the two groups (Table 2). 
Relationship between CACS and FRS. As shown in Figure 1A, calcium was 
absent in 112 (70%) patients with low FRS, 26 (34%) patients with 
intermediate FRS, and in 19 (24%) patients with high FRS. Overall, a 
decrease in the prevalence of CACS zero and an increase in the 
prevalence of severe CACS were observed in line with increasing FRS 
(Figure 1A). However, among all three FRS categories still a significant 
proportion of patients presented with low and moderate CACS. 
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As shown in Figure 1B and C, this positive relationship between FRS and 





Figure 1. Relationship between CACS and Framingham 10-year risk of hard 
coronary heart disease events in the overall population (panel A), among 
asymptomatic patients (panel B), and among symptomatic patients (panel C). 
The proportion of patients with no calcium, low CACS, intermediate CACS, and 
severe CACS differed significantly across the three FRS categories. CACS: 
Coronary artery calcium score; FRS: Framingham risk score. 
 
MSCT coronary angiography 
As shown in Table 2, 120 (38%) patients were classified as having no 
CAD based on MSCT. A total of 92 (29%) patients showed non-
obstructive CAD, whereas at least one significant (≥50% luminal 
narrowing) stenosis was observed in the remaining 102 (33%) patients. 
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Obstructive single-vessel disease was present in 54 (17%) patients, 
whereas multi-vessel disease was noted in 48 (15%) patients. 
Obstructive CAD in the LM and/or proximal LAD was present in 37 (12%) 
patients, of which 24 also showed multi-vessel disease. Accordingly, 61 
(19%) patients were identified as having high-risk features. 
No difference in the prevalence of no CAD, and non-obstructive and 
obstructive CAD was observed between asymptomatic and symptomatic 




Figure 2. Relationship between MSCT coronary angiography and Framingham 
10-year risk of hard coronary heart disease events in the overall population 
(panel A), among asymptomatic patients (panel B), and among symptomatic 
patients (panel C). The proportion of patients with normal coronary arteries, 
non-obstructive CAD, and obstructive CAD differed significantly across the three 
FRS categories. CAD: Coronary artery disease; FRS: Framingham risk score. 
 
Relationship between MSCT coronary angiography results and FRS. As 
shown in Figure 2A, normal coronary arteries were observed in 97 (61%) 
patients with low FRS, 16 (21%) patients with intermediate FRS, and 7 
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(9%) patient with high FRS. Overall, a decrease in the prevalence of 
normal coronary arteries and an increase in the prevalence of obstructive 
CAD were observed in line with increasing FRS (Figure 2A). Moreover, an 
increase in the prevalence of high-risk features was observed across the 
FRS categories (13 (8%) patients in the low FRS versus 21 (27%) in the 
intermediate FRS versus 27 (35%) in the high FRS; p <0.0001). 
Nevertheless, a significant proportion of patients with non-obstructive 
CAD was present in each category. 
As shown in Figure 2B and C, this positive relationship between FRS and 





The present study describes the prevalence and extent of CAD, assessed 
by means of both CACS and MSCT coronary angiography, across the FRS 
categories in a large cohort of patients. Both CACS and MSCT coronary 
angiography showed a high prevalence of normal coronary arteries in low 
FRS patients (70% and 61%, respectively), which decreased in patients 
with intermediate and high FRS. Similarly, an increase in the prevalence of 
high CACS and obstructive or even high-risk CAD were observed with 
increasing FRS. However, moderate calcium on CACS as well as non-
obstructive CAD on MSCT coronary angiography were identified across all 
FRS categories. 
In line with the current observations, an overall increase in the prevalence 
and extent of atherosclerosis in relation to FRS has been reported in 
several previous studies.18-21 At the same time, these studies have also 
highlighted a discrepancy between the presence of traditional risk factors 
and the presence of subclinical atherosclerosis: substantial 
atherosclerosis was frequently observed in patients at low to 
intermediate risk, while being absent in patients deemed at high risk. Also 
in the current study, atherosclerosis was identified across all FRS 
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categories. These observations have led to the notion that (selective) 
atherosclerosis imaging may provide valuable information in addition to 
traditional risk assessment. Indeed, several large clinical trials have 
demonstrated that CACS has incremental value over risk factors.7,22,23 In a 
large cohort of 1461 asymptomatic individuals, Greenland et al.7 
demonstrated that knowledge of a high CACS resulted in superior risk 
stratification as compared to FRS alone. Other investigations have 
reported similar observations.22,23 Accordingly, addition of an 
atherosclerosis marker such as CACS can significantly modify initially 
predicted risk and can alter clinical decision-making and subsequent 
therapy/patients management. Knowledge of subclinical atherosclerosis 
may be of particular value in patients at intermediate risk. In these 
patients, who represent a substantial part of the population, clinical 
management is frequently uncertain. In the present study, evaluation by 
means of MSCT showed that coronary calcium was absent in 34% of 
patients. In contrast, a CACS exceeding 100 was observed in 45% of 
patients. Similarly, MSCT coronary angiography showed normal coronary 
arteries in 21%, whereas obstructive disease was noted in 43% of 
patients. Moreover, high-risk features were identified in 27%. Accordingly, 
these observations indicate that underlying atherosclerosis can be 
identified (but also ruled out) in a substantial proportion of patients at 
intermediate FRS. Possibly, refinement of risk using atherosclerosis 
imaging may allow more appropriate targeting of preventive measures in 
these patients. Indeed, the current American College of Cardiology 
appropriateness criteria for cardiac computed tomography suggest that 
assessment of calcium may be a “reasonable approach” among 
intermediate FRS patients, although substantial uncertainty remains 
regarding its general applicability.24 
In low risk patients, the use of imaging remains controversial. In general, 
the prevalence of abnormal coronary arteries will be low. Indeed, in the 
present study, the prevalence of normal coronary arteries was high both 
on CACS and MSCT coronary angiography. Also, prognostic studies 
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addressing CACS in relation to FRS observed that CACS had no additive 
value in patients with a FRS <10%.7 Still, recent data suggest that 
perhaps in certain subsets of individuals deemed at low risk by FRS, such 
as women younger than 70 years old, CACS may identify higher risk in a 
considerable proportion.25,26 Nevertheless, more data are needed before 
evaluation of atherosclerosis can be recommended in patients with low 
FRS. 
In patients with high FRS on the other hand, the incremental value of 
atherosclerosis imaging remains debatable as well. In line with previous 
investigations, we observed a high prevalence of coronary calcium (76%). 
Moreover, the prevalence of abnormal coronary arteries on MSCT 
coronary angiography was even higher, 91%. Finally, a high prevalence of 
high-risk features was noted on MSCT coronary angiography as well 
(35%). Indeed, in this group of patients, the presence of high risk has 
already been established and these patients should receive targeted anti-
atherosclerotic measures regardless of imaging results. In this context, 
assessment with MSCT coronary angiography may be favored over CACS 
as the former may provide a superior estimate of total plaque burden. 
Moreover, another advantage of MSCT coronary angiography could be the 
fact that it allows identification of high-risk features such as left main or 
multi-vessel disease. Possibly, these patients may benefit from even more 
aggressive measures, including revascularization, although supporting 
data in asymptomatic patients are scarce. 
It is important to realize that thus far, the majority of data relating 
coronary atherosclerosis to FRS have been obtained using CACS with 
EBCT and data relating MSCT coronary angiography to clinical 
characteristics are scarce. Moreover, MSCT coronary angiography has 
mainly been applied in high-risk symptomatic patients in order to 
determine its value in the diagnosis of CAD rather than in risk assessment. 
As a result, only few data are available concerning its prognostic 
value.27,28 Preliminary studies however suggest that MSCT coronary 
angiography may provide prognostic information incremental to baseline 
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risk stratification,29 although no systematic comparisons to FRS are 
currently available. In addition, no studies are available that evaluate the 
relative merits of CACS and MSCT coronary angiography with regard to 
risk stratification. Importantly, efficacy in improving patient outcome 
remains to be confirmed for both techniques. 
The present study has some limitations that should be acknowledged. 
First, it is a single center experience with a relatively low sample size as 
compared to previous studies relating CACS to FRS. However, it is also 
one of the first relating both CACS and MSCT coronary angiography to 
FRS in patients without symptoms typical for CAD. Unfortunately, no 
follow-up data were available. Future studies should address whether 
MSCT coronary angiography may allow re-stratification of risk similar or 
even superior to CACS. Second, the FRS was developed in, and should be 
applied to, asymptomatic individuals only; however, due to the radiation 
exposure associated with MSCT coronary angiography, and the lack of 
evidence in this setting, use in truly asymptomatic patients cannot be 
recommended at present. This limitation could be overcome by more 
extensive implementation of dose-saving algorithms, which are likely to 





A strong positive relationship exists between FRS and the prevalence and 
extent atherosclerosis on CACS and MSCT coronary angiography. Both 
techniques showed a high prevalence of normal coronary arteries in low 
FRS patients versus a low prevalence in high FRS patients. In intermediate 
FRS patients, however, CACS and MSCT coronary angiography may 
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Noninvasive assessment of subclinical atherosclerosis by multislice 
computed tomographic (MSCT) coronary angiography and demonstration 
of significant, flow-limiting coronary artery disease (CAD) by stress 
testing may improve patients' risk stratification. However, data relating 
the complementary information provided by these noninvasive techniques 
to traditional risk assessment are scarce. In 255 subjects (45% women, 
mean age 54±12 years) without known CAD, 64-slice MSCT coronary 
angiography and stress testing (exercise electrocardiographic test or 
myocardial perfusion imaging) were performed. Framingham risk score 
(FRS) was calculated from baseline characteristics (50% low, 22% 
intermediate, 28% high). Angiograms showing atherosclerosis were 
classified as obstructive (≥50% luminal narrowing) CAD or not. Stress 
tests were classified as normal or abnormal. Multislice computed 
tomogram identified 155 patients (61%) with CAD, of whom 78 (31%) 
showed obstructive CAD. A positive stress test result was observed in 36 
patients (46%) with obstructive CAD. In line with increasing FRS 
categories, a significant increase in the prevalence of functionally relevant 
obstructive CAD was observed (6% low vs 45% intermediate vs 63% 
high, p <0.001). In conclusion, a strong positive relation exists between 
FRS and prevalence of functionally relevant obstructive CAD. Selective 
use of MSCT coronary angiography and stress testing may refine the 
traditional risk assessment of CAD events, especially in patients deemed 








Relation	  Between	  Framingham	  Risk	  Categories	  and	  the	  Presence	  of	  Functionally	  
Relevant	  Coronary	  Lesions	  as	  Determined	  on	  Multislice	  Computed	  Tomography	  




Recently, coronary artery calcium score (CACS) and multislice computed 
tomographic (MSCT) coronary angiography have emerged as useful 
techniques for the noninvasive direct visualization of coronary 
atherosclerosis.1 Their use in selected patients has been suggested to be 
of potential utility to improve the traditional risk assessment of coronary 
artery disease (CAD) events.2-5 However, these imaging techniques, 
despite providing meaningful information about the presence and extent 
of coronary atherosclerosis, do not provide information about the 
functional relevance of the observed coronary lesions.6-8 This issue 
appears significant, considering that a large proportion of patients with 
abnormal CACS or MSCT coronary angiogram has a normal stress test 
result and thus do not require further invasive imaging.6,7 Indeed, a better 
understanding of the complementary information provided by these 
noninvasive methods (imaging of coronary atherosclerosis vs evidence of 
inducible ischemia), especially in relation to traditional risk assessment, is 
needed to define an optimal strategy for patients' risk assessment. The 
aim of the present study therefore was to evaluate the relation between 
evidence of coronary atherosclerosis (by CACS and MSCT coronary 
angiography) and presence of abnormal stress testing result across 




Two hundred fifty-five consecutive outpatients clinically referred to 
multislice computed tomography for coronary evaluation were included in 
the study. In addition, patients underwent stress testing 
(electrocardiographic exercise test [EET] or myocardial perfusion 
imaging) within 1 month of MSCT coronary angiography. The patient 
population is part of an ongoing study protocol addressing the value of 
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multislice computed tomography and other imaging techniques compared 
to traditional risk assessment. From this prospective registry, results 
addressing the relation between CACS and MSCT coronary angiographic 
data across FRS categories have been recently published.5 
Patients with typical angina, known history of CAD, and/or 
contraindications to multislice computed tomography were not included in 
the study, as were patients who were not in sinus rhythm before MSCT 
examination. History of CAD was defined as the presence of previous 
acute coronary syndrome, percutaneous or surgical coronary 
revascularization, and/or ≥1 angiographically documented coronary artery 
stenosis ≥50% luminal diameter.7 Contraindications for multislice 
computed tomography were (1) known allergy to iodinated contrast 
agent, (2) renal failure (defined as glomerular filtration rate <30 ml/min), 
and (3) pregnancy. 
For each patient, the presence of coronary risk factors (diabetes mellitus, 
systemic hypertension, hypercholesterolemia, positive family history, 
cigarette smoking, and obesity) and the presence of chest pain 
complaints (atypical angina and noncardiac chest pain), defined in 
accordance to previously published guidelines,9-13 were recorded. The 
Framingham 10-year risk of hard CAD events was also calculated as 
previously described in the National Cholesterol Education Program's 
Adult Treatment Panel III report.11 In accordance to the FRS, the study 
population was then categorized as at low (<10%), intermediate (10% to 
20%), and high (>20%) risk.11 
MSCT coronary angiography was performed with a 64-slice MSCT scanner 
(Aquilion 64, Toshiba Medical Systems, Tokyo, Japan). Heart rate and 
blood pressure were monitored before the examination in each patient. In 
the absence of contraindications, patients with a heart rate ≥65 
beats/min were administered oral β blockers (metoprolol 50 or 100 mg, 
single dose, 1 hour before the examination). 
First, a prospective coronary calcium scan without contrast was 
performed, followed by 64-slice MSCT coronary angiography, performed 
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according to protocols previously described.14 Data were subsequently 
transferred to dedicated workstations for postprocessing and evaluation 
(Advantage, GE Healthcare, Milwaukee, Wisconsin; Vitrea 2, Vital Images, 
Minnetonka, Minnesota). 
MSCT data analysis was performed by 2 experienced observers who had 
no knowledge of a patient's medical history and symptom status; 
disagreement was solved by consensus or evaluation by a third observer. 
CAC was identified as a dense area in the coronary artery >130 HU. A 
total CACS was recorded for each patient. In accordance to the value of 
total CACSs, patients were subsequently categorized as having no 
calcium (total score 0) or a low (total score 1 to 100), moderate (total 
score 101 to 400), or severe (total score >400) CACS.15 
MSCT coronary angiograms were evaluated for the presence of 
obstructive CAD (≥50% luminal narrowing) on a patient and vessel level. 
For this purpose, the original axial dataset and curved multiplanar 
reconstructions were used. Each vessel was evaluated for the presence of 
any atherosclerotic plaque, defined as structures >1 mm2 within and/or 
adjacent to the coronary artery lumen, which could be clearly 
distinguished from the vessel lumen and the surrounding pericardial 
tissue, as described previously.16 Subsequently, the vessels were further 
classified as (1) completely normal, (2) having nonobstructive CAD when 
atherosclerotic lesions <50% of luminal diameter were present, or (3) 
having obstructive CAD when atherosclerotic lesions ≥50% of luminal 
diameter were present. Prevalences of CAD (including obstructive and 
nonobstructive CAD) and obstructive CAD were evaluated. 
Symptom-limited EET was performed on a bicycle ergometer according to 
standard protocols.17 Patients not able to reach ≥85% of age-predicted 
maximum heart rate in the absence of ischemic changes were not 
included in the study. Tests were classified as positive or negative for 
ischemia. The test was considered positive based on the presence of 
≥0.1-mV horizontal or downsloping ST-segment depression at 80 ms 
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after the J point in 2 contiguous leads during exercise or recovery. All 
tests were analyzed by an experienced reader without knowledge of the 
MSCT results. 
Myocardial perfusion imaging during stress and at rest was performed 
with symptom-limited bicycle exercise or pharmacologic (adenosine or 
dobutamine) stress using technetium-99m tetrofosmin or technetium-
99m sestamibi. Images were acquired on a triple-head (GCA 9300/HG, 
Toshiba Corp., Tokyo, Japan) single-photon emission computed 
tomographic camera and reconstructed into long- and short-axis 
projections perpendicular to the heart axis. Perfusion defects were 
identified on stress images (segmental tracer activity <75% of maximum) 
and divided into ischemia (reversible defects, with ≥10% increase in 
tracer uptake on images at rest) or scar tissue (irreversible defects). 
Accordingly, examinations were classified as negative or positive. Positive 
examinations were further divided into those demonstrating reversible 
defects and those demonstrating fixed defects. Gated images were used 
to assess regional wall motion to improve differentiation between 
perfusion abnormalities and attenuation artifacts.18 
Continuous variables are expressed as mean±SD or median (25th to 75th 
percentile range), when not normally distributed. Categorical variables are 
expressed as absolute numbers (percentages). Differences in categorical 
variables were assessed using chi-square test. A p value <0.05 was 
considered statistically significant. Statistical analyses were performed 




Baseline characteristics of the study population are listed in Table 1. 
Table 2 presents the results of calcium scoring and MSCT coronary 
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Table 1. Baseline characteristics of the study population 
Variable n = 255 
Age (years) 54±12 
Male/female 140/115 
Diabetes mellitus 65 (25%) 
Hypertension 
- Systolic blood pressure (mmHg) 





- Total cholesterol (mg/dl) 




Family history of coronary artery disease 103 (40%) 
Smoke 80 (31%) 
Obesity 
- Body mass index (kg/m²) 
53 (21%) 
27±5 
≥ 3 risk factors 78 (31%) 
Chest pain complaints 
- Asymptomatic 
- Atypical angina pectoris 













Data are expressed as means±SD and n (%). 
 
Based on calcium scoring, coronary calcifications were found in 37 
patients (29%) with a low FRS, 34 patients (61%) with an intermediate 
FRS, and 53 patients (74%) with a high FRS. Based on MSCT coronary 
angiogram, normal coronary arteries were found in 79 patients (62%) 
with a low FRS, 14 patients (25%) with an intermediate FRS, and 7 
patients (10%) with a high FRS. Obstructive CAD was found in 17 
patients (13%) with a low FRS, 20 patients (36%) with an intermediate 
FRS, and 41 patients (57%) with a high FRS. Table 3 lists stress testing 
results. Positive stress test results were observed in 5 patients (4%) with 
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a low FRS, 16 patients (29%) with an intermediate FRS, and 36 patients 
(50%) with a high FRS. 
 
Table 2. Results of coronary artery calcium scoring and multi-slice computed tomography 
coronary angiography in the study population (n = 255) 
Coronary artery calcium score  
- Score 
- Zero  
- Low (total score = 1-100) 
- Moderate (total score = 101-400) 






MSCT coronary angiography  
- Normal coronary arteries 
- Non-obstructive CAD (<50% luminal diameter narrowing) 




Data are expressed as median (25th to 75th percentile range), and n (%).  
 
Table 3. Results of stress testing in the study population (n = 255) 
Type of stress test  
- Electrocardiographic exercise test 
- Myocardial perfusion imaging 
47 (18%) 
208 (82%) 
Electrocardiographic exercise test  
Mean peak double product 27702±8231 
Mean peak workload (Watt) 196±57 
Ischemic ST-segment depression 3 (6%) 
Myocardial perfusion imaging  
- Symptom-limited bicycle exercise * 80 (38%) 
- Pharmacologic stress (adenosine or dobutamine) 128 (62%) 
- Stress and rest normal perfusion 
- Reversible perfusion defect 
- Fixed perfusion defect 










*: In all these patients, ≥85% of maximum age-predicted heart rate was achieved if no 
stress-induced symptoms or changes in electrocardiogram or blood pressure occurred. Data 
are expressed as means±SD, and n (%). 
Relation	  Between	  Framingham	  Risk	  Categories	  and	  the	  Presence	  of	  Functionally	  
Relevant	  Coronary	  Lesions	  as	  Determined	  on	  Multislice	  Computed	  Tomography	  
and	  Stress	  Testing	   77	  
	  
Prevalence of positive stress test results in patients with a CACS 0 was 
low (n = 14, 11%). Conversely, 43 patients (35%) with a CACS >0 had a 
positive stress test result; as shown in Figure 1, a significant increase in 
the prevalence of positive stress test results was observed in this group 
of patients in line with an increasing FRS. Prevalence of positive stress 
test results in patients with normal coronary arteries or nonobstructive 
CAD was low (n = 21, 12%). In patients with obstructive CAD, in contrast, 
a positive stress test result was observed in 36 (46%). As illustrated in 
Figure 2, a positive relation between prevalence of positive stress test 
results and FRS was observed in this group of patients and prevalence of 
positive stress test results increased from 6% in patients with a low FRS 




Figure 1. Relation between presence of CAC identified by MSCT calcium scan and 
stress test results in overall population and across FRS categories. 
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Figure 2. Relation between obstructive CAD identified by MSCT coronary 





The present study describes the prevalence of positive stress testing 
compared to evidence of coronary atherosclerosis (by CACS and MSCT 
coronary angiography) across FRS categories. A significant increase in the 
prevalence of functionally relevant coronary lesions was observed in line 
with an increasing FRS. In particular, abnormal stress test results were 
observed in 53% of high-risk patients with abnormal CACSs and 63% of 
high-risk patients with obstructive CAD on MSCT coronary angiogram. 
Previous studies have underlined the potential value of additional risk 
assessment with stress testing (EET or myocardial perfusion imaging) to 
improve the identification of patients at risk of CAD events. Gibbons et 
al,19 for instance, observed a significant relation between the prognostic 
information provided by an abnormal EET result in a large cohort of 
asymptomatic men and the number of coronary risk factors. More 
recently, Balady et al.20 showed that different EET variables (including 
ischemic ST-segment depression) provided incremental prognostic 
information over the FRS in asymptomatic men. The additional prognostic 
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value of EET has been confirmed by Cournot et al.21 in men and women 
with intermediate and high FRSs. 
Fewer data are available regarding the prognostic role of myocardial 
perfusion imaging in asymptomatic subjects.22 However, it has been 
suggested that myocardial perfusion imaging may be of incremental value 
especially in high-risk patients (i.e., diabetic patients or patients with 
multiple risk factors), taking into account the high prevalence of 
myocardial perfusion abnormalities despite the absence of symptoms in 
this group.23-25 
Direct visualization of subclinical atherosclerosis, by CACS or MSCT 
coronary angiography, also may possibly refine traditional risk 
assessment. Greenland et al,26 in a large cohort of asymptomatic 
subjects, demonstrated that a high CACS improved the risk stratification 
provided by FRS alone. More recently, Budoff et al.27 demonstrated, in a 
cohort of 25,253 asymptomatic patients, that CACS is an independent 
predictor of mortality, with significant incremental value over traditional 
coronary risk factors. A preliminary analysis by Choi et al.4 suggested also 
that MSCT coronary angiography may provide prognostic information 
incremental to baseline risk stratification. The ability of noninvasive 
coronary imaging techniques to obtain a direct estimate of total 
atherosclerotic plaque burden in coronary arteries likely explains these 
findings. Previous studies indeed have demonstrated that a non-negligible 
proportion of patients with high plaque burden with CACSs or on MSCT 
coronary angiogram are not identified as at high risk based on FRS 
categories.5,28,29 
Stress testing and noninvasive imaging of coronary arteries provide 
complementary information about CAD (i.e., evidence of myocardial 
ischemia and evidence of coronary atherosclerosis, respectively).6-8 The 2 
tests may be useful in refining the risk assessment strategy, but data 
showing how they relate each other in relation to FRS are still missing. 
Improved knowledge of the different information provided by stress 
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testing and noninvasive coronary imaging is needed to appropriately 
refine the risk assessment strategy. 
In the present study, in patients with a low FRS, the prevalence of an 
abnormal CACS (29%) and of coronary atherosclerosis on MSCT coronary 
angiogram (38%) was not negligible. In contrast, prevalence of an 
abnormal stress testing result (4%) was relatively lower. In addition, an 
abnormal CACS and obstructive CAD on MSCT coronary angiogram rarely 
resulted in abnormal findings on stress testing (5% and 6%, respectively). 
Considering the low prevalence of ischemia, use of stress testing seems 
to carry limited additional value for risk stratification. Conversely, use of 
atherosclerosis imaging may possibly provide some benefit, considering 
the non-negligible prevalence of coronary plaques in this group of 
patients. However, larger studies with long-term follow-up are needed to 
demonstrate that identification of atherosclerosis may result in improved 
treatment and outcome before noninvasive coronary atherosclerosis 
imaging can be recommended in patients with a low FRS. Currently, use of 
atherosclerosis imaging may be not justified in this group of patients due 
to the associated radiation exposure (in particular for MSCT coronary 
angiography). 
In patients with a high FRS, a high burden of coronary atherosclerosis and 
inducible myocardial ischemia were observed. However, in this group of 
patients, a high prevalence of coronary atherosclerosis is a priori 
anticipated and based on the high-risk profile; many patients will already 
have received medical therapy. Noninvasive coronary atherosclerosis 
imaging therefore is unlikely to further refine patients' risk assessment. 
Moreover, taking into account that a large proportion of patients with an 
abnormal CACS or obstructive CAD on MSCT coronary angiogram also 
showed an abnormal functional test result (53% and 63%, respectively), 
it seems reasonable to perform stress testing first, to establish or rule out 
the presence of flow-limiting stenoses. High-risk patients with evidence of 
inducible myocardial ischemia should then be referred to invasive 
coronary angiography and possibly may benefit from revascularization 
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Figure 3. Proposed integration of noninvasive imaging of coronary arteries and 
stress testing into traditional risk assessment of CAD events. MPI = myocardial 
perfusion imaging. 
 
In patients with an intermediate-risk profile, however, coronary 
atherosclerosis imaging may provide valuable information to refine risk 
stratification and determine further management. A non-negligible 
prevalence of coronary atherosclerosis (abnormal CACSs in 61% and 
abnormal MSCT coronary angiographic finding in 75%, including 
obstructive CAD in 36%) was observed in this population, whereas the 
prevalence of an abnormal stress test result (29%) was lower. In addition, 
comparison of coronary imaging data to stress testing data revealed that 
38% of patients with an abnormal CACS and 45% of patients with 
obstructive CAD on MSCT coronary angiogram had an abnormal stress 
test result. Accordingly, noninvasive imaging of coronary arteries seems 
to be a reasonable first-line approach to improve risk stratification of 
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intermediate-risk patients. Patients with an abnormal CACS or obstructive 
CAD on MSCT coronary angiogram should then be referred to stress 
testing, to establish or rule out the presence of inducible myocardial 
ischemia. 
A flow chart describing the proposed integration of noninvasive imaging 
of coronary arteries and stress testing into the traditional risk assessment 
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Background. Although atrial fibrillation (AF) has been linked to 
underlying coronary artery disease (CAD), data supporting this 
association have been based on ECG and clinical history for the definition 
of CAD rather than direct visualization of atherosclerosis. 
Methods and Results. The prevalence of CAD among patients with 
paroxysmal or persistent AF and without history of CAD was evaluated 
using multislice computed tomography. Multislice computed tomography 
was performed in 150 patients with AF (61±11 years, 67% males, 58% 
asymptomatic) with predominantly low (59%) or intermediate (25%) 
pretest likelihood of CAD. CAD was classified as obstructive (≥50% 
luminal narrowing) or not. A population of 148 patients without history of 
AF, similar to the AF group as to age, gender, symptomatic status, and 
pretest likelihood, served as a control group. Logistic regression analysis 
was applied to evaluate the relationship between demographic and clinical 
data and the presence of obstructive CAD. On the basis of multislice 
computed tomography, 18% of patients with AF were classified as having 
no CAD, whereas 41% showed nonobstructive CAD and the remaining 
41% had obstructive CAD. Among patients without AF, 32% were 
classified as having no CAD, whereas 41% showed nonobstructive CAD 
and 27% had obstructive CAD (p = 0.010 compared with patients with 
AF). At logistic regression analysis, age, male gender, and the presence of 
AF were significantly related to obstructive CAD. 
Conclusion. A higher prevalence of obstructive CAD was observed 
among patients with AF, confirming the hypothesis that AF could be a 
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Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, 
with an estimated prevalence of 0.4% to 1% in the general population.1 In 
addition, the mortality rate of patients with AF is almost double than that 
of patients in normal sinus rhythm. This observation has been attributed 
to an increased cardiac death rate due to underlying heart disease 2–5 
rather than to thromboembolism.6 
Coronary artery disease (CAD) is considered to be highly prevalent among 
patients with AF and may be one of its underlying causes.7 Furthermore, it 
has been suggested that AF may be the sole manifestation of CAD.8 
However, most data supporting this association have been derived from 
studies using the presence of ECG abnormalities and a history of ischemic 
heart disease to define CAD 4,9,10 rather than direct visualization of 
atherosclerosis. Thus far, only 2 cardiac imaging studies are available. In 
these investigations, stress myocardial perfusion single-photon emission 
computed tomography (SPECT) was applied to evaluate the prevalence of 
CAD in patients with AF.11,12 Abidov et al.11 showed a significantly higher 
prevalence of abnormal myocardial perfusion SPECT studies in patients 
with AF as compared with patients without AF. However, in this study 
patients with symptoms and known CAD were included while investigation 
of a strictly asymptomatic population, as performed by Askew et al,12 
failed to confirm this observation.  
Recently, multislice computed tomography (MSCT) has been introduced 
as an alternative cardiac imaging modality.13,14 This technique allows 
noninvasive direct visualization of the coronary arteries, including 
detection of coronary atherosclerosis by assessing the coronary artery 
calcium burden (calcium scoring) and by performing noninvasive 
angiography. Accordingly, this technique allows evaluation of CAD at an 
early stage. 
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The aim of the present study was to evaluate the prevalence of CAD, by 
means of MSCT, among patients with paroxysmal or persistent AF and 





The study population consisted of 150 patients from the outpatient clinic 
with a history of paroxysmal (n = 99, 66%) or persistent (n = 51, 34%) 
AF referred to MSCT for coronary evaluation, due to an elevated risk 
profile and/or chest pain. Patients with history of CAD and 
contraindications to MSCT were excluded, as well as patients who were 
not in sinus rhythm during MSCT examination. Paroxysmal and persistent 
AF were diagnosed according to the American Heart 
Association/American College of Cardiology/European Society of 
Cardiology criteria.1 Briefly, paroxysmal AF was defined as self-
terminating episodes of AF lasting ≤7 days whereas persistent AF was 
defined as episodes lasting >7 days, requiring pharmacological or electric 
cardioversion, respectively. Accordingly, no patient with permanent 
(defined as long-lasting) AF was included in the study; all the patients 
were in sinus rhythm during the MSCT examination.1 A history of CAD was 
defined as the presence of previous acute coronary syndrome, 
percutaneous or surgical coronary revascularization, and/or one or more 
angiographically documented coronary stenosis ≥50% luminal diameter.15 
Contraindications for MSCT were (1) known allergy to iodinated contrast 
agent, (2) renal failure, and (3) pregnancy. 
For each patient, the presence of coronary risk factors (diabetes mellitus, 
systemic hypertension, hypercholesterolemia, positive family history, and 
cigarette smoking) and symptoms was recorded. In addition, the 
prevalence of ≥3 coronary risk factors and the pretest likelihood of 
obstructive CAD was evaluated using the Diamond and Forrester’s 
criteria.16,17 
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Using the same exclusion criteria, a population of 148 patients from the 
outpatient clinic without a history of AF, similar to the AF group as to age, 
gender, chest pain complaints, and pretest likelihood of obstructive CAD, 
who underwent MSCT for coronary evaluation due to an elevated risk 
profile and/or chest pain, was identified from the clinical database to 
serve as a control group for comparison purposes. 
Patients were included at 4 centers in 3 different countries (Leiden 
University Medical Center, Leiden, the Netherlands; Medisch Centrum 
Haaglanden, Leidschendam, The Netherlands; Turku PET Center, Turku, 
Finland; University Hospital Zurich, Zurich, Switzerland). 
 
MSCT Data Acquisition 
MSCT coronary angiography was performed with 2 different 16-slice 
MSCT scanners (Aquilion 16, Toshiba Medical Systems, n = 39; and 
Discovery STE, GE Healthcare, n = 8) and 3 different 64-slice MSCT 
scanners (Aquilion 64, Toshiba Medical Systems, n = 202; LightSpeed 
VCT, GE Healthcare, n = 19; and Discovery VCT, GE Healthcare, n = 30). 
The heart rate and blood pressure were monitored before the examination 
in each patient. In the absence of contraindications, patients with a heart 
rate ≥65 bpm were administered β-blocking medication (50 to 100 mg 
metoprolol, oral or 5 to 10 mg metoprolol, intravenous). First, a 
prospective coronary calcium scan without contrast was performed, 
followed by 16- or 64-slice MSCT coronary angiography performed 
according to protocols described previously.13,18,19 Data were 
subsequently transferred to dedicated workstations for postprocessing 
and evaluation (Advantage, GE Healthcare; Vitrea 2, Vital Images; and 
Aquarius, TeraRecon). 
 
MSCT Data Analysis 
The MSCT data analysis was performed in each center by 2 experienced 
observers who had no knowledge of the patient’s medical history and 
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symptom status; disagreement was solved by consensus or evaluation by 
a third observer. Standardized MSCT data evaluation methodology and 
scoring system described later were used in each center. 
 
Coronary Artery Calcium Score 
Coronary artery calcium was identified as a dense area in the coronary 
artery >130 Hounsfield units. A total coronary artery calcium score was 
recorded for each patient. In accordance to the value of total calcium 
score, the study population was then categorized as having no calcium 
(total score = 0) or minimal (total score = 1 to 10), mild (total score = 11 
to 100), moderate (total score = 101 to 400), and severe (total score 
>400) coronary calcifications.20 
 
Coronary Angiography 
MSCT coronary angiograms obtained with 16- and 64-slice scanners were 
evaluated for the presence of obstructive CAD (≥50% luminal narrowing) 
on a patient, vessel, and segment level. For this purpose, both the original 
axial dataset and curved multiplanar reconstructions were used. Coronary 
segments were evaluated in accordance to the 17 segments American 
Heart Association classification.21 First, each segment was classified as 
interpretable or not. Then, the interpretable segments were evaluated for 
the presence of any atherosclerotic plaque, defined as structures >1 
mm2 within and/or adjacent to the coronary artery lumen, which could be 
clearly distinguished from the vessel lumen and the surrounding 
pericardial tissue, as described previously.22 One coronary plaque was 
assigned per coronary segment. Subsequently, segments were further 
classified as (1) completely normal, (2) having nonobstructive CAD when 
atherosclerotic lesions <50% of luminal diameter were present, or (3) 
having obstructive CAD when atherosclerotic lesions ≥50% of luminal 
diameter were present. 
The prevalence of CAD (including obstructive and nonobstructive CAD), 
obstructive CAD, the presence of obstructive CAD in 1 vessel (single-
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vessel disease) or 2 or 3 vessels (multivessel disease) and location in the 
left main (LM) and/or proximal left anterior descending (LAD) coronary 
artery were evaluated. In addition, the number of diseased coronary 
segments (segments containing plaques) and the number of coronary 
segments with obstructive as well as nonobstructive plaques were 
determined for each patient. 
 
Statistical Analysis 
Continuous variables are expressed as mean and standard deviation. 
Categorical variables are expressed as absolute numbers and 
percentages. 
The differences in continuous variables were assessed using the Student t 
test when normally distributed and the Mann–Whitney test when not 
normally distributed. All continuous variables were normally distributed, 
except coronary artery calcium score, the number of diseased coronary 
segments, of segments with obstructive CAD and nonobstructive CAD per 
patient. Chi-square test was computed to test for differences in 
categorical variables. 
Multivariable logistic regression analyses (backward stepwise with 
retention level set at 0.1) were performed to evaluate the relationship 
between demographic and clinical data (age, gender, coronary risk 
factors, symptoms, pretest likelihood of CAD, and history of AF) and the 
presence of CAD and obstructive CAD at MSCT coronary angiography. 
Only significant univariate predictors were entered as covariates in the 
multivariable models. Odds ratios and 95% CI were calculated. 
The diagnostic accuracy of MSCT coronary angiography for the detection 
of obstructive (≥50% luminal narrowing) coronary artery stenoses was 
assessed in the subgroup of patients who underwent invasive coronary 
angiography. The sensitivity and specificity, including 95% CI, were 
calculated using invasive coronary angiography as the reference standard. 
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A probability value <0.05 was considered statistically significant. 
Statistical analyses were performed using SPSS software (version 14.0, 
SPSS Inc). 
 
Statement of Responsibil ity 
The authors had full access to and take full responsibility for the integrity 





Baseline characteristics of each group are shown in Table 1. In accordance 
to the study design, AF and non-AF groups did not differ as to mean age 
(61±11 versus 59±10 years), male gender (67% versus 65%), 
symptomatic status, and pretest likelihood of CAD. In particular, a history 
of typical or atypical angina pectoris was present in 42% of patients with 
AF and in 43% of patients without AF and the pretest likelihood of CAD 
according to Diamond and Forrester was low, intermediate, and high, 
respectively, in 59%, 25%, and 16% of patients with AF and in 58%, 
28%, and 14% of patients without AF. 
Patients with AF, as compared with patients without AF, were less 
frequently diabetic (13% versus 28%, p <0.001) and smoker (21% 
versus 31%, p = 0.027). Overall, the prevalence of ≥3 coronary risk 
factors was not statistically different between the 2 groups. 
 
MSCT Calcium Scoring and Noninvasive Angiography 
A total of 24 (16%) patients with AF and 23 (16%) patients without AF 
underwent examination with 16-slice MSCT, whereas the remaining study 
population underwent 64-slice MSCT. Table 2 and Figures 1-3 depict the 
results of calcium scoring and MSCT coronary angiography in the study 
population. 
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Coronary Artery Calcium Score 
Coronary artery calcium score was effectively performed in 133 (89%) 
patients with AF and in all patients without AF. The median Agatston 
calcium score did not differ between patients with AF and patients 
without AF (27, interquartile range 0 to 308, versus 75, interquartile 
range 0 to 350; p = 0.19). The prevalence of no calcium and minimal, 
mild, moderate, and severe coronary calcifications was not statistically 
different between the 2 groups, although absence of any calcium was less 
frequently observed among patients with AF (Figure 1). 
 
Table 1. Baseline characteristics of the study population 
 AF  
patients  
(n = 150) 
Non-AF  
patients  
(n = 148) 
p 
value 
Age (years) 61±11 59±10 0.16 
Male gender 100 (67%) 96 (65%) 0.81 
Diabetes mellitus 19 (13%) 41 (28%) * 0.001 
Hypertension 92 (61%) 94 (63%) 0.72 
Hypercholesterolemia 64 (43%) 57 (39%) 0.48 
Family history of CAD 46 (31%) 59 (40%) 0.062 
Current or previous smoking 31 (21%) 46 (31%) † 0.027 
≥ 3 coronary risk factors 37 (25%) 48 (32%) 0.16 
Body mass index (kg/m²) 26.2±5.7 26.8±4.4 0.31 
Symptoms 
- Asymptomatic 
- Atypical angina 



























94	   Chapter	  5	  
	  
Noninvasive Coronary Angiography 
Noninvasive coronary angiography was successfully performed in all the 
patients of the study population. Mean heart rate during the scan was 
64±6 bpm among patients with AF and 65±9 bpm among patients 
without AF (p = 0.24). 
 
 
Figure 1. Bar graph showing the coronary artery calcium score categories in 
patients with and without history of paroxysmal or persistent AF. Solid bars 
indicate patients with AF; open bars, patients without AF. P = 0.31 for comparison 
between the 2 groups. 
 
As shown in Figure 2, 28 (18%) patients with AF were classified as having 
no CAD based on MSCT, whereas 61 (41%) showed nonobstructive CAD 
and at least 1 significant (≥50%) luminal narrowing was observed in the 
remaining 61 (41%) patients. The prevalence of CAD among patients 
without AF was significantly lower: 47 (32%) were classified as having no 
CAD, whereas 61 (41%) showed nonobstructive CAD and 40 (27%) had 
obstructive CAD, based on MSCT (p = 0.010 compared with patients with 
AF). 
Obstructive single-vessel disease was present in 35 (23%) patients with 
AF, whereas obstructive LM and/or proximal LAD disease was present in 
37 (25%) patients with AF. Multivessel disease was observed in 26 (17%) 
(Figure 3). 
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As also indicated by Figure 3, patients without AF showed a significantly 
lower prevalence of obstructive single-vessel disease and obstructive LM 
and/or proximal LAD disease, as compared with patients with AF, but not 
a significantly lower prevalence of multivessel disease. Obstructive single-
vessel disease was indeed observed in 19 (13%) patients without AF, 
obstructive CAD in the LM and/or proximal LAD in 15 (10%) and 
multivessel disease in 21 (14%) (p = 0.024, p = 0.001, and p = 0.53, 
respectively, compared with patients with AF). 
 
 
Figure 2. Prevalence of CAD in patients without and with history of paroxysmal 
or persistent AF. Solid bars indicate patients with AF; open bars, patients without 
AF. P = 0.010 for comparison between the 2 groups. 
 
 
Figure 3. Prevalence of obstructive single-vessel, LM, or proximal LAD CAD and 
of multivessel disease in patients with and without history of paroxysmal or 
persistent AF. Solid bars indicate patients with AF; open bars, patients without AF. 
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Because of motion artifacts, 39 (1.5%) segments in the AF group and 38 
(1.5%) segments in the non-AF group were excluded from the segment-
based analysis, respectively. A significantly higher number of diseased 
coronary segments, of segments with obstructive CAD and 
nonobstructive CAD per patient was present in the AF group, as 
compared with non-AF group (5.5±3.9 versus 4.0±4.0, p = 0.001; 
1.1±1.9 versus 0.8±1.7, p = 0.010 and 4.4±3.2 versus 3.2±3.3, p = 
0.001, respectively). 
Age (p <0.001), male gender (p = 0.002), diabetes mellitus (p = 0.004), 
hypertension (p <0.001), hypercholesterolemia (p <0.001), and history 
of AF (p = 0.010) were selected as significant univariate predictors of 
(any) CAD. Age (p <0.001), male gender (p = 0.014), hypertension (p = 
0.006), hypercholesterolemia (p = 0.026), pretest likelihood of CAD (p = 
0.021), and history of AF (p = 0.013) were selected as significant 
univariate predictors of obstructive CAD. At multivariable logistic 
regression analysis, age, history of AF, male gender, and 
hypercholesterolemia were identified as significantly associated to the 
presence of (any) CAD whereas the variables age, history of AF, and male 
gender were identified as significantly associated to obstructive CAD 
(Table 2). 
 
Table 2. Multivariable logistic regression analysis: demographic and clinical variables related 
to coronary artery disease 
CORONARY ARTERY DISEASE 
 p value OR CI 
Age <0.0001 1.13 1.09-1.18 
Atrial fibrillation 0.006 2.52 1.30-4.90 
Male gender <0.0001 3.80 1.93-7.61 
Hypercholesterolemia 0.033 2.2 1.06-4.44 
OBSTRUCTIVE CORONARY ARTERY DISEASE 
 p value OR CI 
Age <0.0001 1.10 1.04-1.19 
Atrial fibrillation 0.049 1.70 1.00-2.89 
Male gender 0.001 2.67 1.48-4.84 
CI: confidence intervals; OR: odds ratio. 
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Figure 4 shows an example of an asymptomatic patient with paroxysmal 
AF and evidence of extensive coronary atherosclerosis on MSCT.  
 
 
Figure 4. Example of a patient with extensive coronary atherosclerosis on MSCT. 
Panel A and B. 3D volume-rendered reconstructions are provided, showing the 
LAD, left circumflex (LCX), and right coronary arteries (RCA). Panel C–E. Curved 
multiplanar reconstructions of the LAD, LCX, and RCA, respectively. Calcifications 
(arrowheads) can be observed in the entire coronary tree (particularly in the LAD 
and RCA). An obstructive noncalcified plaque is present in the RCA (arrow in 
panel E and enlargement in panel F). 
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Diagnostic Accuracy of MSCT Coronary Angiography 
A total of 79 patients underwent invasive coronary angiography. The 
overall number of obstructive (≥50% luminal narrowing) coronary artery 
stenoses was 151. The sensitivity/specificity of MSCT coronary 
angiography was 92.1% (95% CI, 86.5% to 95.8%) and 96.4% (95% CI, 




This is one of first studies using anatomic assessment to examine the 
prevalence of CAD among patients with paroxysmal or persistent AF and 
without a history of CAD.23 A higher prevalence of obstructive CAD was 
detected among patients with AF, as compared with a cohort of patients 
without AF, with similar age and pretest likelihood of CAD, but with a 
higher prevalence of diabetes mellitus. Moreover, LM and/or proximal LAD 
disease was more frequently identified (25% of patients with AF versus 
10% of patients without AF). At logistic regression analysis, AF, together 
with age and male gender, was identified as an independent predictor of 
the presence of obstructive CAD. 
Although a casual relationship between CAD and AF has not yet been 
established, CAD is considered to be highly prevalent among patients with 
AF and may be one of its potential etiologic factors.7 Indeed, AF and CAD 
may simply be different, concurrent consequences of long-lasting 
exposure to coronary risk factors, but, on the other hand, AF could be a 
consequence of CAD, directly or indirectly, through an increase of left 
atrial pressure secondary to episodes of left ventricular ischemia.24,25 
Previous population studies such as the Framingham 9 and Manitoba 4 
studies reported CAD to be one of the etiologic factors most commonly 
associated with the development of AF. Moreover, once diagnosed with 
AF, the presence of CAD has been shown to be related with recurrent AF 
episodes,26 presence of symptoms (including arrhythmic, heart failure, 
and angina symptoms) 27 and increased risk of death.28,29 Interestingly, 
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epidemiological data disclosed that ischemic heart disease is one of the 
most common underlying cause of death among patients with AF 30 and a 
more recent community-based longitudinal cohort study showed that 
patients diagnosed with first AF but yet without established CAD 
constitute a high-risk group with increased risk for subsequent new 
coronary ischemic events and mortality.31 
Accordingly, these observations have lead to an increased interest in the 
evaluation of underlying CAD in patients with AF. Two recent studies 
assessed the value of cardiac imaging to detect CAD in patients with AF, 
using stress myocardial perfusion SPECT.11,12 Abidov et al.11 reported that 
patients with AF have larger perfusion abnormalities on SPECT and a 
higher risk of cardiac death as compared with patients without AF. 
However, >50% of enrolled patients had symptoms and/or known CAD, 
and the reported difference in SPECT studies results was mostly due to a 
higher amount of hypoperfused myocardium at rest in the AF group. More 
recently, Askew et al.12 showed a prevalence of abnormal myocardial 
perfusion SPECT studies of 51.6% among asymptomatic patients with AF. 
After an average follow-up of 5.7 years, a significantly higher mortality 
rate was observed in patients with AF as compared with patients without 
AF. Interestingly, no significant difference in the rate of abnormal SPECT 
studies between patients with and without AF was observed, suggesting 
that the increased mortality was not related to a higher prevalence of 
obstructive CAD. 
However, SPECT reflects only indirectly the presence of CAD, because it is 
based on the detection of coronary lesions that result in compromised 
blood flow during stress,15 whereas the actual prevalence of 
atherosclerosis in patients with AF may be higher. 
In this study, imaging of atherosclerosis with MSCT was used to determine 
the prevalence of CAD. By means of calcium scoring, the presence and 
extensions of coronary calcifications was not statistically different 
between patients with AF and patients without AF. However, using 
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noninvasive coronary angiography, patients with AF were found to have 
more frequently coronary atherosclerosis (82%) and obstructive CAD 
(41%), as compared with patients without AF (68% and 27%, 
respectively). Furthermore, LM/proximal LAD disease was identified in 
25% of patients with AF versus 10% of patients without AF. These 
findings are particular striking, when considering that the patients of the 
study population were mostly asymptomatic and with low pretest 
likelihood for CAD. In addition, a higher prevalence of diabetes, a condition 
that is generally associated with a significantly higher extent of CAD, was 
observed in patients without AF. Indeed, at multivariable logistic 
regression analysis, only AF, age and male gender were identified as 
significantly related to the presence of obstructive CAD. 
 
Clinical Implications 
Because of the lack of follow-up data, the clinical significance and 
implications of these findings are still unknown at this time. However, 
taking into account the suspected association between AF, underlying 
CAD and increased risk for coronary events,11,12 our observations suggest 
that patients with AF (despite the absence of symptoms) potentially may 
benefit from noninvasive diagnostic procedures to evaluate the presence 
of CAD. In this study, the feasibility of MSCT coronary angiography was 
evaluated, showing a higher prevalence of atherosclerosis and even 
obstructive CAD in patients with AF, as compared with patients without 
AF, confirming the hypothesis that AF could be a marker of advanced 
coronary atherosclerosis. However, in this regard, it remains important to 
realize that MSCT coronary angiography does not provide information 
about the hemodynamic consequences of observed coronary lesions.15 In 
patients with obstructive CAD on MSCT functional testing remains needed 
to determine the presence of ischemia and to guide further therapeutic 
decisions (aggressive medical therapy and risk factor modification or 
referral for invasive angiography with potentially revascularization). 
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Study Limitations 
This study has several limitations that should be acknowledged. First, it is 
a case-control study, the limitations of which are well known. Moreover, 
no prognostic data were available. A larger study, with follow-up data, 
may provide more conclusive information. Second, only patients with 
paroxysmal or persistent AF were studied. We preferred to exclude 
patients with permanent AF. Despite the introduction of 64-slice MSCT, 
the technique still suffers from limited diagnostic accuracy in case of 
irregular heart rate. With the more recent generations of dual source and 
320-slice MSCT scanners, imaging in patients with permanent AF could 
potentially be possible, although no consistent data are available. Third, 
MSCT coronary angiography is not able to discriminate between flow-
limiting and non–flow-limiting stenoses; accordingly, no data regarding the 
hemodynamic consequences of observed coronary lesions can be 
provided. Fourth, because the presence of history of paroxysmal or 
persistent AF was used to identify the study population, it is possible that 
some patients with unacknowledged episodes of paroxysmal AF have 
been included in the control group. In addition, although standardized 
MSCT evaluation protocols were used in the participating centers, 
acquisition protocols were not completely uniform as scanners from 
different generations and manufacturers were used. This, however, 
reflects the daily clinical routine and confers generalized applicability to 
our observations. In addition, no off-site reading of MSCT coronary 
angiography was performed, possibly influencing interobserver variability. 
Finally, MSCT coronary angiography still has a high radiation exposure, 
which limits its use in asymptomatic patients. However, the use of more 
recent generation scanners and the implementation of dose-saving 
algorithms is likely to result in substantial dose reduction, without 
degradation of image quality.32 
 
 




A higher prevalence of obstructive CAD was detected among patients 
with AF, as compared with patients without AF, confirming the hypothesis 
that AF could be a marker of advanced coronary atherosclerosis. In 
addition, the presence of AF was identified as a significant and 
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Atrial fibrillation (AF) has been linked to the presence of underlying 
coronary artery disease (CAD). However, whether the higher burden of 
CAD observed in AF patients translates into higher burden of myocardial 
ischemia is unknown. In 87 patients (71% male, mean age 61±10 years) 
with paroxysmal or persistent AF and without history of CAD, MSCT 
coronary angiography and stress testing (exercise ECG test or myocardial 
perfusion imaging) were performed. CAD was classified as obstructive 
(≥50% luminal narrowing) or not. Stress tests were classified as normal or 
abnormal. A population of 122 patients without history of AF, similar to 
the AF group as to age, gender, symptomatic status and pre-test 
likelihood, served as a control group. Based on MSCT, 17% of AF patients 
were classified as having no CAD, whereas 43% showed non-obstructive 
CAD and the remaining 40% had obstructive CAD. A positive stress test 
was observed in 49% of AF patients with obstructive CAD. Among non-AF 
patients, 34% were classified as having no CAD, while 41% showed non-
obstructive CAD and 25% had obstructive CAD (p = 0.013 compared to 
AF patients). A positive stress test was observed in 48% of non-AF 
patients with obstructive CAD. In conclusion, the higher burden of CAD 
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Atrial fibrillation (AF) has been shown to be an independent risk factor for 
future coronary artery disease (CAD) events.1–6 Accordingly, evaluation of 
AF patients for CAD may potentially be useful, in order to improve their 
outcome. 
Multi-slice computed tomography (MSCT) coronary angiography has 
emerged as an accurate technique for the non-invasive imaging of 
coronary atherosclerosis.7 In a recent study using MSCT coronary 
angiography, a higher prevalence of CAD and obstructive CAD was found 
among patients with paroxysmal or persistent AF, as compared to 
patients without a history of AF; in addition, a significant independent 
relation between AF and CAD was observed.8 However, MSCT coronary 
angiography does not provide information about the hemodynamic 
consequences of observed coronary lesions;9,10 therefore, whether the 
higher burden of CAD observed in AF patients is associated also to a 
higher burden of myocardial ischemia remains to be determined. 
Accordingly, the aim of the present study was to evaluate the relation 
between the evidence of coronary atherosclerosis (by means of MSCT 
coronary angiography) and the presence of abnormal stress testing 
among patients with paroxysmal or persistent AF and compare findings to 





A total of 87 patients from the outpatient clinic with a history of 
paroxysmal (n = 54, 62%) or persistent (n = 33, 38%) AF, referred to 
MSCT for coronary evaluation, due to an elevated risk profile and/or chest 
pain, were included. In addition, patients underwent stress testing 
(exercise ECG testing [EET] or myocardial perfusion imaging [MPI]) within 
1 month of MSCT coronary angiography. 
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The patient population is part of an ongoing study protocol addressing 
the value of MSCT and other imaging techniques in patients with 
paroxysmal or persistent AF. From this prospective registry, results 
addressing the prevalence of CAD by MSCT coronary angiography in AF 
patients have been recently published.8 
Patients with history of CAD and contraindications to MSCT were 
excluded. Only patients in sinus rhythm were included, and patients with 
AF at the time of SPECT or MPI were excluded. Paroxysmal and persistent 
AF were diagnosed according to the American Heart 
Association/American College of Cardiology/European Society of 
Cardiology criteria.11 A history of CAD was defined as the presence of 
previous acute coronary syndrome, percutaneous or surgical coronary 
revascularization, and/or one or more angiographically documented 
coronary stenosis ≥50% luminal diameter.9 Contraindications for MSCT 
were (1) known allergy to iodinated contrast agent, (2) renal failure, (3) 
pregnancy. 
For each patient, the presence of coronary risk factors (diabetes, 
systemic hypertension, hypercholesterolemia, positive family history of 
CAD and cigarette smoking) and symptoms was recorded. In addition, the 
pre-test likelihood of obstructive CAD was evaluated using the Diamond 
and Forrester criteria.12,13 
A control group was selected from the clinical database for comparison 
purposes. Accordingly, 122 patients were included without history of AF 
and with similar baseline clinical characteristics; these patients were 
clinically referred to MSCT for coronary evaluation and stress testing 
within 1 month. 
Patients were included at 4 centers in 3 different countries (Leiden 
University Medical Center, Leiden, the Netherlands; Medisch Centrum 
Haaglanden, Leidschendam, The Netherlands; Turku PET Center, Turku, 
Finland; University Hospital Zurich, Zurich, Switzerland). 
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MSCT data acquisition 
The heart rate and blood pressure were monitored before the examination 
in each patient. In the absence of contraindications, patients with a heart 
rate ≥65 beats/min were administered beta-blocking medication (50–100 
mg metoprolol, oral or 5–10 mg metoprolol, intravenous). 
MSCT coronary angiography was performed with either 16-slice MSCT 
scanner (n = 39; Aquilion 16, Toshiba Medical Systems, Japan and 
Discovery STE, General Electrics, USA) or 64-slice MSCT scanner (n = 
170; Aquilion 64, Toshiba Medical Systems, Japan, LightSpeed VCT, GE 
Healthcare, USA and Discovery VCT, General Electrics, USA). The 
estimated radiation dose was between 10 and 18 mSv. 
Data were subsequently transferred to dedicated workstations for post-
processing and evaluation (Advantage, GE Healthcare, USA; Vitrea 2, Vital 
Images, USA; and Aquarius, TeraRecon, USA). 
 
MSCT data analysis 
The MSCT data analysis was performed in each center by two experienced 
observers who had no knowledge of the patient’s medical history, 
symptom status and stress testing results; disagreement was solved by 
consensus or evaluation by a third observer. Standardized MSCT data 
evaluation methodology and scoring system described below were used in 
each center. 
MSCT coronary angiograms obtained with 16 and 64-slice scanners were 
evaluated for the presence of obstructive CAD (≥50% luminal narrowing) 
on a patient and vessel level. For this purpose, both the original axial 
dataset as well as curved multiplanar reconstructions were used. Each 
vessel was evaluated for the presence of any atherosclerotic plaque, 
defined as structures >1 mm² within and/or adjacent to the coronary 
artery lumen, which could be clearly distinguished from the vessel lumen 
and the surrounding pericardial tissue, as described previously.14 
Subsequently, the vessels were further classified as (1) completely 
normal, (2) having non-obstructive CAD when atherosclerotic lesions 
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<50% of luminal diameter were present or (3) having obstructive CAD 
when atherosclerotic lesions ≥50% of luminal diameter were present. 
The presence of CAD (including obstructive and non-obstructive CAD), 
and obstructive CAD were evaluated. In addition, the presence of (1) 
single-vessel disease (obstructive CAD in one vessel); (2) multi-vessel 
disease (obstructive CAD in more than one vessel) and (3) obstructive 
CAD in the left main (LM) and/or proximal left anterior descending (LAD) 
coronary artery was evaluated. Multi-vessel disease and LM and/or 
proximal LAD disease were considered to represent high-risk features. 
 
Stress testing 
Stress testing was performed in all patients within 1 month of MSCT 
coronary angiography after an adequate pharmacological wash-out; beta-
blockers, long-acting nitrates and calcium channel blockers were 
discontinued at least 48 h before the test. 
 
Exercise ECG test 
Symptom-limited EET was performed on a bicycle ergometer according to 
standard protocols.15 Patients not able to reach ≥85% age-predicted 
maximum heart rate in the absence of ischemic changes were not 
included in the study. 
The test was analyzed by an experienced reader who had no knowledge of 
the MSCT results and was classified as positive or negative for ischemia. 
The test was considered positive based on the presence of ≥0.1 mV 
horizontal or downsloping ST-segment depression at 80 ms after the J 
point in two contiguous leads during exercise or recovery. 
 
Myocardial perfusion imaging 
Stress-rest MPI was performed with symptom-limited bicycle exercise or 
pharmacologic (adenosine or dobutamine) stress using either technetium-
99 m tetrofosmin or technetium-99 m sestamibi. Images were acquired 
with either a dual-head (Millenium VG & Hawkeye; GE Healthcare, 
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Waukesha, Wisconsin) or a triple-head (GCA 9300/HG, Toshiba Corp., 
Japan) single-photon emission computed tomographic (SPECT) camera, 
and reconstructed into long- and short-axis projections perpendicular to 
the heart axis. The estimated radiation dose for stress-rest MPI was 
approximately 7 mSv. 
The test was analyzed by an experienced reader who had no knowledge of 
the MSCT results. Perfusion defects were identified on the stress images 
(segmental tracer activity <75% of maximum) and divided into ischemia 
(reversible defects, with ≥10% increase in tracer uptake on the resting 
images) or scar tissue (irreversible defects). Accordingly, examinations 
were classified as being either negative or positive. Positive examinations 
were further divided into those demonstrating reversible defects and 
those demonstrating fixed defects. The gated images were used to 
assess regional wall motion to improve differentiation between perfusion 
abnormalities and attenuation artifacts.16 
 
Statistical analysis 
Continuous variables are expressed as mean and standard deviation. 
Categorical variables are expressed as absolute numbers and 
percentages. 
The differences in continuous variables were assessed using the Student t 
test. Chi-square or Fisher exact test, when appropriate, were computed to 
test for differences in categorical variables. 
A p value < 0.05 was considered statistically significant. Statistical 
analyses were performed using SPSS software (version 15.0, SPSS Inc, 





Baseline characteristics of each group are shown in Table 1. By definition, 
AF and non-AF groups did not differ as to mean age (61±10 vs. 59±11 
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years), male gender (71% vs. 66%), symptomatic status and pre-test 
likelihood of CAD. In addition, no difference in coronary risk factor profile 
was observed between the two groups. 
 
Table 1. Baseline characteristics of the study population 
 AF 
patients 
(n = 87) 
Non-AF 
patients  
(n = 122) 
p 
value 
Age (years) 61±10 59±11 0.25 
Male gender 62 (71%) 80 (66%) 0.39 
Diabetes  13 (15%) 30 (25%) 0.089 
Hypertension 56 (64%) 79 (65%) 0.95 
Hypercholesterolemia 44 (51%) 53 (43%) 0.31 
Family history of coronary artery 
disease 
30 (35%) 50 (41%) 0.34 
Current or previous smoking 23 (26%) 39 (32%) 0.39 
≥ 3 coronary risk factors 26 (30%) 40 (33%) 0.66 
Body mass index (kg/m²) 26.4±3.6 26.4±3.7 0.97 
Symptoms 
- Asymptomatic 
- Atypical angina 















































Data are expressed as mean±SD and n (%). 
 
MSCT coronary angiography 
Table 2 shows the results of MSCT coronary angiography among AF and 
non-AF patients. Overall, a significantly higher prevalence of obstructive 
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CAD was observed among AF patients, as compared to non-AF patients 
(p = 0.013; Table 2). Single-vessel disease and LM and/or proximal LAD 
disease were more frequently observed in AF patients (p = 0.027 and p = 
0.003, respectively; Table 2). 
 
Table 2. MSCT coronary angiography results in the study population 
 AF 
patients  
(n = 87) 
Non-AF 
patients  
(n = 122) 
p value 










Mean heart rate during the scan 
(beats/min) 
64±7 66±10 0.13 
Prevalence of CAD 
- Normal coronary arteries 
- Non-obstructive CAD 











Obstructive single-vessel disease 19 (22%) 13 (11%) 0.027 
Multi-vessel disease 16 (18%) 18 (15%) 0.48 
LM and/or proximal LAD 22 (25%) 12 (10%) 0.003 
High-risk features 24 (28%) 21 (17%) 0.072 
Data are expressed as mean±SD and n (%). 
 
Stress testing 
Table 3 shows the stress testing results among AF and non-AF patients. 
Symptom-limited EET was performed in 38 (44%) AF patients and in 48 
(39%) non-AF patients. Ischemic ST-segment depression was observed in 
15 (39%) AF patients and in 14 (29%) non-AF patients (p = 0.32; Table 
3). When considering only the symptomatic patients, symptom-limited 
EET was performed in 13 AF patients and in 23 non-AF patients. In this 
sub-group of asymptomatic subjects, ischemic ST-segment depression 
was observed in 8 (62%) AF patients and in 5 (22%) non-AF patients (p = 
0.030). 
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Table 3. Stress testing results in the study population 
 AF 
patients  
(n = 87) 
Non-AF 
patients  
(n = 122) 
p value 
Type of stress test 
- Exercise ECG test 








Exercise ECG test    
Mean peak double product 28996±7346 28854±6678 0.93 
Mean peak workload (Watt) 191±52 186±41 0.60 
Ischemic ST-segment depression 15 (39%) 14 (29%) 0.32 
Myocardial perfusion imaging    
Myocardial perfusion findings 
- Normal perfusion 
- Reversible perfusion defect 
- Fixed perfusion defect 
























Data are expressed as mean±SD and n (%). 
 
Stress-rest MPI was performed in 49 (56%) AF patients and in 74 (61%) 
non-AF patients. Symptom-limited bicycle exercise was performed in 21 
AF patients and in 11 non-AF patients; in all these patients, ≥85% of 
maximum age-predicted heart rate was achieved if no stress-induced 
symptoms or changes in electrocardiogram or blood pressure occurred. 
Pharmacologic stress using adenosine or dobutamine was applied in 28 AF 
patients and in 63 non-AF patients.  
Thirty (61%) AF patients had normal perfusion at both stress and rest. In 
the remaining 19 (39%) AF patients, reversible and fixed defects were 
observed in 17 and 2 patients, respectively. None of the AF patients 
showed both reversible and fixed defects (Table 3). The prevalence of 
abnormal MPI scans among non-AF patients was similar. Normal 
myocardial perfusion was observed in 50 (68%) non-AF patients. In the 
remaining 24 (32%) non-AF patients, reversible, fixed and both reversible 
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and fixed defects were observed in 17, 5 and 2 patients, respectively 
(see Table 3). When considering only the symptomatic patients, stress-
rest MPI was performed in 29 symptomatic AF patients and in 31 
symptomatic non-AF patients. The prevalence of abnormal MPI scans 
between these two groups of patients was similar (8, 28% vs. 11, 36%; p 
= 0.58). 
Overall, considering the combined EET and stress-rest MPI results, no 
statistically significant difference in the prevalence of abnormal stress 
tests was observed between AF and non-AF patients (39% vs. 31%, p = 
0.23; Table 3). Similarly, no statistically significant difference in the 
prevalence of abnormal stress tests was observed between symptomatic 
AF and non-AF patients (38% vs. 30%, p = 0.38). 
 
Relationship between obstructive coronary artery disease and 
abnormal stress testing 
Figure 1 illustrates the relationship between observations on MSCT 
coronary angiography and stress test results among AF and non-AF 
patients. The majority of AF and non-AF patients with normal coronary 
arteries had a normal stress test (87% vs. 88%; p = 0.90). In patients 
with (any) CAD, 32 (44%) AF patients and 33 (41%) non-AF patients had 
an abnormal stress test (p = 0.64). 
Figure 2 illustrates the relationship between non-obstructive and 
obstructive CAD identified by MSCT coronary angiography and stress test 
results among AF and non-AF patients. The majority of AF and non-AF 
patients with non-obstructive CAD had a normal stress test (59% vs. 
64%; p = 0.66). In patients with obstructive CAD, 17 (49%) AF patients 




The results of the present study show that AF patients have a higher 
prevalence of CAD, and in particular of obstructive CAD, as compared to 
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non-AF patients. However, no difference in the prevalence of abnormal 
stress testing and of functionally relevant coronary lesions was observed 




Figure 1. Pie charts illustrating the relationship between normal coronary 
arteries (panel A) and any coronary artery disease (CAD) (panel B) identified by 
MSCT coronary angiography and stress test results among atrial fibrillation (AF) 
and non-AF patients. White: negative stress test. Black: positive stress test. 
 
 
Figure 2. Pie charts illustrating the relationship between non-obstructive 
coronary artery disease (CAD) (panel A) and obstructive CAD (panel B) 
identified by MSCT coronary angiography and stress test results among atrial 
fibrillation (AF) and non-AF patients. White: negative stress test. Black: positive 
stress test. 
 
Clinical relevance of CAD in AF patients 
Previous studies have shown that AF patients have a low risk of CAD 
events at the time of first AF,17,18 but a higher long-term risk, as 
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compared to patients without AF.3,6 Aronow et al.3, for instance, in a 
prospective study of 1359 patients, demonstrated that AF patients have 
a 2.2 times increased probability of developing CAD events during a 
follow-up of 42±26 months, as compared to non-AF patients. A more 
recent community-based longitudinal cohort study of 2768 patients 
showed that AF patients without known CAD represent a high-risk group 
with increased risk for subsequent new coronary ischemic events and 
mortality during a follow-up of 6.0±5.2 years.6 
These observations raise the question whether routine evaluation of 
underlying CAD in AF patients should be recommended.19 Thus far, only 
few studies addressed this issue. Abidov et al.20, for instance, assessed 
the prevalence of CAD in 384 AF patients using stress-rest MPI; a higher 
prevalence of abnormal MPI studies was observed in AF patients as 
compared to patients without AF. However, in that study, a non-negligible 
proportion of enrolled patients had symptoms and/or known CAD, and the 
observed difference in MPI studies results was mainly related to a higher 
amount of fixed defects in the AF group. Conversely, Askew et al.19 
showed a similar prevalence of abnormal stress-rest MPI studies in 374 
asymptomatic AF patients with no history of CAD, as compared to 374 
age- and gender-matched controls without AF. More recently, the 
prevalence of CAD in 150 AF patients was assessed using MSCT coronary 
angiography; a significantly higher prevalence of CAD and obstructive 
CAD was observed among AF patients, as compared to 148 patients with 
similar age, gender, and pre-test likelihood of obstructive CAD. In 
addition, AF was independently related to the presence of CAD and 
obstructive CAD, strengthening the hypothesis that AF could be a marker 
of advanced coronary atherosclerosis.8 
 
Atherosclerosis versus abnormal stress testing in AF patients 
Stress testing and MSCT coronary angiography provide different, 
complementary information about CAD (i.e. evidence of myocardial 
ischemia and evidence of coronary atherosclerosis, respectively).9,10 
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However, how these data relate each other in AF patients is still unknown. 
In the present study, the relation between evidence of coronary 
atherosclerosis, assessed by means of MSCT coronary angiography, and 
the presence of abnormal stress testing was assessed among 87 patients 
with paroxysmal or persistent AF. Findings were compared to 122 
patients without a history of AF. In line with the study of Askew et al.19, a 
similar prevalence of abnormal stress tests was observed between AF and 
non-AF patients (39% vs. 31%). In addition, and importantly, no 
difference in the prevalence of functionally-relevant obstructive coronary 
lesions was observed between the two groups of patients (49% vs. 48%). 
These data suggest that the higher atherosclerotic burden associated to 




The results of the present and of previous studies suggest that a history 
of AF, per se, should not represent an indication to stress testing as 
indiscriminate first-line approach to rule out the presence of CAD.19 AF 
patients have indeed a similar prevalence of functionally-relevant 
coronary lesions as compared to non-AF patients. Nevertheless, a higher 
burden of subclinical coronary atherosclerosis is observed in patients with 
AF and this higher prevalence may potentially explain the previously 
observed higher long-term risk of CAD event in this group.3,6 Accordingly, 
more aggressive medical therapy and risk factor modification may be 
justified in AF patients. Further follow-up studies, with follow-up data, are 
however needed in order to confirm this hypothesis. 
 
Study l imitations 
This study has several limitations that should be acknowledged. First, it is 
a case–control study, the limitations of which are well known. Moreover, 
the patient population is relatively small, including both symptomatic and 
asymptomatic subjects, and no prognostic data are available; a larger 
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study, with follow-up data, may provide more conclusive information. 
Second, only patients with paroxysmal or persistent AF were enrolled, 
while patients with permanent AF were not included. Sixty-four-slice 
MSCT suffers indeed from limited diagnostic accuracy in case of irregular 
heart rate. More recent generations of dual source MSCT or 320-row 
scanners could potentially allow imaging of the coronary arteries also in 
patients with permanent AF.21 Third, MSCT scanners from different 
generations as well as manufacturers were used and the stress testing 
protocol was not standardized, including either symptom-limited EET or 
stress-rest MPI; this, however, reflects the daily clinical practice, and 
allows wider applicability to the present observations. In addition, no off-
site reading of MSCT coronary angiography and stress testing was 




AF patients have a higher prevalence of CAD, and in particular of 
obstructive CAD, as compared to non-AF patients. However, the higher 
burden of CAD observed in AF patients is not associated with a higher 
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The presence of cardiac and aortic calcific deposits has been related to 
coronary artery disease (CAD) and cardiovascular events. The present 
study aimed to evaluate whether comprehensive echocardiographic 
assessment of cardiac and ascending aorta calcific deposits could predict 
coronary calcium and obstructive CAD. A total of 140 outpatients (age 
61±11 years; 90 men) without a history of CAD were studied. Aortic 
valve sclerosis and mitral annular, papillary muscle, and ascending aorta 
calcific deposits were assessed using echocardiography and 
semiquantified using an echocardiography-derived calcium score (ECS) 
ranging from 0 (no calcium visible) to 8 (severe calcific deposits). 
Coronary calcium scoring and noninvasive coronary angiography were 
performed using multislice computed tomography. Angiograms showing 
atherosclerosis were classified as having obstructive (≥50% luminal 
narrowing) CAD or not. The relation between ECS and multislice computed 
tomographic findings was explored using multivariate and receiver-
operator characteristic curve analyses. Only ECS was associated with 
coronary calcium score >400 (odds ratio [OR] 3.6, 95% confidence 
interval [CI] 2.4 to 5.5, p <0.001). Similarly, only ECS (OR 1.8, 95% CI 
1.4 to 2.4, p <0.001) and pretest likelihood of CAD (OR 1.7, 95% CI 1.0 
to 2.8, p = 0.04) were associated with obstructive CAD. ECS ≥3 had high 
sensitivity and specificity in identifying patients with coronary calcium 
score >400 (87% for both) and obstructive CAD (74% and 82%, 
respectively). In conclusion, echocardiographic assessment of cardiac and 
ascending aorta calcium may allow detection of patients with extensive 
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The presence of cardiac and aortic calcium has been related to coronary 
artery disease (CAD) and cardiovascular events.1-4 Moreover, it was 
suggested that mitral annular calcium and aortic valve sclerosis were not 
merely passive age-related degenerative processes. Rather, these 
phenomena may be a form of atherosclerosis, sharing many risk factors 
and a similar cause with both systemic and coronary atherosclerosis.5-7 
Possibly, recognition of cardiac and ascending aorta calcific deposits using 
transthoracic echocardiography, a simple, noninvasive, and widely 
available technique, could be helpful for the identification of patients with 
obstructive CAD. Therefore, the aim of the present study was to 
determine whether an echocardiography-derived calcium score (ECS), 
obtained using comprehensive assessment of the burden of cardiac and 
ascending aorta calcium, was able to predict coronary artery calcium 
score (CACS) and the presence of obstructive CAD, assessed using 




A total of 140 consecutive outpatients referred for MSCT for coronary 
evaluation because of increased risk profile and/or stable chest pain 
symptoms were included. Transthoracic echocardiography was performed 
in all patients within 1 month of MSCT coronary angiography. Patients 
with aortic valve stenosis, rheumatic valvular disease, prosthetic valves, 
or bicuspid aortic valves were excluded. Also, patients with a history of 
CAD, cardiomyopathy, rhythm other than sinus, suboptimal 
echocardiographic studies (i.e., inadequate visualization of the left 
ventricular endocardium, valves, and ascending aorta), or 
contraindications to multislice computed tomography were excluded. 
History of CAD was defined as the presence of previous acute coronary 
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syndromes, percutaneous or surgical coronary revascularization, and/or 
≥1 angiographically documented coronary stenosis ≥50% luminal 
diameter.8 Contraindications for multislice computed tomography were 
(1) known allergy to iodinated contrast agent, (2) renal insufficiency, and 
(3) pregnancy. 
MSCT coronary angiography was performed using a 64-slice MSCT 
scanner (Aquilion 64; Toshiba Medical Systems, Tokyo, Japan). Heart rate 
and blood pressure were monitored before the examination in each 
patient. In the absence of contraindications, patients with a heart rate 
≥65 beats/min were administered oral β blockers (metoprolol 50 or 100 
mg, single dose, 1 hour before the examination). First, a prospective 
coronary calcium scan without contrast enhancement was performed, 
followed by MSCT coronary angiography performed according to the 
protocol described elsewhere.9 Data were subsequently transferred to 
dedicated workstations for postprocessing and evaluation (Advantage; GE 
Healthcare, Milwaukee, Wisconsin, and Vitrea 2; Vital Images, Minnetonka, 
Minnesota). MSCT data analysis was performed by 2 experienced 
observers who had no knowledge of the patient's medical history and 
symptom status. Disagreement was solved by consensus or evaluation by 
a third observer. Coronary artery calcium was identified as a dense area in 
the coronary artery >130 Hounsfield units. A total CACS was recorded for 
each patient. According to the total CACS, patients were subsequently 
categorized as having no calcium (total score = 0) or low (total score = 1 
to 100), moderate (total score = 101 to 400), and severe (total score 
>400) coronary artery calcium.10 MSCT coronary angiograms were 
evaluated for the presence of CAD on patient, vessel, and segment levels. 
For this purpose, both the original axial data set and curved multiplanar 
reconstructions were used. Coronary arteries were divided into 17 
segments according to the modified American Heart Association 
classification.11 Each segment was evaluated for the presence of 
atherosclerotic plaque, and 1 coronary plaque was assigned per coronary 
segment. Subsequently, type of plaque was determined as (1) 
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noncalcified plaques, plaques with a lower density compared with the 
contrast-enhanced vessel lumen; (2) calcified plaques, plaques with high 
density; and (3) mixed plaques, plaques with noncalcified and calcified 
elements within a single plaque. Finally, plaques were classified as 
obstructive (≥50% luminal narrowing) or nonobstructive. 
 
Table 1. Grading system of the cardiac and ascending aorta calcifications 










0 Absent Absent Absent Absent 
1 Mild <5 mm Present Present 
2 Moderate 5-10 mm   
3 Severe >10 mm   
Aortic valve sclerosis (AVS) was defined by focal areas of increased echogenicity and 
thickening of the aortic valve leaflets with a velocity ≤2.5 m/s across the aortic valve. Each 
aortic valve leaflet was graded according to leaflet thickening and calcification. The highest 
score for a given cusp was assigned as the overall degree of AVS. Mitral annular calcification 
(MAC) was defined as an intense and bright echo-producing structure located at the junction 
of the atrio-ventricular groove and posterior mitral valve leaflet and was measured from the 
leading anterior to the trailing posterior edge. Papillary muscle calcification was defined as a 
bright echo involving the head of one or both papillary muscles. Ascending aorta calcification 
was defined as a focal or diffuse area of increased echoreflectance and thickening in the 
aortic root on the parasternal long-axis view.  
 
Complete transthoracic echocardiographic studies were performed using 
a commercially available system (Vivid 7 Dimension; GE Healthcare, 
Horten, Norway) equipped with a M3S phased-array transducer (3.5 
MHz). A careful search for cardiac calcific deposits was systematically 
performed. All studies were digitally stored for off-line analysis. Off-line 
analysis was performed using dedicated software (EchoPAC 7.0.0; GE 
Healthcare, Horten, Norway) by an observer who had no knowledge of 
clinical data and MSCT coronary angiography results. Criteria for judging 
aortic valve sclerosis, mitral annular calcium, and ascending aorta and 
130	   Chapter	  7	  
	  
papillary muscle calcium were similar to grading systems used in previous 
studies 3,12-14 and are listed in Table 1. Accordingly, a final score was 
derived as the sum of all identified cardiac calcific deposits and was in the 
range of 0 (no calcium visible) to 8 (extensive cardiac and ascending 
aorta calcific deposits). 
A total of 40 patients were randomly selected and analyzed again 1 
month later by a second observer to assess interobserver agreement for 
the ECS. According to weighted κ test, interobserver agreement was 
good (weighted κ = 0.84). 
Continuous variables were expressed as mean±SD or median and 25th to 
75th percentile range when non-normally distributed. Categorical 
variables were expressed as absolute number and percentage. 
Multivariable logistic regression analysis (backward stepwise with 
retention level set at 0.1) was applied to evaluate the association 
between clinical and echocardiographic data and the presence of severe 
coronary artery calcium and obstructive CAD at MSCT coronary 
angiography. Variables entered in multivariable models were age, gender, 
diabetes mellitus, hypertension, hypercholesterolemia, positive family 
history, smoking, pretest likelihood of CAD, mitral annular calcium, aortic 
valve sclerosis, papillary muscle calcium, ascending aorta calcium, and 
ECS. Odds ratios (ORs) and 95% confidence intervals (CIs) were 
calculated. Relations between ECS and the presence of severe coronary 
artery calcium, presence of obstructive CAD, number of significantly 
diseased vessels, number of significantly diseased segments, and 
numbers of segments with noncalcified, calcified, and mixed plaques were 
also evaluated. The general population was divided into 3 groups 
accordingly to ECS (group 1, ECS <3; group 2, ECS 3 to 5; and group 3, 
ECS >5). Comparison between continuous variables was performed using 
1-way analysis of variance test with polynomial contrast to assess the 
presence of a linear trend across ordered levels of ECS. Chi-square test 
for >2 × 2 and Fisher's exact test for 2 × 2 contingency tables were 
computed to assess differences in categorical variables. Receiver-
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operator characteristic (ROC) curves were used to evaluate the ability of 
the ECS to predict the presence of severe coronary artery calcium and the 
presence of obstructive CAD at MSCT coronary angiography. In addition, 
ROC curve analysis was performed to evaluate the ability of the CACS to 
predict the presence of obstructive CAD at MSCT coronary angiography. 
A p value <0.05 was considered statistically significant. Statistical 





Table 2 lists baseline characteristics of the study population, and Table 3 
lists results of MSCT coronary angiography and transthoracic 
echocardiography. 
 
Table 2. Baseline characteristics of the study population 
Variable n = 140 
Age (years) 61±11 
Men/women 90/50 
Diabetes mellitus 54 (39%) 
Hypertension 89 (64%) 
Hypercholesterolemia (total cholesterol ≥240 mg/dl) 73 (52%) 
Family history of CAD 44 (31%) 
Current or previous smoker 53 (38%) 
Body mass index (kg/m²) 27±4 
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Table 3. Results of multislice computed tomographic (MSCT) coronary angiography and 
transthoracic echocardiography (n = 140) 
MSCT coronary angiography  
CACS 









CAD 123 (88%) 
Obstructive CAD 
- Single vessel disease 
- Multivessel disease 
- Left main/proximal left anterior descending coronary artery disease 
80 (57%) 
33 (24%)  
47 (34%)  
37 (26%) 
Segments 
- n˚ of diseased segments 
- n˚ of segments with obstructive plaques 
- n˚ of segments with nonobstructive plaques 
- n˚ of segments with non calcified plaques 
- n˚ of segments with calcified plaques 








Transthoracic echocardiography  
Aortic valve sclerosis 77 (55%) 
Mitral annular calcium 55 (39%) 
Papillary muscle calcium 21 (15%) 










Multivariable logistic regression analysis identified ECS as the only variable 
among the clinical and echocardiographic variables with a significant 
association with severe coronary artery calcium (OR 3.6, 95% CI 2.4 to 
5.5, p <0.001). ECS (OR 1.8, 95% CI 1.4 to 2.4, p <0.001) and pretest 
likelihood of CAD (OR 1.7, 95% CI 1.0 to 2.8, p = 0.04) were identified as 
significantly associated with obstructive CAD. 
 
 
Usefulness	  of	  Echocardiographic	  Assessment	  of	  Cardiac	  and	  Ascending	  Aorta	  
Calcific	  Deposits	  to	  Predict	  Coronary	  Artery	  Calcium	  and	  Presence	  and	  Severity	  




Figure 1. Relation between ECS and (panel A) severe coronary artery calcium 




Figure 2. Relation between ECS and (panel A) number of vessels with 
obstructive CAD, (panel B) number of segments with obstructive CAD, and 
(panel C) number of segments with calcified, noncalcified, and mixed plaque. 
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As shown in Figure 1, patients with ECS of 3 to 5 and >5 more frequently 
had severe coronary artery calcium and obstructive CAD compared with 
the group with ECS <3 (p <0.001). Furthermore, a significant increasing 
linear trend in number of vessels with obstructive plaques, number of 
segments with obstructive plaques, and number of segments with 
calcified plaques was observed across the ordered levels of ECS (p 
<0.001, respectively; Figure 2). 
At ROC curve analysis (Figure 3), ECS ≥3 had the highest sensitivity and 
specificity for identification of patients with severe coronary artery 
calcium (87% for both) and obstructive CAD (74% and 82%, 
respectively). Moreover, the ability of ECS to predict obstructive CAD was 




Results of the present study showed that an ECS obtained through 
comprehensive assessment of cardiac and ascending aorta calcium was 
able to predict the presence of extensive coronary calcium and 
obstructive CAD, assessed using MSCT coronary angiography. 
Furthermore, significant linear trends were observed between ECS and 
extent and severity of coronary atherosclerosis and number of calcified 
coronary artery lesions. 
Vascular deposition of mineral calcium is an organized and regulated 
process that typically occurs in areas of atherosclerotic lipid 
accumulation, sharing many features with cortical bone formation.7 In the 
last 2 decades, the clinical relevance of vascular calcific deposits has 
emerged. The amount of calcium in both coronary arteries and the aorta 
correlates with atherosclerotic plaque burden in each vascular bed 15,16 
and is associated with increased risk of cardiovascular events.4,17 Severe 
coronary calcific deposits are associated with the presence of myocardial 
ischemia,18 and extent of calcium in the aorta is related to coronary, 
carotid, and peripheral artery disease.14 
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Mitral annular calcium and aortic valve sclerosis appears to be the result 
of similar pathologic processes. Both are not simple passive degenerative 
disorders influenced by mechanical stress, but active inflammatory 
processes with histopathologic features similar to atherosclerosis.5-7 
Figure 3. ROC curve analyses. Panel A. 
Area under the ROC curve (AUC) of the ECS 
for the prediction of severe coronary artery 
calcium. The highest sensitivity and 
specificity in identification of patients with 
severe coronary artery calcium (87% for 
both) was provided by ECS ≥3. Panel B. 
AUC of the ECS for the prediction of 
obstructive CAD. The highest sensitivity and 
specificity in the identification of patients 
with obstructive CAD (74% and 82%, 
respectively) was provided by ECS ≥3. 
Panel C. AUC of CACS for the prediction of 
obstructive CAD. The highest sensitivity and 
specificity in the identification of patients 
with obstructive CAD (81% and 75%, 
respectively) was provided by CACS ≥208. 
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Previous clinical studies have shown significant associations between 
mitral annular calcium and aortic valve sclerosis with cardiovascular risk 
factors,12,19 impaired coronary microvascular function,20,21 subclinical 
systemic calcified atherosclerosis,22 inducible myocardial ischemia,13 and 
obstructive CAD at conventional coronary angiography.23,24 Large 
population cohort studies showed that aortic valve sclerosis and mitral 
annular calcium are associated with increased cardiovascular morbidity 
and mortality.1-3 Because it is unlikely that aortic valve sclerosis and mitral 
annular calcium directly lead to adverse cardiovascular outcomes, their 
relation with coronary atherosclerosis most likely explains these 
observations. 
Calcific deposits of the papillary muscles are less commonly observed in 
the general population and usually limited to their apical portion. Similarly 
to mitral annular calcium and aortic valve sclerosis, papillary muscle 
calcium is associated with the presence of CAD despite potentially 
different underlining mechanisms,5 more likely a consequence of necrosis 
or fibrosis caused by narrowing of the coronary arterial lumen by 
atherosclerosis.25 
Noninvasive modalities for the diagnosis of CAD are important for both 
screening of asymptomatic subjects and risk stratification of 
symptomatic patients to identify those who could benefit from invasive 
coronary angiography. Recently, MSCT coronary angiography has 
emerged as a feasible and accurate technique allowing detection of 
coronary atherosclerosis by assessing the coronary artery calcium burden 
and performing noninvasive angiography.9 However, it is expensive and 
not widely available. Moreover, it still carries high radiation exposure, 
which limits its widespread use in asymptomatic patients, and a potential 
associated risk of allergic reactions and nephrotoxicity related to the use 
of iodinated contrast agents. 
According to the previously described association between cardiovascular 
calcific deposits and coronary atherosclerosis, recognition of cardiac and 
ascending aorta calcium using transthoracic echocardiography could be 
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helpful to optimize the identification of patients with obstructive CAD. 
Transthoracic echocardiography has the advantage of being a simple, low-
cost, radiation-free technique that is widely available and used in clinical 
practice. Based on previous echocardiographic studies, sensitivity and 
specificity of aortic valve sclerosis and mitral annular calcium for the 
detection of obstructive CAD has been reported to be in the range of 
38% to 64% and 60% to 86% and 57% to 60% and 33% to 56%, 
respectively.23,26-28 However, most studies had drawbacks, such as (1) 
inclusion of patients with a history of CAD; (2) use of invasive coronary 
angiography for the diagnosis of CAD, possibly introducing a selection 
bias; (3) lack of information about coronary plaque composition; and (4) 
simple assessment of the presence/absence of single cardiac calcific 
deposits, rather than a graded approach. 
In the present study, in a consecutive group of patients without a history 
of CAD, comprehensive echocardiographic assessment of cardiac and 
ascending aorta calcific deposits was performed. Moreover, not only the 
presence/absence of calcific deposits was assessed, but their burden was 
also quantified, deriving a global score. MSCT coronary angiography was 
used to diagnose CAD. Use of this technique allowed us to show coronary 
atherosclerosis even in patients asymptomatic or with low pretest 
likelihood and assess coronary plaque composition, thereby reducing 
(although not completely obviating) the selection bias that hampered 
previous studies relying on invasive coronary angiography.23,26-28 The 
derived global ECS was able to predict the presence of severe coronary 
artery calcium with sensitivity and specificity of 87% for both and the 
presence of obstructive CAD with sensitivity of 74% and specificity of 
82%. Furthermore, a linear trend between ECS and number of vessels and 
segments with obstructive CAD and number of segments with calcified 
plaques was observed, strengthening the evidence of a relation between 
cardiac and aortic calcific deposits and advanced calcified coronary 
atherosclerosis. 
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This study had some limitations that should be acknowledged. First, it is a 
single-center experience. Second, conventional coronary angiography, the 
gold standard for diagnosing CAD, was not used. However, 64-slice MSCT 
coronary angiography has been validated against invasive angiography 
and intravascular ultrasound, allowing detection of significant stenoses 
and assessment of plaque composition with high accuracy.9,29 Moreover, 
the higher spatial resolution and lower voxel size of 64-slice MSCT 
compared with 16-slice MSCT decreased the blooming artifacts related to 
coronary calcifications.30 Third, no follow-up data were available. 
Therefore, it is unknown whether comprehensive assessment of cardiac 
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Background. Left ventricular (LV) diastolic dysfunction and subclinical 
systolic dysfunction may be markers of coronary artery disease (CAD). 
However, whether these markers are useful for prediction of obstructive 
CAD is unknown. 
Methods. A total of 182 consecutive outpatients (54±10 years, 59% 
males) without known CAD and overt LV systolic dysfunction underwent 
64-slice multislice computed tomography (MSCT) coronary angiography 
and echocardiography. The MSCT angiograms showing atherosclerosis 
were classified as showing obstructive (≥50% luminal narrowing) CAD or 
not. Conventional echocardiographic parameters of LV systolic and 
diastolic function were obtained; in addition, (1) global longitudinal strain 
(GLS) and strain rate (indices of systolic function) and (2) global strain 
rate during the isovolumic relaxation period and during early diastolic 
filling (indices of diastolic function) were assessed using speckle-tracking 
echocardiography. In addition, the pretest likelihood of obstructive CAD 
was assessed using the Duke Clinical Score. 
Results. Based on MSCT, 32% of patients were classified as having no 
CAD, whereas 33% showed nonobstructive CAD and the remaining 35% 
had obstructive CAD. Multivariate analysis of clinical and 
echocardiographic characteristics showed that only high pretest likelihood 
of CAD (odds ratio [OR] 3.21, 95% 1.02-10.09, p = 0.046), diastolic 
dysfunction (OR 3.72, 95% CI 1.44-9.57, p = 0.006), and GLS (OR 1.97, 
95% CI 1.43-2.71, p <0.001) were associated with obstructive CAD. A 
value of GLS ≥−17.4 yielded high sensitivity and specificity in identifying 
patients with obstructive CAD (83% and 77%, respectively), providing a 
significant incremental value over pretest likelihood of CAD and diastolic 
dysfunction. 
Conclusions. The GLS impairment aids detection of patients without 
overt LV systolic dysfunction having obstructive CAD. 
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Among patients with suspected coronary artery disease (CAD), scoring 
tools that take demographic and clinical characteristics into account are 
traditionally used to estimate the likelihood of obstructive CAD and to 
identify those who could benefit from further diagnostic tests.1-3 In the 
diagnostic workup of these patients, the assessment of left ventricular 
(LV) function can provide additional information, refining the initial clinical 
evaluation.4 In particular, the presence of reduced LV ejection fraction 
(EF) or wall motion abnormalities significantly increase the likelihood of 
obstructive CAD.4,5 In addition, the presence of LV diastolic dysfunction 
may also be a marker of coronary atherosclerosis, even when global LV 
systolic function is normal.6-8 
In patients without overt LV systolic dysfunction, the presence of 
subclinical reduction of myocardial function may be a marker of CAD as 
well.9 For instance, the Multiethnic Study of Atherosclerosis (MESA) 
observed that a progressive impairment of myocardial contraction 
(despite normal LVEF) was associated with an increasing severity of 
coronary atherosclerosis (detected by multislice computed tomography 
[MSCT] or electron-beam computed tomography).9 
Although LV diastolic dysfunction and subclinical LV systolic dysfunction 
have been shown as possible markers of CAD, it is unknown whether their 
detection could improve patients' stratification. Accordingly, the aim of 
the present evaluation was 2-fold. First, to explore the relation between 
obstructive CAD, LV diastolic dysfunction, and subclinical LV systolic 
dysfunction. Second, to assess the potential incremental value of LV 
diastolic dysfunction and subclinical LV systolic dysfunction over the 
initial estimate of pretest likelihood of obstructive CAD. The MSCT 
coronary angiography was performed to detect coronary atherosclerosis 
and obstructive CAD;10 2-dimensional echocardiography with speckle-
tracking analysis was used to evaluate LV systolic and diastolic 
function.11-13 





A total of 182 consecutive outpatients referred to MSCT for coronary 
evaluation, because of increased risk profile and/or stable chest pain, 
were included. Two-dimensional echocardiography with speckle-tracking 
analysis was performed in all patients within 1 month of MSCT coronary 
angiography. Both MSCT coronary angiography and extensive 
echocardiographic examination are part of clinical diagnostic workup of 
patients with known or suspected CAD. 
Patients with overt LV systolic dysfunction (LVEF <50%) or with LV wall 
motion abnormalities were excluded. Also, patients with a history of CAD, 
cardiomyopathy, significant (moderate or severe) valvular heart disease, 
congenital heart disease, rhythm other than sinus, conduction 
abnormalities, technically inadequate echocardiographic studies, or 
contraindications to MSCT were excluded. Known CAD was defined as 
history of acute coronary syndrome, percutaneous or surgical coronary 
revascularization, and/or angiographically documented coronary stenoses 
≥50% luminal diameter.14 Contraindications for MSCT were known allergy 
to iodinated contrast agent, renal failure (defined as glomerular filtration 
rate <30 ml/min), and pregnancy. 
For each patient, the presence of coronary risk factors (diabetes, 
systemic hypertension, hypercholesterolemia, positive family history, 
cigarette smoking) and the presence of chest pain were recorded. In 
addition, the pretest likelihood of obstructive CAD was assessed using the 
Duke Clinical Score,2 which takes age, gender, coronary risk factors, and 
type of chest pain into account. In accordance to the Duke Clinical Score, 
the patient population was then categorized as having a low (≤30%), 
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Two-dimensional echocardiography 
Echocardiography was performed using a commercially available system 
(Vivid 7 Dimension, GE Health care, Horten, Norway) equipped with a 3.5-
MHz transducer. Standard M-mode, 2-dimensional images, and Doppler 
and color Doppler data were acquired from the parasternal and apical 
views (4, 2, and 3 chambers) and digitally stored in cine-loop format; 
analyses were subsequently performed off-line using EchoPAC version 
7.0.0 (GE Health care, Horten, Norway). 
Left ventricular end-diastolic volume (EDV) and end-systolic volume 
(ESV) were measured according to the Simpson's biplane method, and 
LVEF was calculated as [(EDV-ESV)/EDV] ×100. The LV mass was 
calculated using the formula proposed by Lang et al.16 and Devereux and 
Reicheck 17 and normalized for body surface area (LV mass index, gram 
per square meter). 
Transmitral and pulmonary vein flows were obtained by pulsed-wave 
Doppler tracings, obtained in accordance to the recommendations of the 
American Society of Echocardiography.18 Early (E) and late (A) diastolic 
waves, deceleration time (DT) of E wave, and pulmonary vein systolic 
(PVs) and diastolic (PVd) velocities were measured. Diastolic function was 
then classified as follows:19 (1) normal, when the E/A ratio = 0.9-1.5, DT 
= 160-240 milliseconds, and PVs ≥ PVd; (2) diastolic dysfunction grade 1 
(mild), when the E/A ratio was <0.9, DT >240 milliseconds, and PVs > > 
PVd; (3) diastolic dysfunction grade 2 (moderate), when the E/A ratio = 
0.9-1.5, DT = 160-240 milliseconds, and PVs < PVd; (4) diastolic 
dysfunction grade 3 (severe), when the E/A ratio >2.0, DT <160 
milliseconds, and PVs > > PVd; and (5) diastolic dysfunction grade 4 
(severe), when the E/A ratio >2.5, DT <130 milliseconds, and PVs > > 
PVd.  
In addition, the septal mitral annulus early (E') velocity was measured by 
tissue Doppler imaging and the E/E' ratio was calculated, as estimate of 
LV filling pressures.19,20 
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Speckle-tracking analysis 
Longitudinal strain analysis of the LV was performed by speckle-tracking 
imaging (EchoPAC version 7.0.0). Grayscale 2-dimensional apical images 
of the LV (4-, 2-, and 3-chamber views) were used with frame rate 
ranging from 80 to 100 frames/s. From an end-systolic frame, the 
endocardial border was manually traced, and the software traces 
automatically 2 more concentric regions of interest to include the entire 
myocardial wall. Speckle-tracking analysis detects and tracks the unique 
myocardial ultrasound patterns frame by frame. The in-plane frame-to-
frame displacement of each pattern over time is used to derive strain. The 
software validates automatically the segmental tracking along the cardiac 
cycle and allows the operator further adjustment of the region of interest 
to improve the tracking quality.  
As described previously,11 mean global longitudinal strain (GLS) and strain 
rate (GLSR) were calculated, as indices of global LV systolic function, by 
averaging the global longitudinal strains and strain rates obtained 
automatically from each apical view (Figure 1). Similarly, the following 
indices of diastolic function were obtained (Figure 1):21 (1) global strain 
rate during the isovolumic relaxation period (GSRivrt) and (2) global strain 
rate during early diastolic filling (GSRe). 
 
 
Figure 1. Global longitudinal strain and strain rate curves. Global longitudinal 
strain (panel A) and strain rate (panel B) curves obtained by speckle-tracking 
analysis from an apical 4-chamber view. 
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Multisl ice computed tomography 
 
Data acquisition 
The MSCT coronary angiography was performed with a 64-slice MSCT 
scanner (Aquilion 64, Toshiba Medical Systems, Tokyo, Japan). The heart 
rate and blood pressure were monitored before the examination in each 
patient. In the absence of contraindications, patients with a heart rate ≥ 
65 beat/min were administered oral β-blockers (metoprolol 50 or 100 
mg, single dose, 1 hour before the examination). Noninvasive MSCT 
coronary angiography was therefore performed according to protocols 
previously described.10 Data were subsequently transferred to dedicated 
workstations for postprocessing and evaluation (Vitrea 2, Vital Images, 
Minnetonka, Minnesota, USA). 
 
Data analysis 
The MSCT data analysis was performed by 2 experienced observers who 
had no knowledge of the patient's medical history, symptom status, and 
echocardiographic data; disagreement was solved by consensus or 
evaluation by a third observer. The MSCT coronary angiograms were 
evaluated for the presence of obstructive CAD (≥50% luminal narrowing) 
on a patient level. For this purpose, both the original axial dataset as well 
as curved multiplanar reconstructions were used. Each coronary artery 
was evaluated for the presence of any atherosclerotic plaque, defined as 
structures >1 mm2 within and/or adjacent to the coronary artery lumen, 
which could be clearly distinguished from the vessel lumen and the 
surrounding pericardial tissue, as described previously.22 Subsequently, 
the coronary arteries were further classified as (1) completely normal, (2) 
having nonobstructive CAD when atherosclerotic lesions <50% of luminal 
diameter were present, or (3) having obstructive CAD when 
atherosclerotic lesions ≥50% of luminal diameter were present. The 
prevalence of normal coronary arteries, (any) CAD (including obstructive 
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Continues variables are expressed as mean and SD. Categorical data are 
presented as absolute numbers and percentages. Differences in 
continuous and categorical variables between patients with normal 
coronary arteries, nonobstructive CAD, and obstructive CAD at MSCT 
coronary angiography were assessed using the 1-way analysis of variance 
test and the chi-square test, respectively; if the result of the analysis was 
significant, post hoc test with Bonferroni's correction was applied. 
Univariate and multivariate logistic regression analysis (enter model) were 
performed to evaluate the association between the presence of 
obstructive CAD at MSCT coronary angiography, the traditional 
assessment of pretest likelihood of obstructive CAD (Duke Clinical Score), 
and the following echocardiographic variables: LVEF, LV mass index, 
presence of diastolic dysfunction, E/E' ratio, GLS, GLSR, GSRivrt, and 
GSRe. Only significant (p <0.05) univariate predictors were entered as 
covariates in the multivariate model. Odds ratios and 95% CI were 
calculated. Model discrimination was assessed using C-statistic, and model 
calibration was assessed using Hosmer-Lemeshow statistic. 
Receiver operator characteristic (ROC) curve analysis was performed to 
determine the accuracy of GLS to detect obstructive CAD, with an area 
under the curve value of 0.50 indicating no accuracy and a value of 1.00 
indicating maximal accuracy. In addition, to determine the potential 
incremental value of diastolic dysfunction and GLS over the traditional 
assessment of pretest likelihood of obstructive CAD (Duke Clinical Score), 
ROC curves were constructed for 3 models: model 1, Duke Clinical Score 
alone; model 2, combination of Duke Clinical Score and presence of 
diastolic dysfunction; and model 3, combination of Duke Clinical Score, 
diastolic dysfunction, and GLS. For this purpose, the statistical 
significance of the difference between the areas under the ROC curves 
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was tested using the method proposed by Hanley and McNeil.23 The 
Bayes' theorem was then applied to estimate the posttest likelihood of 
obstructive CAD yielded by the variables that provided incremental value 
over the pretest likelihood of obstructive CAD (Duke Clinical Score). 
In addition, variability and reproducibility of speckle-tracking 
measurements were assessed. The coefficient of variation (ie, the ratio 
between the mean value and the SD) was computed for each parameter. 
Reproducibility of speckle-tracking measurements was analyzed with 
repeated measurements by 1 experienced observer at 2 different time 
points and by a second experienced observer in 20 randomly selected 
individuals. Intraobserver and interobserver agreements for each 
parameter were evaluated by Bland-Altman analysis. Furthermore, 
intraclass correlation coefficients were used as indicators of 
reproducibility. 
All statistical tests were 2 sided, and a P value <0.05 was considered 
statistically significant. Statistical analysis was performed using the SPSS 
software package (SPSS 15.0; SPSS Inc, Chicago, IL). 
The authors are solely responsible for the design and conduct of this 
study, all study analyses, and the drafting and editing of the paper and its 




Clinical and echocardiographic characteristics of the patient 
population 
Clinical and echocardiographic characteristics of the patient population 
are summarized in Table 1. The mean age was 54±10 years, and 108 
patients (59%) were male. A total of 76 patients (42%) were 
asymptomatic, whereas 76 patients (42%) had history of noncardiac 
chest pain or atypical angina, and 30 patients (16%) had a history of 
typical angina. The Duke Clinical Score was low, intermediate, and high, 
respectively, in 88 (48%), 60 (33%), and 34 (19%) patients. 
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Table 1. Baseline characteristics of the patient population 
Variable n = 182 
Age (years) 54±10 
Male gender 108 (59%) 
Family history of CAD 81 (45%) 
Diabetes  42 (23%) 
Hypertension 95 (52%) 
Smoker 59 (32%) 




- non-anginal or atypical chest pain 













LVEDV (ml) 108±30 
LVESV (ml) 41±15 
LVEF (%) 62±7 
LV mass index (g/m2) 100±26 
Diastolic function 
- normal 
- diastolic dysfunction grade 1 





E/E’ ratio 10.0±4.3 
GLS (%) -17.6±2.4 
GLSR (s-1) -0.87±0.13 
GSRivrt (s-1) 0.31±0.13 
GSRe (s-1) 0.97±0.28 
BMI: body mass index; CAD: coronary artery disease; EDV: end-diastolic volume; EF: ejection 
fraction; ESV: end-systolic volume; GLS: global longitudinal strain; GLSR: global longitudinal 
strain rate; GSRe: global strain rate during early diastolic filling; GSRivrt: global strain rate 
during the isovolumic relaxation period; LV: left ventricular. 
 
By definition, LVEF was within normal limits in all patients, whereas 
diastolic dysfunction was observed in 83 patients (45%). Regarding the 
speckle-tracking–derived parameters, GLS was −17.6±2.4%, GLSR was 
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−0.87±0.13 s−1, GSRivrt was 0.31±0.13 s−1, and GSRe was 0.97±0.28 
s−1. 
 
Coronary artery disease: correlation with clinical and 
echocardiographic parameters 
Based on the results of MSCT coronary angiography, 59 patients (32%) 
were classified as having no CAD. A total of 60 patients (33%) showed 
nonobstructive CAD, whereas at least 1 significant (≥50% luminal 
narrowing) stenosis was observed in the remaining 63 patients (35%).  
The clinical and echocardiographic characteristics of these 3 groups are 
summarized in Table 2 and Figure 2. Patients with normal coronary 
arteries were younger and more frequently female; in addition, they 
showed a lower prevalence of coronary risk factors and less often had 
typical angina. Consequently, the pretest likelihood of obstructive CAD, 
assessed using the Duke Clinical Score, was significantly lower in this 
group of patients as compared to those with nonobstructive CAD and 
obstructive CAD (analysis of variance p <0.001). No significant difference 
in LVEF was noted among the 3 groups, whereas the patients with 
obstructive CAD showed a higher prevalence of diastolic dysfunction, as 
compared to the other 2 groups (Table 2). 
A progressive impairment of the speckle-tracking parameters was 
observed across the 3 groups of patients (Figure 2); specifically, patients 
with obstructive CAD had significantly impaired GLS and GLSR, as 
compared to the other 2 groups (Figure 2). In addition, patients with 
obstructive CAD showed significantly impaired GSRivrt and GSRe, as 
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Table 2. Clinical and echocardiographic characteristics of the patient population in relation 
to the presence of coronary artery disease 
 No CAD 
 
(n = 59) 
Non-obstructive 
CAD 
(n = 60) 
Obstructive 
CAD 
(n = 63) 
p value 
Age (years) 49±9 *† 54±9 57±10 <0.001 
Male gender 26 (44%) 
‡ 
35 (58%) 47 (75%) 0.003 
Family history of CAD 29 (49%) 24 (40%) 28 (44%) 0.60 
Diabetes 8 (14%) 15 (25%) 19 (30%) 0.086 
Hypertension 25 (42%) 30 (50%) 40 (64%) 0.060 
Smoker 13 (22%) 
§ 
19 (32%) 27 (43%) 0.048 
Hypercholesterolemia 11 (19%) 
*† 
26 (43%) 37 (59%) <0.001 
BMI 26.2±4.6 27.8±4.7 26.5±4.0 0.11 
Symptoms 
- asymptomatic 
- non-anginal or 
atypical chest pain 


































LVEDV (ml) 107±32 105±30 111±29 0.51 
LVESV (ml) 41±15 40±15 43±15 0.56 
LVEF (%) 63±8 62±7 62±8 0.86 
LV mass index 
(g/m2) 




dysfunction grade 1 
- diastolic 




















E/E’ ratio 8.7±2.7 § 10.2±3.5 10.9±5.8 0.014 
* = p <0.05 vs. CAD <50%. † = p <0.001 vs. CAD ≥50%. ‡ = p <0.01 vs. CAD ≥50%. § = 
p <0.05 vs. CAD ≥50%. ║ = p <0.001 vs. CAD <50%. Abbreviations as in Table 1. 
 
Incremental	  Value	  of	  Subclinical	  Left	  Ventricular	  Systolic	  Dysfunction	  for	  the	  
Identification	  of	  Patients	  With	  Obstructive	  Coronary	  Artery	  Disease	   153	  
	  
 
Figure 2. Progressive impairment of the speckle-tracking parameters with 
increasing severity of CAD. Differences in GLS (panel A), GLSR (panel B), 
GSRivrt (panel C), and GSRe (panel D) among patients with no CAD (white bars), 
nonobsructive CAD (gray bars), and obstructive CAD (black bars). 
 
Univariate and multivariate analysis 
Table 3 shows the results of the univariate and multivariate logistic 
regression analysis performed to determine the independent correlates of 
obstructive CAD. At univariate analysis, several variables were 
significantly related to obstructive CAD as follows: Duke Clinical Score, LV 
mass index, presence of diastolic dysfunction, GLS, GLSR, GSRivrt, and 
GSRe. However, at multivariate analysis, only high Duke Clinical Score 
(odds ratio [OR] 3.21, 95% CI 1.02-10.09, p = 0.046), presence of 
diastolic dysfunction (OR 3.72, 95% CI 1.44-9.57, p = 0.006), and GLS 
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(OR 1.97, 95% CI 1.43-2.71, p <0.001) were independent factors 
associated with obstructive CAD. 
At ROC curve analysis (Figure 3), GLS ≥−17.4% had the highest 
sensitivity and specificity for identification of patients with obstructive 
CAD (83% and 77%, respectively). 
 
Table 3. Univariate and multivariate logistic regression analyses to determine the 
independent correlates of obstructive coronary artery disease 
 Univariate Multivariate 
 OR (95% CI) p value OR (95% CI) p value 
Duke Clinical Score 
- intermediate vs. low 













LVEF * 0.99 (0.95-1.03) 0.60 - - 
LV mass index * 1.02 (1.01-1.04) 0.001 1.01 (0.99-1.03) 0.33 
Presence of diastolic 
dysfunction 
3.07 (1.63-5.80) 0.001 3.72 (1.44-9.57) 0.006 
E/E’ ratio * 1.09 (0.99-1.19) 0.055 - - 
GLS * 2.20 (1.73-2.80) <0.001 1.97 (1.43-2.71) <0.001 
GLSR † 2.36 (1.69-3.28) <0.001 1.39 (0.91-2.13) 0.13 
GSRivrt † 0.62 (0.48-0.82) 0.001 0.88 (0.61-1.27) 0.50 
GSRe † 0.77 (0.68-0.88) <0.001 1.17 (0.96-1.44) 0.12 
   C-statistic = 0.89 
*: OR and 95% CI are intended for 1 unit increase. †: OR and 95% CI are intended for 0.1 
unit increase. CI: confidence intervals; OR: odds ratio. Other abbreviations as in Table 1. 
 
Incremental value of GLS to predict obstructive CAD 
The ROC curves were generated to determine the predictive value of Duke 
Clinical Score alone (model 1), Duke Clinical Score combined with the 
presence of diastolic dysfunction (model 2), and Duke Clinical Score 
combined with the presence of diastolic dysfunction and GLS (model 3), 
with respect to obstructive CAD. As shown in Figure 4, the presence of 
diastolic dysfunction did not provide any incremental value over the Duke 
Clinical Score (p = .25 for model 2 vs model 1). In contrast, by adding GLS 
(with ≥−17.4% used as cutoff value) (model 3), the ability to detect 
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obstructive CAD was significantly improved (area under the curve 0.83, 
95% CI 0.77-0.88, p <0.001 vs model 1 and model 2). 
The diagnostic impact of GLS on the estimated pretest likelihood of 
obstructive CAD is shown in Figure 5. 
 
 
Figure 3. Accuracy of GLS to detect obstructive CAD. Receiver-operator 
characteristic curve, testing the accuracy of GLS to detect obstructive CAD. GLS 
≥−17.4% provided the highest sensitivity (83%) and specificity (77%) for 
identification of patients with obstructive CAD (positive likelihood ratio 3.51, 
negative likelihood ratio 0.23). AUC indicates area under the curve. 
 
 
Figure 4. Incremental value of GLS. Receiver-operator characteristic curves 
testing the potential incremental value of diastolic dysfunction and GLS ≥−17.4% 
over the Duke Clinical Score to detect obstructive CAD. AUC indicates area under 
the curve. 




Figure 5. Effect of GLS on probability of obstructive CAD as a function of pretest 
likelihood. Estimated posttest likelihood of obstructive CAD yielded by the GLS 
compared to the pretest likelihood of obstructive CAD estimated using the Duke 
Clinical Score. The positive and negative likelihood ratios provided in the legend of 
Figure 3 were used to calculate the estimated posttest likelihood of obstructive 
CAD. 
 
Variabil ity and reproducibil ity of speckle-tracking parameters 
Variability and reproducibility of speckle-tracking measurements are 
shown in Table 4. The assessment of GLS had lower variability and higher 
reproducibility, as compared to the assessment of strain rate parameters. 
 
Table 4. Variability and reproducibility of speckle-tracking measurements 




 CV Mean±2SD ICC Mean±2SD ICC 
GLS 0.14 -0.20±0.53% 99% -0.25±1.37% 97% 
GLSR 0.15 -0.02±0.07s-1 97% -0.03±0.10s-1 93% 
GSRivrt 0.42 –0.01±0.10s-1 95% 0.01±0.13s-1 91% 
GSRe 0.29 0.03±0.14s-1 97% -0.02±0.21s-1 95% 
CV: coefficient of variation; ICC: intraclass correlation coefficient; SD: standard deviation. 
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The results of the present evaluation can be summarized as follows: (1) 
both LV diastolic dysfunction and subclinical LV systolic dysfunction are 
independently related to obstructive CAD and (2) only the presence of 
subclinical LV systolic dysfunction provides significant incremental value 
over the Duke Clinical Score for the identification of patients having 
obstructive CAD. 
 
Relation between CAD and LV diastolic dysfunction 
Coronary artery disease is considered one of the potential causes of LV 
diastolic dysfunction.24 Previous studies indeed showed a high prevalence 
of global and regional LV diastolic dysfunction in patients with CAD and 
normal LV systolic function.6-8 Moreover, a progressive impairment of LV 
relaxation has been observed in relation to the severity of coronary 
atherosclerosis and the number of diseased vessels,6,25 and a reversal of 
these abnormalities has been described after percutaneous coronary 
intervention.26,27 Several mechanisms have been proposed to explain this 
association. In particular, it has been postulated that repetitive episodes 
of subclinical ischemia may impair LV relaxation, which is an active, 
energy-dependent process.28 In addition, the presence of severely 
reduced coronary flow may induce structural remodeling of the 
myocardium (ie, myocardial fibrosis and hypertrophy and glycogen 
accumulation), leading to LV diastolic dysfunction.6 
Confirming these previous observations, an independent relation between 
LV diastolic dysfunction and obstructive CAD was observed in the present 
evaluation. However, the clinical use of this relation appeared to be 
limited because the presence of LV diastolic dysfunction did not provide 
any incremental value over the traditional assessment of pretest 
likelihood of obstructive CAD (Duke Clinical Score). Indeed, other factors 
(ie, diabetes mellitus, hypertension) also can play a role in determining LV 
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diastolic dysfunction,29,30 potentially reducing its accuracy in identifying 
patients with obstructive CAD. 
 
Relation between CAD and subclinical LV systolic dysfunction 
Few previous studies addressed the issue of subclinical LV systolic 
dysfunction in relation to CAD, providing contradictory results. For 
instance, Bolognesi et al.31 observed an impairment of LV longitudinal 
shortening (assessed by tissue-Doppler and long-axis M-mode 
echocardiography), despite normal LVEF, among patients with 
obstructive CAD. Conversely, Yuda et al.6 did not observe any difference 
in systolic myocardial velocity and strain rate (assessed by tissue-Doppler 
echocardiography) between LV segments subtended by vessels with and 
without obstructive CAD. More recently, Edvardsen et al.9 evaluated the 
relation between myocardial systolic strain and strain rate (assessed by 
tagged magnetic resonance imaging) and CAD (expressed as calcium 
score by MSCT or electron-beam computed tomography) in a large cohort 
of patients without history of CAD and with normal LVEF. An impairment 
of regional LV systolic function was observed in relation to the presence 
of coronary atherosclerosis. 
In the present evaluation, speckle-tracking echocardiography and MSCT 
coronary angiography were used to evaluate the presence of subclinical 
LV systolic dysfunction and CAD, respectively, in a cohort of patients with 
increased risk profile and/or stable chest pain and normal LVEF. Speckle-
tracking echocardiography (used to assess strain and strain rate) 
provides a direct measure of myocardial deformation and can therefore be 
used to detect subtle abnormalities in LV systolic function.13 The MSCT 
coronary angiography provides direct noninvasive visualization of the 
coronary arteries, allowing evaluation of CAD at an early stage.10 
Interestingly, a progressive impairment of GLS and GLSR was observed 
with increasing severity of CAD; in addition, an independent relation 
between GLS and obstructive CAD was found. These data support the 
hypothesis that subclinical myocardial damage may be a marker of 
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coronary atherosclerosis even in the absence of myocardial infarction, 
mainly because of small-vessel microembolization, endothelial 
dysfunction, or chronic ischemia.9 
 
Clinical implications 
Besides demonstrating a strong independent relation between subclinical 
LV systolic dysfunction and obstructive CAD, the present evaluation 
showed a significant incremental value of GLS over the Duke Clinical Score 
for identification of patients with obstructive CAD. Especially among the 
patients with low or intermediate Duke Clinical Score, the presence of 
subclinical LV systolic dysfunction significantly increased the likelihood of 
having obstructive CAD. Importantly, the assessment of GLS had lower 
variability and higher reproducibility, as compared to the assessment of 
strain rate parameters; these data further confirm the clinical use of GLS 
and may partially explain why strain rate parameters were not 
independently related to obstructive CAD. 
Accordingly, routine screening for subclinical LV systolic dysfunction 
among patients with coronary risk factors and/or stable chest pain may 
possibly refine the traditional clinical assessment and may be useful for 




The LV diastolic dysfunction and subclinical systolic dysfunction are 
independently related to the presence of obstructive CAD. In particular, 
subclinical LV systolic dysfunction provides significant incremental value 
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Doppler flow techniques in patients with coronary artery disease and normal 
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Background. Accurate and reproducible assessment of left ventricular 
(LV) systolic function is important in patients with acute myocardial 
infarction (AMI). Real-time 3-dimensional echocardiography (RT3DE) is an 
accurate technique, but it relies heavily on good image quality. The aim of 
the present study was to evaluate the incremental value of contrast-
enhanced RT3DE. 
Methods. A total of 140 consecutive patients (58±11 years, 78% men) 
with ST-elevation AMI clinically underwent nonenhanced and contrast-
enhanced RT3DE within 24 hours from AMI to evaluate global and regional 
LV systolic function. Endocardial border definition was graded for each of 
the 16 LV segments as follows: 0 = border invisible, 1 = border visualized 
only partially, and 2 = complete visualization of the border. Three image-
quality groups (good, fair, and uninterpretable) were identified. Left 
ventricular volumes and ejection fraction were measured off-line. Wall 
motion was graded for each visible segment as follows: 1 = normal, 2 = 
hypokinetic, 3 = akinetic, and 4 = dyskinetic. 
Results. During contrast-enhanced RT3DE, as compared with 
nonenhanced RT3DE, the number of segments with complete visualization 
of the endocardial border increased from 66% to 84% (p <0.001); and 
the number of patients with a good-quality echocardiogram increased 
from 59% to 94% (p <0.001). Intra- and interobserver agreement for 
assessment of global and regional LV systolic function improved during 
contrast-enhanced RT3DE, as compared with nonenhanced RT3DE. 
Conclusions. Assessment of LV systolic function in AMI patients with 
RT3DE is frequently hampered by suboptimal echocardiographic quality. 
Contrast-enhanced RT3DE is of incremental value, improving the 
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The assessment of global and regional left ventricular (LV) systolic 
function is extremely important among patients with acute myocardial 
infarction (AMI) because it carries significant therapeutic and prognostic 
implications.1-6 Recently, real-time 3-dimensional echocardiography 
(RT3DE) has been introduced for assessment of LV function and volumes. 
Real-time 3D echocardiography has been validated against magnetic 
resonance imaging and found to be more accurate and reproducible as 
compared with 2-dimensional echocardiography (2DE).7-13 However, even 
more than 2DE, RT3DE relies heavily on the presence of good image 
quality.14,15 The use of intravenous contrast agents during 2DE has been 
shown to be of incremental value, improving LV endocardial border 
visualization among patients with suboptimal image quality and increasing 
the accuracy and reproducibility of LV systolic function measurements.16-
22 In contrast, data regarding the use of echo-contrast during RT3DE are 
scarce.14,23-25 In particular, no specific data exist about the efficacy of 
contrast-enhanced RT3DE performed early after AMI; the safety of 
contrast-enhanced echocardiography early after AMI was recently 
reported.26 The aim of the present study was therefore to investigate, in 
a large cohort of consecutive patients with AMI, the potential incremental 
value of contrast-enhanced RT3DE over nonenhanced RT3DE for 





The study population consisted of 140 patients admitted to the coronary 
care unit because of ST-elevation AMI. The diagnosis of ST-elevation AMI 
was made on the basis of typical electrocardiographic changes and/or 
ischemic chest pain associated with elevation of cardiac biomarkers.27 
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All patients underwent immediate coronary angiography and primary 
percutaneous coronary intervention. As part of the clinical workup, RT3DE 
(with echo-contrast) was performed in the coronary care unit within 24 
hours from patients' admission to accurately evaluate global and regional 
LV systolic function. Of note, the safety profile of echo-contrast infusion 




Patients were imaged in left lateral decubitus position with a commercially 
available system (Vivid 7; GE Healthcare, Horten, Norway) equipped with 
a 3-V phased array transducer (2.5 MHz). First, apical full-volume 3D data 
sets were acquired in harmonic mode, integrating, during a brief breath 
hold, 8 R wave–triggered subvolumes into a larger pyramidal volume 
(90° by 90°) with a complete capture of the LV. Thereafter, the same 
acquisition was repeated during echo-contrast administration (Luminity; 
Bristol-Myers Squibb Pharma, Bruxelles, Belgium) to optimize LV border 
delineation. Each patient received an intravenous infusion of 1.3 ml of 
echo-contrast diluted in 50 ml of 0.9% NaCl solution; the rate of infusion 
was initially set at 4.0 ml/min and then titrated to achieve optimal LV 
chamber opacification and endocardial border delineation.28 Contrast-
enhanced RT3DE was performed in harmonic mode at low mechanical 
index (0.26), and care was taken to record the images at a phase when 
echo-contrast flow was relatively stable with absent or minimal swirling in 
the apex. The 3D data sets were digitally stored for the off-line analysis. 
 
Echocardiographic analysis 
The 3D data sets were analyzed online for the analysis of LV chamber 
opacification and off-line for the analysis of LV endocardial border 
definition and LV volumes and function. The off-line analysis was 
performed using a dedicated software (4D LV-Analysis; TomTec, Munich, 
Germany) by an observer who had no knowledge of the patient's identity, 
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medical history, and symptom status. As described elsewhere,29 the 
software automatically displays in a quad screen the 4-chamber view, as a 
reference view; the 2- and 3- chamber views with default interplane 
angles at 60°; and a short-axis view (Figure 1). The interplane angles can 
be manually modified to obtain adequate orientation of the 3 apical views, 
and their meeting point can be adjusted in the middle of the LV cavity to 
avoid LV foreshortening. This procedure can also be used to evaluate 
regions between the 3 adjacent conventional apical views. 
 
 
Figure 1. Panel A. Example of fair-quality echocardiogram during nonenhanced 
RT3DE. Panel B. Optimal LV chamber opacification and improved endocardial 
border definition during contrast-enhanced RT3DE in the same patient. The 3 
apical views are shown with the 4-chamber view as a reference view in the top 
right and the 2- and 3-chamber views in the bottom left and bottom right, 
respectively. Top left: short-axis view. 
 
LV chamber opacification 
The degree of LV chamber opacification during echo-contrast 
administration was graded according to 5-point rating scale:17,28 0 = no 
contrast enhancement, 1 = weak or little contrast enhancement, 2 = 
adequate contrast enhancement that facilitates image interpretation, 3 = 
full contrast enhancement that definitely aids image interpretation, and 4 
= excessive contrast enhancement that hampers interpretation. The 
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percentage of patients with adequate-to-full contrast enhancement was 
calculated. The mean time needed to achieve adequate-to-full contrast 
enhancement was measured. 
 
LV endocardial border definition 
Qualitative assessment of the endocardial border was performed in both 
nonenhanced and contrast-enhanced images. A standard 16-segment 
model was used.30 Adequacy of LV endocardial border definition was 
graded for each of the 16 cardiac segments as follows:22 0 = border 
invisible, 1 = border visualized only partially throughout the cardiac cycle 
and/or incomplete segment length, and 2 = complete visualization of the 
border. A global endocardial visualization score was calculated as the sum 
of each LV segment's score. 
On basis of the global score, 3 image-quality groups were defined: good 
(score 25-32), fair (score 17-24), and uninterpretable (score ≤16).15,22 
Uninterpretable echocardiograms were deemed nondiagnostic, and 
further analyses of LV volumes and global and regional LV functions were 
considered not feasible. 
 
LV volumes and global systolic function 
The algorithm used by the software to calculate LV end-diastolic volume 
(EDV), LV end-systolic volume (ESV), and LV ejection fraction (EF) is 
described in detail elsewhere.29 Briefly, the endocardial border is manually 
traced in the 3 apical views (including LV trabeculations and papillary 
muscles within the cavity) in both the end-diastolic and end-systolic 
frames. Subsequently, the software automatically identifies the 
endocardial border in the entire 3D data set; further manual adjustments 
are possible in approximately 30 coronal and sagittal planes. Finally, a 




Real-­‐time	  3-­‐Dimensional	  Echocardiography	  Early	  After	  Acute	  Myocardial	  
Infarction:	  Incremental	  Value	  of	  Echo-­‐Contrast	  for	  Assessment	  of	  Left	  
Ventricular	  Function	   173	  
	  
LV regional function 
Qualitative assessment of the regional wall motion was performed in both 
nonenhanced and contrast-enhanced images, according to the same 16-
segment model used for the evaluation of LV endocardial border 
definition.30 Segments with invisible endocardial border were excluded 
from this analysis. Wall motion was graded for each of the visualized 
segments as follows: 1 = normal, 2 = hypokinetic, 3 = akinetic, and 4 = 
dyskinetic. A global wall motion score index (WMSI) was calculated as the 
sum of each LV segment's score divided by the number of visualized 
segments. 
 
Reproducibil ity of RT3DE measurements 
The data sets of 20 patients with a good-quality echocardiogram and 20 
patients with a fair-quality echocardiogram during nonenhanced RT3DE 
were randomly selected and analyzed again 1 month later by the original 
observer and by a second observer who was blinded to the results of the 
previous analysis. Intra- and interobserver agreement was assessed for 




Continues variables are expressed as mean and SD. Categorical data are 
presented as absolute numbers and percentages. The global endocardial 
visualization score and the measurements of LV volumes, LVEF, and WMSI 
were compared between the 2 imaging techniques with the paired t test. 
To determine whether there was a statistically significant difference in 
the comparison between categorical variables, the McNemar test was 
performed for binary data and the marginal homogeneity test for 
multinomial response data. 
Intra- and interobserver agreement in the measurements of LV volumes 
and LVEF were assessed using Bland-Altman analysis and expressed as 
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the mean difference between the 2 measurements ±2 SDs. To evaluate 
intra- and interobserver agreement in the grading of regional wall motion, 
weighted κ test was used and the level of agreement was interpreted as 
follows: 0 to 0.2 = poor to slight, 0.21 to 0.4 = fair, 0.41 to 0.6 = 
moderate, 0.61 to 0.8 = substantial, and 0.81 to 1.0 = nearly perfect. A 
p value < 0.05 was considered statistically significant. Statistical analysis 
was performed using the SPSS software package (SPSS 15.0, Chicago, 
IL). 
The authors are solely responsible for the design and conduct of this 
study, all study analyses, the drafting and editing of the paper, and its 
final contents. No extramural funding was used to support this work. 
 
Table 1. Clinical and echocardiographic patient characteristics 
Variable n = 140 
Age (years) 58±11 
Gender (male/female) 109/31 
Diabetes 16 (11%) 
Family history of coronary artery disease 54 (39%) 
Hypercholesterolemia 26 (19%) 
Hypertension 50 (36%) 
Current or previous smoking 85 (61%) 
Previous myocardial infarction 15 (11%) 
Previous myocardial revascularization 12 (9%) 
Body mass index (kg/m²) 27±4 
Current anterior myocardial infarction 60 (43%) 
Current infarct-related artery 
- left anterior descending coronary artery 
- left circumflex coronary artery 










The baseline characteristics of the study population are summarized in 
Table 1. Mean age of the patients was 58±11 years; 109 (78%) were 
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male. The infarct-related artery was the left anterior descending coronary 
artery in 60 (43%) patients, the left circumflex coronary artery in 19 
(13%), and the right coronary artery in 61 (44%). Obstructive 
multivessel disease (ie, >1 vessel with a luminal narrowing ≥70%) was 
present in 51 (36%) patients. 
 
Echocardiography 
The mean infusion rate of echo-contrast was 3.0±0.6 ml/min, and the 
total infusion dose was on average 16 μL/kg. 
 
LV chamber opacification 
Adequate-to-full enhancement during echo-contrast infusion was noted in 
130 (93%) patients. Weak or little contrast enhancement was observed 
in 9 (6%) patients and excessive contrast enhancement in 1 (1%) 
patient. The mean time needed to achieve adequate-to-full LV contrast 
enhancement was 65±20 seconds. 
 
LV endocardial border definition 
During nonenhanced RT3DE, from the total number of 2,240 LV 
segments, the endocardial border was invisible in 243 (11%) and 
visualized only partially in 509 (23%). A complete visualization of the 
border was possible in 1,488 (66%) segments (Table 2). The mean global 
endocardial visualization score was 25±6. A total of 82 (59%) patients 
had a good-quality echocardiogram, whereas 44 (31%) and 14 (10%) 
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Overall segments  
(n = 2240) 
- border invisible 
- border visualized only partially 












Anterior wall segments  
(n = 420) 
- border invisible 
- border visualized only partially 












Antero-lateral wall segments 
(n = 420) 
- border invisible 
- border visualized only partially 













Anterior septum segments  
(n = 280) 
- border invisible 
- border visualized only partially 













Inferior wall segments  
(n = 420) 
- border invisible 
- border visualized only partially 












Infero-lateral wall segments  
(n = 280) 
- border invisible 
- border visualized only partially 













Inferior septum segments  
(n = 420) 
- border invisible 
- border visualized only partially 
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Figure 2. Image quality during nonenhanced and contrast-enhanced RT3DE. P 
<0.001 for comparison between the 2 imaging techniques. 
 
During contrast-enhanced RT3DE, a complete visualization of the border 
was possible in 1,890 (84%) segments (p <0.001 vs nonenhanced 
RT3DE) (Table 2). The LV endocardial border definition significantly 
improved in the segments of each LV wall (Table 2). As compared with 
nonenhanced RT3DE, the mean global endocardial visualization score 
improved to 29±3 (p <0.001). A total of 131 (94%) patients had a 
good-quality echocardiogram, whereas 7 (5%) and 2 (1%) had a fair-
quality and uninterpretable echocardiogram, respectively (p <0.001 vs 
nonenhanced RT3DE) (Figure 2). 
An example of LV chamber opacification and improved endocardial border 
definition during contrast-enhanced RT3DE, as compared with 
nonenhanced RT3DE, is displayed in Figure 1. 
 
LV volumes and global systolic function 
Nonenhanced RT3DE provided significantly lower values of LVEDV as 
compared with contrast-enhanced RT3DE (107±28 vs 113±27 ml, p 
<0.001). The values of LVESV were not statistically different between 
the 2 techniques (59±21 vs 61±20 ml, p = not significant). Accordingly, 
nonenhanced RT3DE provided slightly but significantly lower values of 
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LVEF (45±9% [median 46%, interquartile range 39-51%] vs 47±9% 
[median 47%, interquartile range 39-53%], p = 0.003). 
 
LV regional systolic function 
Wall motion score index assessed on nonenhanced and contrast-enhanced 
images was 1.8±0.4 and 1.7±0.4, respectively (p = 0.04). 
 
Reproducibil ity of RT3DE measurements 
Intra- and interobserver agreement for the measurements of LV volumes 
and LVEF and the grading of regional wall motion obtained with the 2 
techniques is shown in Table 3 and Table 4. The weakest agreements 
were observed among patients with a fair-quality echocardiogram. 
Contrast-enhanced RT3DE improved intra- and interobserver agreement 
in both good and fair echocardiograms. 
 
Table 3.  Intra- and inter-observer agreements for the measurements of left ventricular 
volumes and left ventricular global function, in relation to image quality during non-enhanced 
RT3DE 
 Good quality echocardiogram  
during non-enhanced RT3DE 
Fair quality echocardiogram  

















































Intra- and interobserver agreements for the measurements of LV volumes and LVEF were 
assessed using the method proposed by Bland and Altman and expressed as the mean 
difference between the 2 measurements ±2 SDs. 
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Table 4. Intra- and inter-observer agreements for the grading of left ventricular regional 
wall motion, in relation to image quality during non-enhanced RT3DE 
 Good quality echocardiogram  
during non-enhanced RT3DE 
Fair quality echocardiogram  




















LV RWM 0.65 0.87 0.54 0.85 
Intra- and interobserver agreements for the grading of LV RWM were assessed using the 




The current results show that, among unselected patients in the early 
stage of AMI, contrast-enhanced RT3DE has a high feasibility (93%) and is 
of incremental value for the assessment of LV systolic function. 
Specifically, as compared with nonenhanced RT3DE, (1) it significantly 
increased the number of LV segments with a complete visualization of the 
endocardial border (from 66% to 84%); (2) it increased the number of 
good-quality echocardiograms (from 59% to 94%); and (3) it reduced the 
number of fair-quality and uninterpretable echocardiograms (from 41% to 
6%). Moreover, intra- and interobserver agreement for the measurements 
of global and regional LV systolic function improved during contrast-
enhanced RT3DE, particularly among patients with fair-quality 
echocardiogram during nonenhanced RT3DE. 
 
Advantages and l imitations of RT3DE 
The most commonly used imaging modality for the evaluation of global 
and regional LV systolic function is 2DE. However, 2DE relies on 
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significant geometric assumptions, resulting in modest agreement with 
reference methods and fair reproducibility.17,31 
More recently, RT3DE has been proposed to overcome the above-
mentioned limitations of 2DE; RT3DE correlated well with magnetic 
resonance imaging for assessment of LV volumes and LVEF.8-11 In 
addition, it has been suggested that RT3DE has potential advantages for 
the evaluation of regional LV function in regions/planes that could not be 
adequately visualized with 2DE.7,13 
Because of its higher accuracy and reproducibility, RT3DE could be 
extremely useful for serial assessment of systolic function.32 Real-time 3D 
echocardiography would be particularly useful in AMI patients, in whom 
accurate assessment of LV function and volumes is important for 
prediction of future adverse events.2,3 
However, RT3DE still has several limitations; particularly, RT3DE image 
quality is highly dependent on the acoustic window because of a lower 
spatial and temporal resolution as compared with 2DE.11,24 Accordingly, 
adequate endocardial border delineation may be difficult on RT3DE still 
frames, even in the presence of relatively good-quality 2DE.33 Because of 
this limitation, most of the previous RT3DE studies included only patients 
with an optimal acoustic window.8-10 Few studies explored the feasibility 
of RT3DE, in relation to the image quality, for the assessment of LV 
systolic function in unselected population and reported a prevalence of 
uninterpretable or poor-quality RT3DE images in the range of 35%.15,24 
This issue may be even more prominent in patients with AMI, in whom 
adequate assessment of LV function and volumes is important for 
prognosis, but in whom RT3DE data acquisition may be hampered by 
reduced patient mobility.12,34 In the present study, 41% of 140 
consecutive patients referred to RT3DE within 24 hours from AMI had a 
fair-quality or uninterpretable echocardiogram. This percentage is in line 
with previous studies 15,24 and may also be related to technical limitations 
associated to the performance of RT3DE in the coronary care unit, as well 
as the high body mass index of our study population. 
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Incremental value of contrast-enhanced RT3DE 
In the subset of patients with inadequate RT3DE images, contrast agents 
could improve LV endocardial border visualization, increasing the 
feasibility, accuracy, and reproducibility of LV function assessment as 
previously reported with 2DE.16-22 
Thus far, few small studies 14,23-25 (16, 20, 39, and 50 patients, 
respectively) previously assessed the accuracy of contrast-enhanced 
RT3DE, reporting a good agreement between contrast-enhanced RT3DE 
and magnetic resonance imaging for assessment of LV function and 
volumes. 
However, data regarding the feasibility of contrast-enhanced RT3DE and 
its incremental value over nonenhanced RT3DE (in terms of improved 
image quality) have not been shown. In the present study, we reported 
our experience on the feasibility and efficacy of contrast-enhanced RT3DE 
in a large, unselected cohort of patients in the early stage of AMI. Echo-
contrast infusion ensured optimal LV opacification in 93% of the patients. 
Moreover, the definition of the endocardial border significantly increased 
with the use of echo-contrast, allowing more reliable and reproducible 
assessment of regional wall motion abnormalities. Of note, visualization of 
the anterior and anterolateral walls particularly improved with the use of 
echo-contrast. 
Overall, the prevalence of good-quality echocardiograms increased from 
59% to 94% with the intravenous contrast. The prevalence of fair image 
quality and uninterpretable echocardiograms decreased from 31% to 5% 
and from 10% to 1%, respectively. 
Taking into account these data, the use of echo-contrast should therefore 
be advocated whenever a confident and reproducible assessment of LV 
systolic function is not possible because of suboptimal RT3DE images to 
increase the number of patients who could benefit from an RT3DE 
assessment of LV systolic function. 
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Study l imitations 
The present study has some limitations that should be acknowledged. 
First, the semiautomated algorithm used for LV volume analysis requires 
manual tracing of the endocardial border in the 3 apical planes, which is a 
subjective procedure that could alter the reproducibility of the technique. 
Second, an independent criterion standard (eg, magnetic resonance 
imaging) was not performed; and therefore, data about accuracy of 
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Left ventricular (LV) diastolic filling is characterized by the formation of 
intraventricular rotational bodies of fluid (termed “vortex rings”) that 
optimize the efficiency of LV ejection. The aim of the present study was 
to evaluate the morphology and dynamics of LV diastolic vortex ring 
formation early after acute myocardial infarction (AMI), in relation to LV 
diastolic function and infarct size. A total of 94 patients with a first ST-
segment elevation AMI (59±11 years; 78% men) were included. All 
patients underwent primary percutaneous coronary intervention. After 48 
hours, the following examinations were performed: 2-dimensional 
echocardiography with speckle-tracking analysis to assess the LV systolic 
and diastolic function, the vortex formation time (VFT, a dimensionless 
index for characterizing vortex formation), and the LV untwisting rate; 
contrast echocardiography to assess LV vortex morphology; and 
myocardial contrast echocardiography to identify the infarct size. 
Patients with a large infarct size (≥3 LV segments) had a significantly 
lower VFT (p <0.001) and vortex sphericity index (p <0.001). On 
univariate analysis, several variables were significantly related to the VFT, 
including anterior AMI, LV end-systolic volume, LV ejection fraction, grade 
of diastolic dysfunction, LV untwisting rate, and infarct size. On 
multivariate analysis, the LV untwisting rate (β = −0.43, p <0.001) and 
infarct size (β = −0.33, p = 0.005) were independently associated with 
VFT. In conclusion, early in AMI, both the LV infarct size and the 
mechanical sequence of diastolic restoration play key roles in modulating 











The assessment of left ventricular (LV) diastolic function usually relies on 
noninvasive measures of LV relaxation and stiffness.1 More recently, the 
evaluation of LV muscle and fluid mechanics, using novel 
echocardiographic indexes and techniques, has been proposed to refine 
the assessment of LV diastolic function.2-5 In particular, 2-dimensional 
speckle tracking imaging enables the assessment of the complex torsional 
mechanics of the left ventricle. During systole, the contraction of the 
helically arranged subendocardial and subepicardial layers leads to the 
opposite rotation of the LV apex and LV base, the so-called LV twist.3,6 
During isovolumic relaxation, the reverse rotation of the LV apex and LV 
base (LV untwisting) releases the energy stored during LV systole. The 
restoring forces generate intraventricular pressure gradients contributing 
to early LV filling.3,6,7 These complex LV mechanics are associated with 
characteristic intraventricular fluid dynamics.4,8 During early LV filling, the 
blood flow forms intraventricular rotational bodies of fluid (so-called 
vortex rings) that are critical in optimizing the blood flow during LV 
ejection.4,8 These diastolic fluid dynamics can be noninvasively evaluated 
using color Doppler echocardiography or contrast echocardiography.9 In 
addition, a novel echocardiographic dimensionless index (vortex formation 
time [VFT]) has recently been introduced to quantitatively characterize 
the optimal conditions leading to vortex formation.5 
It is well known that myocardial injuries, such as those induced by acute 
myocardial infarction (AMI), negatively affect the LV diastolic function;10 
conversely, not much data regarding the effect of AMI on the VFT or 
vortex morphology are available. The knowledge of abnormalities 
involving the LV vortex formation in clinical setting would be useful, 
because it would provide direct information regarding the ultimate goal of 
LV performance (i.e., optimal blood flow). Accordingly, the aim of the 
present study was to quantify vortex ring formation using the 
dimensionless index of the VFT and to estimate the morphology of the 
190	   Chapter	  10	  
	  
vortex during routine contrast echocardiography early after AMI. In 
addition, we sought to correlate the dynamics of vortex ring formation 
with LV diastolic function, torsional mechanics, and the extent of 




The population consisted of 110 consecutive patients admitted to the 
coronary care unit for a first ST-segment elevation AMI. The diagnosis of 
AMI was determined from typical electrocardiographic changes and/or 
ischemic chest pain associated with the elevation of cardiac biomarkers.11 
All patients underwent immediate coronary angiography and primary 
percutaneous coronary intervention. The infarct-related artery was 
identified by the site of coronary occlusion during coronary angiography 
and electrocardiographic criteria. 
The clinical evaluation included 2-dimensional echocardiography with 
speckle-tracking analysis to assess the LV systolic and diastolic function, 
dimensionless index of VFT (see paragraph with equation below), and LV 
untwisting rate; contrast echocardiography to assess LV vortex 
morphology; and myocardial contrast echocardiography (MCE) to assess 
the extent of perfusion abnormalities and infarct size. These 
echocardiographic examinations were performed 48 hours after primary 
percutaneous coronary intervention. Subsequently, the relations between 
VFT and vortex morphology with LV diastolic function, LV untwisting rate, 
and infarct size (as assessed from MCE) were evaluated. 
Patients with significant (moderate or severe) valvular heart disease or 
rhythm other than sinus were not included. 
The local ethical committee approved the study protocol, and all patients 
provided informed consent. 
All patients with AMI underwent imaging in the left lateral decubitus 
position using a commercially available system (Vivid 7 Dimension, GE 
Healthcare, Horten, Norway) equipped with a 3.5-MHz transducer. 
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Standard 2-dimensional images and Doppler and color Doppler data were 
acquired from the parasternal and apical views (2-, 3- and 4-chamber) 
and digitally stored in cine-loop format. The analyses were subsequently 
performed off-line using EchoPAC, version 7.0.0 (GE Healthcare, Horten, 
Norway). The LV end-diastolic and end-systolic volumes were measured 
according to the Simpson's biplane method, and the LV ejection fraction 
was calculated as [(end-diastolic volume − end-systolic volume)/end-
diastolic volume] × 100.12 
As previously reported,1 transmitral and pulmonary vein pulsed-wave 
Doppler tracings were used to classify the diastolic function as normal, 
diastolic dysfunction grade 1 (mild), diastolic dysfunction grade 2 
(moderate), diastolic dysfunction grade 3 (severe), or diastolic 
dysfunction grade 4 (severe). 
The VFT, a dimensionless index that characterizes the optimal conditions 




where SV is the stroke volume, β the fraction of stroke volume 
contributed from the atrial component of LV filling and calculated from 
Doppler spectra of the E and A waves, and D the mitral valve diameter in 
centimeters. The mitral valve diameter was obtained by averaging the 
largest mitral orifice diameters measured during early diastolic filling in 
the 2-, 3-, and 4-chamber apical views. 
Speckle tracking analysis was applied to evaluate the LV untwisting rate. 
Parasternal short-axis images of the left ventricle were acquired at 2 
different levels: the basal level, identified by the mitral valve and the 
apical level, identified as the smallest cavity achievable distally to the 
papillary muscles (moving the probe down and slightly laterally, if 
needed). The frame rate was 60 to 100 frames/s, and 3 cardiac cycles 
for each short-axis level were stored in cine-loop format for off-line 
analysis (EchoPAC, version 7.0.0, GE Healthcare). The endocardial border 
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was traced at an end-systolic frame, and the region of interest was 
chosen to fit the whole myocardium. The software allows the operator to 
check and validate the tracking quality and to adjust the endocardial 
border or modify the width of the region of interest, if needed. Each 
short-axis image was automatically divided into 6 standard segments: 
septal, anteroseptal, anterior, lateral, posterior, and inferior. The software 
calculated the LV rotation from the apical and basal short-axis images as 
the average angular displacement of the 6 standard segments, referring 
to the ventricular centroid, frame by frame. Counterclockwise rotation 
was marked as a positive value and clockwise rotation as a negative value 
when viewed from the LV apex. LV twist was defined as the net difference 
(in degrees) of the apical and basal rotation at the isochronal points. The 
opposite rotation after LV twist was defined as the LV untwist and the 
time derivative of the LV untwist was defined as the LV untwisting rate 
(°/s). 
Immediately after 2-dimensional echocardiography, contrast 
echocardiography was performed using the same ultrasound system. 
Luminity (Bristol-Myers Squibb Pharma, Brussels, Belgium) was used as 
the contrast agent. A slow intravenous bolus of echocardiographic 
contrast (0.1 to 0.2 ml) was administered, followed by 1 to 3 ml of 
normal saline flush.4 Apical 3- and 4-chamber views were acquired using a 
low-power technique (0.1 to 0.4 mechanical index), and the focus was set 
in the middle of the left ventricle. The machine settings were optimized to 
obtain the best possible visualization of LV vortex formation. The frame 
rate was 60 to 100 frames/s, and ≥3 cardiac cycles were stored in cine-
loop format for off-line analysis (EchoPAC, version 7.0.0, GE Healthcare). 
For the evaluation of vortex morphology, the vortex length and width 
relative to the LV volume were measured during early diastolic filling in 
the apical 3-chamber view. A vortex sphericity index was calculated as the 
vortex length/vortex width ratio. 
Immediately after contrast echocardiography, MCE was performed to 
evaluate myocardial perfusion to assess the infarct size after AMI. The 
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same ultrasound system was used, and the 3 standard apical views were 
acquired using a low-power technique (0.1 to 0.26 mechanical index). The 
background gains were set such that minimal tissue signal was seen, and 
the focus was set at the level of the mitral valve. Luminity (Bristol-Myers 
Squibb Pharma) was used as the contrast agent. Each patient received an 
infusion of 1.3 ml of echocardiographic contrast diluted in 50 ml of 0.9% 
NaCl solution through a 20-gauge intravenous catheter in a proximal 
forearm vein. The infusion rate was initially set at 4.0 ml/min and then 
titrated to achieve optimal myocardial enhancement without attenuation 
artifacts.14 The machine settings were optimized to obtain the best 
possible myocardial opacification with minimal attenuation. At least 15 
cardiac cycles after high mechanical index (1.7) microbubble destruction 
were stored in cine-loop format for off-line analysis (EchoPAC, version 
7.0.0, GE Healthcare).15 The left ventricle was divided according to a 
standard 16-segment model, and a semiquantitative scoring system was 
used to assess contrast intensity after microbubble destruction:12 1, 
normal/homogenous opacification; 2, reduced/patchy opacification; and 
3, minimal or absent contrast opacification.15,16 A myocardial perfusion 
index (MPI) was derived by adding the contrast scores of all segments and 
dividing by the total number of segments.15,16 In accordance with the 
number of segments showing minimal or absent contrast opacification, 
patients were categorized as having a small infarct size (<3 segments 
with minimal or absent contrast opacification) or a large infarct size (≥3 
segments with minimal or absent contrast opacification).17 
Continues variables are expressed as the mean±SD, when normally 
distributed, and as the median and interquartile range, when non-normally 
distributed. Categorical data are presented as absolute numbers and 
percentages. Differences in continuous variables were assessed using the 
Student t test or the Mann-Whitney U test, as appropriate. The chi-square 
test or Fisher's exact test, if appropriate, were computed to assess 
differences in categorical variables. 
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Linear regression analyses were performed to evaluate the relation 
between the VFT and the vortex sphericity index; the vortex parameters 
and the grade of diastolic dysfunction; the vortex parameters and the LV 
untwisting rate; and the vortex parameters and infarct size (as assessed 
from MCE). Univariate and multivariate linear regression analyses (enter 
model) were performed to evaluate the relation between VFT and the 
following clinical and echocardiographic variables: age, gender, infarct 
location (anterior vs nonanterior), multivessel disease, LV end-diastolic 
volume, LV end-systolic volume, LV ejection fraction, diastolic 
dysfunction grade, LV untwisting rate, and MPI. Only significant variables 
on univariate analysis were entered as covariates in the multivariate 
model. A p value of <0.05 was considered statistically significant. 
Statistical analysis was performed using the Statistical Package for Social 




A total of 16 patients were excluded because of suboptimal 
echocardiographic images that prevented adequate analysis of the 
speckle-tracking data, vortex morphology, or myocardial perfusion. The 
clinical characteristics of the 94 patients included in the study are listed in 
Table 1, and the echocardiographic characteristics are listed in Table 2. 
The mean LV ejection fraction was 47±10%. Most (54%) had grade 1 
diastolic dysfunction. From the speckle tracking analysis findings, the 
diastolic function was characterized by a mean peak untwisting rate of 
−94±32°/s. From the LV hydrodynamics evaluation, the VFT was 
1.4±0.6, and the vortex sphericity index was 1.1±0.2. 
As shown in Figure 1, a good relation between the VFT and vortex 
sphericity index was observed (r = 0.61; p <0.001). Both LV vortex 
parameters were weakly related to the LV diastolic function (Figure 2). In 
contrast, good relations between the VFT and the LV untwisting rate (r = 
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0.65; p <0.001) and between the vortex sphericity index and the LV 
untwisting rate (r = 0.61; p <0.001) were observed (Figure 3). 
 
Table 1. Clinical patient characteristics 
Variable n = 94 
Age (years) 59±11 
Men 73 (78%) 
Diabetes mellitus 12 (13%) 
Hypercholesterolemia * 15 (16%) 
Hypertension † 37 (39%) 
Current or previous smoking 52 (55%) 
Anterior wall myocardial infarction 47 (50%) 
Infarct-related coronary artery 
- left anterior descending 






Multi-vessel coronary disease 36 (38%) 
Peak troponin T (µg/l) 2.9 (1.6-7.5) 
Data are expressed as mean±SD or median (interquartile range), and n (%). *: Defined as 
total cholesterol ≥240 mg/dl. †: Defined as systolic blood pressure ≥140 mmHg and/or 
diastolic blood pressure ≥90 mmHg. 
 
According to the results from MCE, 69 patients (73%) with AMI had a 
small infarct size (<3 segments with minimal or absent contrast 
opacification) and 25 (27%) had a large infarct size (≥3 segments with 
minimal or absent contrast opacification). The echocardiographic 
characteristics of these 2 groups are summarized in Table 2. Patients with 
a small infarct size had a significant greater LV ejection fraction compared 
to patients with a large infarct size (51±8% vs 39±8%; p <0.001). 
No significant difference in the grade of diastolic dysfunction was 
observed between patients with a small and large infarct size; most of the 
patients in both groups (52% and 60%, respectively) had grade 1 
diastolic dysfunction. However, the LV untwisting rate was significantly 
impaired in the patients with a large infarct size (−69±27°/s vs 
−103±29°/s; p <0.001). Regarding the vortex parameters, patients 
with a large infarct size had a significantly lower VFT (1.0±0.5 vs 
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1.6±0.5; p <0.001) and vortex sphericity index (0.9±0.2 vs 1.2±0.2; p 
<0.001). As shown in Figure 4, a good relation between the VFT and MPI 
(expressing infarct size) (r = 0.63; p <0.001) and between the vortex 
sphericity index and MPI (r = 0.71; p <0.001) was observed. 
 
Table 2. Echocardiographic characteristics 
 All AMI 
patients 
(n = 94) 
Small 
infarct 
(n = 69) 
Large 
infarct 
(n = 25) 
p 
value 
Left ventricular end-diastolic 
volume (ml) 
105±28 104±25 107±36 0.69 
Left ventricular end-systolic 
volume (ml) 
56±22 52±18 66±29 0.024 
Left ventricular ejection fraction 
(%) 
47±10 51±8 39±8 <0.001 
E wave velocity (cm/sec) 62±0.18 62±0.18 62±0.18 0.97 
E wave deceleration time (msec) 201±59 207±55 184±67 0.11 
A wave velocity (cm/sec) 68±0.17 68±0.13 70±0.25 0.76 
Diastolic function 
- grade 0 
- grade 1 
- grade 2 



















Untwisting rate (°/sec) -94±32 -103±29 -69±27 <0.001 
Vortex formation time 1.4±0.6 1.6±0.5 1.0±0.5 <0.001 
Vortex length/left ventricular 
volume (cm/ml) 
0.02±0.01 0.02±0.01 0.01±0.01 0.19 
Vortex width/left ventricular 
volume (cm/ml) 
0.01±0.01 0.01±0.01 0.02±0.01 0.026 
Vortex sphericity index 1.1±0.2 1.2±0.2 0.9±0.2 <0.001 
Myocardial perfusion index 1.4±0.3 1.2±0.2 1.7±0.3 <0.001 
Data are expressed as mean±SD and n (%). 
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Figure 1. Relation between VFT and vortex sphericity index. 
 
 
Figure 2. Relation between grades of LV diastolic dysfunction and (left panel) 
VFT and (right panel) vortex sphericity index. 
 
 
Figure 3. Relation between LV untwisting rate and (left panel) VFT and (right 
panel) vortex sphericity index. 
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Figure 4. Relation between infarct size (expressed as MPI) and (left panel) VFT 
and (right panel) vortex sphericity index. 
 
Table 3 lists the results of the univariate and multivariate linear regression 
analyses performed to determine the factors related to VFT among 
patients with AMI. On univariate analysis, several variables were 
significantly related to VFT, including anterior AMI, LV end-systolic 
volume, LV ejection fraction, diastolic dysfunction grade, LV untwisting 
rate, and MPI. On multivariate analysis, only the LV untwisting rate (β = 
−0.43, p <0.001) and MPI (β = −0.33, p = 0.005) were independently 
associated with the VFT. 
 
Table 3. Univariate and multivariate linear regression analyses to determine independent 
correlates of vortex formation time (VFT) 
 Univariate Multivariate 
 β p value β p value 
Age -0.16 0.12 - - 
Men -0.024 0.82 - - 
Anterior myocardial infarction -0.37 <0.001 -0.059 0.49 
Multi-vessel disease -0.15 0.16 - - 
Left ventricular end-diastolic volume 0.065 0.53 0.18 0.62 
Left ventricular end-systolic volume -0.21 0.039 0.053 0.91 
Left ventricular ejection fraction 0.53 <0.001 0.092 0.70 
Grade of diastolic dysfunction  -0.35 0.001 -0.081 0.31 
Untwisting rate -0.65 <0.001 -0.43 <0.001 
Myocardial perfusion index -0.63 <0.001 -0.33 0.005 
Abbreviations as in Table 2. 
 
 




The results of the present study can be summarized as follows: both the 
VFT and the vortex sphericity index were weakly related to global LV 
diastolic function, and a good relation was observed between the LV 
vortex parameters and LV untwisting rate. Second, both the VFT and the 
vortex sphericity index had a good relation with infarct size (as assessed 
by MCE), indicating progressive impairment of LV diastolic fluid dynamics 
with an increasing extent of myocardial damage. Finally, on multivariate 
analysis, a significant independent relation was observed between VFT 
and both the LV untwisting rate and the MPI. 
Several investigators have previously demonstrated the process of vortex 
formation during LV filling using numeric or physical models and flow 
visualization techniques (i.e., cardiac magnetic resonance imaging, color 
Doppler echocardiography, and MCE) in clinical studies.4,8,9,18-21 The 
process of vortex formation starts immediately after the onset of the 
early diastolic phase, lasting the whole diastolic period.4 It is related to the 
difference in velocity between the high-speed inflow jet after mitral valve 
opening and the surrounding still fluid in the left ventricle. The shear layer 
between the moving and the still part of the blood promotes a natural 
swirling of flow inside the left ventricle, leading to the vortex 
formation.4,22 
The LV vortex has been shown to optimize the diastolic fluid dynamics 
and the efficiency of systolic ejection of blood. The LV vortex redirects 
the blood flow from the LV base to the LV apex during isovolumic 
relaxation and toward the LV outflow tract and aorta during isovolumic 
contraction.4,22,23 In addition, the LV vortex constitutes a kinetic energy 
reservoir (storing the kinetic energy of the high-speed inflow jet) and, 
consequently, enhances the ejection of blood during systole.24 The 
premature loss or absence of diastolic LV vortex would conversely lead to 
the dissipation of the stored kinetic energy, resulting in an increased 
myofiber cardiac work and oxygen demand.24 
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In the present study, the effect of AMI on LV vortex flow was assessed. In 
particular, the morphology of the intraventricular vortex was evaluated 
using contrast echocardiography. In addition, the dimensionless index of 
VFT was also evaluated. The VFT is a recently proposed parameter for 
characterizing the process of vortex ring formation.5 It is a measure of the 
length/diameter ratio of the fluid column and is directly proportional to 
the time-averaged velocity of flow through the mitral valve and inversely 
proportional to the mitral valve size.5 A previous in vitro study showed 
that a range of VFT from 3.3 to 4.5 characterizes the optimal 
hemodynamic conditions for vortex ring formation.5 
A good linear relation was observed between the vortex sphericity index 
and the VFT, indicating that suboptimal hemodynamic conditions for 
vortex ring formation (i.e., low values of VFT) are associated with short 
and wide LV vortex rings. In addition, both the VFT and the vortex 
sphericity index were weakly related to the global LV diastolic function, 
and a good relation was observed between the LV vortex parameters and 
LV untwisting rate. This finding suggests that LV hydrodynamics are 
mainly related to LV diastolic suction rather than to global LV diastolic 
function. Suction gradients are necessary for the redirection of flow from 
the LV base to the LV apex and, consequently, for vortex ring formation. 
In addition, suction gradients are mainly determined by the LV untwisting 
mechanics.7 Reduced LV untwisting after AMI might attenuate these 
suction gradients, leading finally to abnormal LV vortex ring formation. 
In the present study, the relation between LV vortex flow and infarct size 
was also evaluated. Both the VFT and the vortex sphericity index had a 
significant linear relation with infarct size (as assessed by MCE), indicating 
that larger infarctions are associated with a more severe alteration in LV 
intracavitary blood flow dynamics. This finding is in line with the study by 
Hong et al,4 showing abnormal LV vortex morphology among patients with 
reduced LV systolic function compared to normal controls. As a 
consequence of impaired VFT and abnormal vortex morphology, the 
relative stasis and delay or modification of the normal blood flow during 
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the cardiac cycle might occur, predisposing to LV thrombus formation.9 
Moreover, taking into account the essential role of LV vortex rings in 
optimizing the ejection of blood during systole, a significant impairment 
of LV vortex ring formation might contribute to a progressive decrease in 
LV systolic function.24 However, follow-up studies that also include other 
parameters of diastolic function (e.g., tissue-Doppler parameters, 
isovolumic relaxation time, and time of untwisting) are needed to 
demonstrate the prognostic role of LV hydrodynamics parameters for the 
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Background. Left ventricular (LV) torsion is emerging as a sensitive 
parameter of LV systolic myocardial performance. The aim of the present 
study was to explore the effects of acute myocardial infarction (AMI) on 
LV torsion and to determine the value of LV torsion early after AMI in 
predicting LV remodeling at 6-month follow-up. 
Methods and Results. A total of 120 patients with a first ST-segment 
elevation AMI (mean±SD age, 59±10 years; 73% male) were included. 
All patients underwent primary percutaneous coronary intervention. After 
48 hours, speckle-tracking echocardiography was performed to assess LV 
torsion; infarct size was assessed by myocardial contrast 
echocardiography. At 6-month follow-up, LV volumes and LV ejection 
fraction were reassessed to identity patients with LV remodeling (defined 
as a ≥15% increase in LV end-systolic volume). Compared with control 
subjects, peak LV torsion in AMI patients was significantly impaired 
(1.54±0.64°/cm vs 2.07±0.27°/cm, p <0.001). By multivariate 
analysis, only LV ejection fraction (β = 0.36, p <0.001) and infarct size 
(β = −0.47, p <0.001) were independently associated with peak LV 
torsion. At 6-month follow-up, 19 patients showed LV remodeling. By 
multivariate analysis, only peak LV torsion (odds ratio = 0.77; 95% CI, 
0.65–0.92; p = 0.003) and infarct size (odds ratio = 1.04; 95% CI, 1.01–
1.07; p = 0.021) were independently related to LV remodeling. Peak LV 
torsion provided modest but significant incremental value over clinical, 
echocardiographic, and myocardial contrast echocardiography variables in 
predicting LV remodeling. By receiver-operating characteristics curve 
analysis, peak LV torsion ≤1.44°/cm provided the highest sensitivity 
(95%) and specificity (77%) to predict LV remodeling. 
Conclusions. LV torsion is significantly impaired early after AMI. The 
amount of impairment of LV torsion predicts LV remodeling at 6-month 
follow-up. 
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Remodeling of the left ventricle (LV) after acute myocardial infarction 
(AMI) is associated with the development of heart failure and a poor 
survival rate.1,2 Accordingly, identification of patients prone to develop 
postinfarction LV remodeling represents an important issue in clinical 
cardiology. These considerations have stimulated research for new 
parameters able to provide quantitative and objective estimation of post-
AMI myocardial damage and to identify patients at risk of LV remodeling.3 
The systolic twisting motion of the LV along its longitudinal axis, resulting 
from opposite rotation of the LV apex compared with the base, is 
emerging as an important, sensitive parameter of LV systolic function.4 
Recently, echocardiographic assessment of LV torsional mechanics based 
on speckle-tracking analysis has been introduced and validated against 
sonomicrometry and magnetic resonance imaging.5,6 In the clinical setting, 
however, not much data on changes in LV torsion after AMI are 
available,7,8 and no specific data exist concerning the role of LV torsion in 
predicting postinfarction LV remodeling. Accordingly, the aim of the 
present evaluation was 2-fold. First, we sought to determine the 
correlates of LV torsion after AMI, and second, we aimed to explore the 





Patient Population and Protocol 
The population consisted of 146 consecutive patients admitted to the 
coronary care unit because of a first ST-segment elevation AMI. Diagnosis 
of AMI was made on the basis of typical ECG changes and/or ischemic 
chest pain associated with elevation of cardiac biomarkers.9 All patients 
underwent immediate coronary angiography and primary percutaneous 
coronary intervention (PCI). The infarct-related artery was identified 
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during coronary angiography and by ECG criteria. During PCI, final TIMI 
(Thrombolysis In Myocardial Infarction) flow was assessed. 
Clinical evaluation included 2-dimensional (2D) echocardiography with 
speckle-tracking analysis to assess LV global longitudinal strain (GLS) and 
torsion, and myocardial contrast echocardiography (MCE) was performed 
48 hours after PCI to assess the extent of perfusion abnormalities and 
infarct size. At 6-month follow-up, 2D echocardiography was performed 
to reassess LV volumes and ejection fraction (LVEF). These 
echocardiographic examinations are part of the routine, comprehensive 
assessment of AMI patients in our clinics. 
In addition, 20 subjects without evidence of structural heart disease and 
without known risk factors for coronary artery disease, matched for age, 
sex, and body surface area and who underwent 2D echocardiography, 
were included as a normal control group. These individuals were derived 
from the echocardiographic database and were clinically referred for 
echocardiographic evaluation because of atypical chest pain, palpitations, 
or syncope without murmur. 
To determine the reduction in LV torsion after AMI, patient data were 
compared with data from the normal controls. In addition, the 
independent correlates of LV torsion after AMI were investigated, and the 
role of LV torsion in predicting LV remodeling (defined as a ≥15% increase 
in LV end-systolic volume [ESV]) at 6-month follow-up was assessed.1,10 
 
2D Echocardiography 
All AMI patients and control subjects were imaged in the left lateral 
decubitus position with a commercially available system (Vivid 7 
Dimension, GE Healthcare, Horten, Norway) equipped with a 3.5-MHz 
transducer. Standard 2D images and Doppler and color-Doppler data were 
acquired from parasternal and apical views (4-, 2-, and 3-chamber views) 
and digitally stored in cine-loop format; analyses were subsequently 
performed offline with EchoPAC version 7.0.0 software (GE Healthcare). 
LV end-diastolic volume (LVEDV) and LVESV were measured according to 
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Simpson's biplane method, and LVEF was calculated as 
[(LVEDV−LVESV)/LVEDV]×100.11 
Qualitative assessment of regional wall motion was performed according 
to the 16-segment model of the American Society of Echocardiography, 
and the global wall-motion score index (WMSI) was calculated for each 
patient.11 As previously described,12 transmitral and pulmonary vein 
pulsed-wave Doppler tracings were used to classify diastolic function as 
(1) normal, (2) diastolic dysfunction grade 1 (mild), (3) diastolic 




Longitudinal Strain Analysis 
Longitudinal strain analysis of the LV was performed by speckle-tracking 
imaging (EchoPAC version 7.0.0). Gray-scale 2D apical images of the LV 
(4-, 2-, and 3-chamber views) were used with a frame rate ranging from 
60 to 100 frames per second. From an end-systolic frame, the 
endocardial border was manually traced, and the software automatically 
traces 2 more concentric regions of interest (ROIs) to include the entire 
myocardial wall. Speckle-tracking analysis detects and tracks the unique 
myocardial ultrasound patterns frame by frame. The in-plane frame-to-
frame displacement of each pattern over time is used to derive strain. The 
software automatically validates the segmental tracking throughout the 
cardiac cycle and allows the operator further adjustment of the ROI to 
improve tracking quality. As previously described,13 mean GLS was 
calculated, as an index of global LV systolic function, by averaging the 
GLSs obtained automatically from each apical view. 
 
Torsional Mechanics Analysis 
Speckle-tracking analysis was applied to evaluate LV basal and apical 
rotations, LV twist, and LV torsion. Parasternal short-axis images of the 
LV were acquired at 2 different levels: (1) basal level, identified by the 
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mitral valve, and (2) apical level, as the smallest cavity achievable distally 
to the papillary muscles (by moving the probe downward and slightly 
laterally, if needed). Frame rate was 60 to 100 frames per second, and 3 
cardiac cycles for each short-axis level were stored in cine-loop format for 
offline analysis (EchoPAC version 7.0.0). The endocardial border was 
traced at an end-systolic frame, and the ROI was chosen to fit the whole 
myocardium. The software allows the operator to check and validate the 
tracking quality and to adjust the endocardial border or modify the width 
of the ROI, if needed. Each short-axis image was automatically divided into 
6 standard segments: septal, anteroseptal, anterior, lateral, posterior, and 
inferior. The software calculated LV rotation from the apical and basal 
short-axis images as the average angular displacement of the 6 standard 
segments by referring to the ventricular centroid, frame by frame. 
Counterclockwise rotations were marked as positive values and clockwise 
rotations, as negative values when viewed from the LV apex. LV twist was 
defined as the net difference (in degrees) of apical and basal rotations at 
isochronal time points. LV torsion was then calculated as the ratio 
between LV twist (in degrees) and the LV diastolic longitudinal length (in 
cm) between the LV apex and the mitral plane.14 
Twenty patients were randomly selected to assess the reproducibility of 
peak LV twist. Bland-Altman analysis was performed to evaluate 
intraobserver and interobserver agreement by repeating the analysis 1 
month later by the same observer and by a second independent observer. 
Intraobserver agreement was excellent. According to Bland-Altman 
analysis, the mean difference ±2 SD for peak LV twist was 0.05±0.35°. 
Interobserver agreement was also good. According to Bland-Altman 
analysis, the mean difference ±2 SD for peak LV twist was 0.16±1.50°. 
 
Myocardial Contrast Echocardiography 
Immediately after 2D echocardiography, MCE was performed to evaluate 
myocardial perfusion to assess infarct size after AMI. The same 
ultrasound system was used, and the 3 standard apical views were 
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acquired with a low-power technique (mechanical index of 0.1 to 0.26). 
Background gains were set so that minimal tissue signal was seen, and the 
focus was set at the level of the mitral valve. Luminity (Perflutren, Bristol-
Myers Squibb Pharma, Brussels, Belgium) was used as the contrast agent. 
Each patient received an infusion of 1.3 ml of echo contrast diluted in 50 
ml of 0.9% NaCl solution through a 20-gauge intravenous catheter in a 
proximal forearm vein. Infusion rate was initially set at 4.0 ml/min and 
then titrated to achieve optimal myocardial enhancement without 
attenuation artifacts.15 Machine settings were optimized to obtain the 
best possible myocardial opacification with minimal attenuation. At least 
15 cardiac cycles after high-mechanical-index (1.7) microbubble 
destruction were stored in cine-loop format for offline analysis (EchoPAC 
version 7.0.0).16 The LV was divided according to a standard 16-segment 
model, and a semiquantitative scoring system was used to assess 
contrast intensity after microbubble destruction: (1) 
normal/homogenous opacification, (2) reduced/patchy opacification, or 
(3) minimal or absent contrast opacification.11,16 Minimal or absent 
contrast opacification identifies myocardial segments with a >50% 
transmural extent of infarction with high accuracy, as previously 
demonstrated by Janardhanan et al.17 A myocardial perfusion index (MPI), 
indicating the extent of infarct size, was derived by adding contrast 
scores of all segments and dividing by the total number of segments.16 
Twenty patients were randomly selected to assess the reproducibility of 
perfusion scoring. A weighted κ test was performed to evaluate 
intraobserver and interobserver agreement by repeating the analysis 1 
month later by the same observer and by a second independent observer. 
Both intraobserver and interobserver agreements were good (weighted κ 
= 0.86 and = 0.84, respectively). To avoid measurements bias, all 
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Statistical Analysis 
Continuous variables are expressed as mean±SD, when normally 
distributed, and as median and interquartile range, when not normally 
distributed. Categorical data are presented as absolute numbers and 
percentages. 
Differences in continuous variables between 2 groups were assessed with 
the Student t test or Mann-Whitney U test, where appropriate. Chi-square 
test or Fisher's exact test, where appropriate, was computed to assess 
differences in categorical variables. Differences in continuous variables 
between >2 groups were assessed by 1-way ANOVA or Kruskal-Wallis 
test, where appropriate; when the result of the analysis was significant, a 
post hoc test with Bonferroni's correction was applied. 
Univariate and multivariate linear-regression analyses (with an automatic 
stepwise selection procedure with backward elimination) were performed 
to evaluate the relation between peak LV torsion among AMI patients and 
the following variables: age, sex, infarct location (anterior versus 
nonanterior), multivessel disease, TIMI flow grade 3 after PCI, peak 
troponin T value, LVEDV, LVESV, LVEF, WMSI, presence of diastolic 
dysfunction, peak LV GLS, and MPI. Age and sex were entered into the 
multivariate model independently of their probability value by univariate 
analysis and were kept fixed throughout the stepwise selection 
procedure. Regarding the remaining variables, only those with a 
probability value <0.20 by univariate analysis were entered as covariates 
in the multivariate model. Linear-regression analyses were performed to 
evaluate the relation between peak LV torsion at baseline and LVESV at 
6-month follow-up, as well as the change in LVESV after 6-month follow-
up compared with the baseline value. 
Univariate and multivariate logistic-regression analyses (with automatic 
stepwise selection procedure with backward elimination) were performed 
to evaluate the relation between the occurrence of LV remodeling at 6-
month follow-up and the following baseline variables: age, sex, infarct 
location (anterior versus nonanterior), multivessel disease, TIMI flow 
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grade 3 after PCI, peak troponin T value, LVEDV, LVESV, LVEF, WMSI, 
presence of diastolic dysfunction, peak LV GLS, peak LV torsion, and MPI. 
Age, sex, and LVESV were entered into the multivariate model 
independently of their probability value by univariate analysis and were 
kept fixed throughout the stepwise selection procedure. Regarding the 
remaining variables, only those with a probability value <0.20 by 
univariate analysis were entered as covariates in the multivariate model. 
The incremental predictive value of peak LV torsion over clinical, 
echocardiographic, and MCE variables was assessed by calculating the 
global χ2 values. 
Receiver-operator-characteristics curve analysis was performed to 
determine the accuracy of baseline peak LV torsion to predict LV 
remodeling at 6-month follow-up in the overall patient population and 
among anterior and nonanterior AMI patients. A probability value <0.05 
was considered statistically significant. Statistical analysis was performed 




Reliable speckle-tracking curves for rotation analysis and diagnostic MCE 
data were obtained in 120 patients; consequently, 26 patients were 
excluded from further analysis. Of note, no significant difference was 
observed between included and excluded patients with regard to age 
(59±10 versus 57±10 years, p = 0.31), male sex (87 [73%] versus 17 
[65%], p = 0.47), anterior location of AMI (55 [46%] versus 13 [50%], p 
= 0.70), and peak value of troponin T (3.04 μg/L [1.65 to 7.03] versus 
3.18 μg/L [1.74 to 12.62], p = 0.58). All control subjects had reliable 
speckle-tracking curves. 
 
Clinical and Echocardiographic Characteristics 
Clinical and echocardiographic characteristics of control subjects and AMI 
patients are listed in Table 1.  
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Table 1. Baseline clinical and echocardiographic characteristics of control subjects and AMI 
patients 
 Control subjects 
(n = 20) 
AMI patients 
(n = 120) 
p 
value 
Age (years) 56±10 59±10 0.37 
Male gender 15 (75%) 87 (73%) 0.82 
Diabetes - 13 (11%)  
Family history of coronary artery 
disease 
- 45 (37%)  
Hypercholesterolemia - 16 (13%)  
Hypertension - 43 (36%)  
Current or previous smoking - 67 (56%)  
Anterior myocardial infarction - 55 (46%)  
Infarct-related artery 
- left anterior descending 
coronary artery 
- left circumflex coronary artery 













Multi-vessel disease - 41 (34%)  
TIMI flow grade 3 - 101 (84%)  
Peak troponin T (µg/l) - 3.04 (1.65-7.03)  
LVEDV (ml) 103±22 104±27 0.91 
LVESV (ml) 40±10 55±21 <0.001 
LVEF (%) 61±7 48±9 <0.001 
LV diastolic longitudinal length 
(cm) 
8.6±0.6 8.3±0.8 0.18 
WMSI - 1.72±0.34  
Diastolic function 
- grade 0 
-  grade 1 
-  grade 2 














Peak LV GLS (%) -19.4±1.7 -14.0±3.8 <0.001 
Peak LV basal rotation (˚) 
Peak LV apical rotation (˚) 
Peak LV twist (˚) 













MPI - 1.28 (1.08-1.50)  
Abbreviations are as defined in text. 
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By definition, control subjects and AMI patients did not differ in age or 
sex. Among AMI patients, the infarct-related artery was the left anterior 
descending coronary artery in 55 (46%) patients; obstructive multivessel 
disease (ie, >1 vessel with a luminal narrowing ≥70%) was present in 41 
(34%) patients. Peak value of troponin T was 3.04 μg/L (1.65 to 7.03 
μg/L). Mean LVEF was 48±9%. 
Compared with control subjects, AMI patients had significantly reduced 
peak LV basal rotation (−5.1±2.7° versus −6.8±2.7°, p = 0.013), 
reduced peak LV apical rotation (8.4±4.6° versus 11.6±2.8°, p 
<0.001), and consequently decreased peak LV twist (12.7±5.2° versus 
17.7±2.1°, p <0.001) and peak LV torsion (1.54±0.64°/cm versus 
2.07±0.27°/cm, p <0.001). Among AMI patients, those with an 
anterior AMI had significantly lower peak LV apical rotation, LV twist, and 
LV torsion compared with the remaining AMI patients (6.5±4.3° versus 
10.1±4.2°, p <0.001; 11.1±5.4° versus 14.0±4.7°, p = 0.002; and 
1.35±0.65°/cm versus 1.70±0.58°/cm, p = 0.003, respectively), 
whereas peak LV basal rotation was not different (−5.4±2.6° versus 
−4.9±2.8°, p = 0.31). Of note, no significant difference was observed 
in peak LV basal rotation, apical rotation, LV twist, and LV torsion 
between patients (n = 37) with anterior AMI due to proximal LAD 
occlusion versus patients (n = 18) with anterior AMI due to mid or distal 
LAD occlusion (−5.2±2.5° versus −5.8±2.7°, p = 0.38; 6.9±4.3° 
versus 5.6±4.2°, p = 0.30; 11.4±5.2° versus 10.7±5.8°, p = 0.67; 
and 1.36±0.63°/cm versus 1.35±0.72°/cm, p = 0.95, respectively). 
Examples of LV rotational mechanics curves obtained by speckle-tracking 












Figure 1. LV rotational mechanics curves of a control subject (panel A) and of a 
patient with anterior AMI (panel B). A, Speckle-tracking analysis shows normal 
peak LV basal (purple line) and apical (green line) rotations and normal peak LV 
twist (18.4°; white line). B, Speckle-tracking analysis shows impaired peak LV 
basal (purple line) and apical (green line) rotations and reduced peak LV twist 
(6.8°; white line). 
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Determinants of LV Torsion Among AMI Patients 
Table 2 shows the results of univariate and multivariate linear regression 
analyses performed to determine the factors related to peak LV torsion 
among AMI patients. By univariate analysis, several variables were 
significantly related to peak LV torsion: anterior AMI, TIMI flow grade 3 
after PCI, peak troponin T value, LVEDV, LVESV, LVEF, WMSI, presence of 
diastolic dysfunction, peak LV GLS, and MPI. However, by multivariate 
analysis, only LVEF (β = 0.36, p <0.001) and MPI (β = -0.47, p <0.001) 
were independently associated with peak LV torsion. The relation 
between peak LV torsion and MPI is shown in Figure 2. 
Patients without myocardial segments with minimal or absent contrast 
opacification had higher peak LV torsion compared with patients with ≥1 
myocardial segment with minimal or absent contrast opacification 
(1.84±0.49°/cm versus 1.27±0.63°/cm; p <0.001). In addition, a 
progressive reduction of peak LV torsion with increasing number of 
myocardial segments with minimal or absent contrast opacification was 
observed (Figure 3). 
 
LV Remodeling at 6-Month Follow-Up 
Eight of 120 AMI patients included in the initial population did not 
complete the 6-month follow-up; consequently, data at baseline and at 6-
month follow-up were available for 112 patients. At 6-month follow-up, 
mean LVEDV was 114±37 ml, whereas mean LVESV was 54±29 ml and 
mean LVEF was 55±10%. A total of 19 patients developed LV 
remodeling. 
Baseline clinical and echocardiographic characteristics of AMI patients 
with versus without LV remodeling are summarized in Table 3. At 
baseline, patients who developed LV remodeling had larger LVESVs (p = 
0.036), lower LVEFs (p <0.001), and higher MPIs (p <0.001), indicating 
larger infarct size. Regarding LV rotational mechanics parameters, at 
baseline patients with LV remodeling had significantly lower peak LV 
apical rotation (p <0.001), peak LV twist (p <0.001), and peak LV 
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torsion (p <0.001) compared with patients without LV remodeling; 
conversely, no difference in peak LV basal rotation was observed between 
the 2 groups. Patients with more impaired peak LV torsion at baseline had 
larger LVESVs at 6-month follow-up and a higher change in LVESV in the 
6-month follow-up period (Figure 4). 
 
Table 2. Univariate and multivariate linear regression analyses to determine the 
independent correlates of peak LV torsion in AMI patients 
   Univariate Multivariate 
 β p value β p value 
Age -0.080 0.38 0.057 0.37 
Male -0.048 0.61 -0.046 0.46 
Anterior myocardial infarction -0.27 0.003 - - 
Multi-vessel disease -0.13 0.17 - - 
TIMI flow grade 3 0.25 0.005 - - 
Peak troponin T -0.40 <0.001 - - 
LVEDV -0.25 0.007 - - 
LVESV -0.51 <0.001 - - 
LVEF 0.65 <0.001 0.36 <0.001 
WMSI -0.66 <0.001 - - 
Presence of diastolic dysfunction  -0.23 0.011 - - 
Peak LV GLS -0.56 <0.001 - - 
MPI -0.69 <0.001 -0.47 <0.001 
Abbreviations are as defined in text. 
 
 
Figure 2. Linear regression analysis illustrating the relation between peak LV 
torsion and MPI. 
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Figure 3. Relation between peak LV torsion and number of myocardial segments 
with minimal or absent contrast opacification. 
 
Table 4 shows the results of univariate and multivariate logistic regression 
analyses performed to determine the relation between clinical and 
echocardiographic characteristics at baseline and LV remodeling at 6-
month follow-up. By univariate analysis, several variables were 
significantly related to LV remodeling: anterior AMI, peak troponin T value, 
LVESV, LVEF, WMSI, presence of diastolic dysfunction, peak LV GLS, peak 
LV torsion, and MPI. However, by multivariate analysis, only peak LV 
torsion (odds ratio = 0.77; 95% CI, 0.65 to 0.92; p = 0.003) and MPI 
(odds ratio = 1.04; 95% CI, 1.01 to 1.07; p = 0.021) were independently 
related to the development of LV remodeling. Furthermore, peak LV 
torsion provided modest but significant incremental value over clinical, 
echocardiographic, and MCE variables in predicting LV remodeling (Figure 
5).  
By receiver-operator-characteristics curve analysis (Figure 6), peak LV 
torsion ≤1.44°/cm provided the highest sensitivity (95%) and specificity 
(77%) to predict LV remodeling; diagnostic accuracy was high in both 
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Table 3. Baseline clinical and echocardiographic characteristics of AMI patients without vs 
with LV remodeling 
 No LV remodeling 
(n = 93) 
LV remodeling 
(n = 19) 
p 
value 
Age (years) 58±10 61±9 0.20 
Male gender 66 (71%) 15 (79%) 0.48 
Diabetes 9 (10%) 2 (11%) 0.91 
Family history of coronary artery 
disease 
36 (39%) 7 (37%) 0.88 
Hypercholesterolemia 13 (14%) 2 (11%) 0.74 
Hypertension 34 (37%) 6 (32%) 0.68 
Current or previous smoking 54 (58%) 9 (47%) 0.39 
Anterior myocardial infarction 35 (38%) 13 (68%) 0.013 
Multi-vessel disease 29 (31%) 9 (47%) 0.18 
TIMI flow grade 3 81 (87%) 14 (74%) 0.16 
Peak troponin T (µg/l) 2.54 (1.29-5.25) 9.63 (4.96-12.51) <0.001 
LVEDV (ml) 101±23 106±34 0.59 
LVESV (ml) 51±15 63±24 0.036 
LVEF (%) 50±8 40±8 <0.001 
LV diastolic longitudinal length 
(cm) 
8.2±0.7 8.3±0.6 0.76 
WMSI 1.63±0.30 2.05±0.21 <0.001 
Presence of diastolic dysfunction 52 (56%) 16 (84%) 0.021 
Peak LV GLS (%) -15.0±3.3 -11.1±3.3 <0.001 
Peak LV basal rotation (˚) 
Peak LV apical rotation (˚) 
Peak LV twist (˚) 













MPI 1.19 (1.00-1.41) 1.75 (1.38-1.81) <0.001 
Medical therapy at discharge 
- Antiplatelets 
- Angiotensin-converting enzyme 
























Abbreviations are as defined in text. 
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Figure 4. Relation between peak LV torsion at baseline and LVESV at 6-month 
follow-up (panel A) and the change in LVESV after 6-month follow-up compared 
with baseline value (panel B). 
 
Table 4. Univariate and multivariate logistic regression analyses to determine the 
independent predictors of LV remodeling at 6-month follow-up 
 Univariate Multivariate 
 OR (95%CI) p value OR (95%CI) p value 
Age 1.03 (0.98-1.09) 0.20 1.00 (0.93-1.08) 0.94 
Male 1.53 (0.47-5.04) 0.48 3.62 (0.66-19.8) 0.14 
Anterior myocardial 
infarction 
3.59 (1.25-10.3) 0.017 - - 
Multi-vessel disease 1.99 (0.73-5.40) 0.18 - - 
TIMI flow grade 3 0.42 (0.13-1.36) 0.15 - - 
Peak troponin T 1.23 (1.11-1.36) <0.001 - - 
LVEDV 1.01 (0.99-1.03) 0.47   
LVESV 1.04 (1.01-1.07) 0.006 0.99 (0.94-1.04) 0.77 
LVEF 0.85 (0.78-0.92) <0.001 - - 
WMSI* 1.73 (1.34-2.24) <0.001 - - 
Presence of diastolic 
dysfunction  
4.21 (1.15-15.4) 0.030 - - 
Peak LV GLS 1.43 (1.19-1.71) <0.001 - - 
Peak LV torsion* 0.72 (0.62-0.82) <0.001 0.77 (0.65-0.92) 0.003 
MPI* 1.79 (1.39-2.31) <0.001 1.04 (1.01-1.07) 0.021 
*: OR and 95%CI are intended for 0.1 unit increase. Abbreviations are as defined in text. OR 
indicates odds ratio. C-statistic = 0.93. 
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Figure 5. Incremental value of peak LV torsion over clinical, echocardiographic, 




The results of the present evaluation show that LV torsion is significantly 
impaired early after AMI, owing to a reduction of both basal and apical 
rotations. Infarct size (assessed by MCE) was independently related to LV 
torsion. In addition, LV torsion early after AMI was significantly and 
independently related to the occurrence of LV remodeling at 6-month 
follow-up. 
 
Impact of AMI on LV Rotational Mechanics 
Previous experimental and clinical studies have consistently shown an 
impairment of LV torsional deformation in the setting of acute and 
chronic MI.7,8,18–21 In addition, LV torsion was related to global LV systolic 
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function and the extent of wall-motion abnormalities.7,8,21 The present 
evaluation confirms and extends these previous observations. LV systolic 
function was indeed significantly related to LV torsion. More important, an 
independent correlation between infarct size (assessed by MCE and 
expressed as MPI) and LV torsion was noted on multivariate analysis. The 
larger damage of the LV subepicardial myofibers and the greater 
disarrangement of the typical architecture of LV myofibers secondary to 





Figure 6. Receiver-operator-characteristics 
curve, testing the accuracy of peak LV 
torsion to predict LV remodeling at 6-month 
follow-up. Panel A. In the overall patient 
population, peak LV torsion ≤1.44°/cm 
provided the highest sensitivity (95%) and 
specificity (77%) to predict LV remodeling. 
Panel B. Among patients with anterior AMI, 
peak LV torsion ≤1.29°/cm provided the 
highest sensitivity (92%) and specificity 
(74%) to predict LV remodeling. Panel C. 
Among patients with nonanterior AMI, peak 
LV torsion ≤1.44°/cm provided the highest 
sensitivity (100%) and specificity (81%) to 
predict LV remodeling. AUC indicates area 
under the curve. 
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Epicardial myofibers are indeed extremely important to maintain LV 
torsional deformation.4 Epicardial myofibers (compared with endocardial 
fibers) produce larger torque (related to the larger radius) and determine 
the overall direction of rotation.4 Damage to epicardial fibers therefore 
appears mandatory for an impairment of LV torsional mechanics. Indeed, 
the present evaluation underscores that larger infarcts (as indicated by 
higher MPI values), leading to more extensive, transmural damage 
(spreading to epicardial myofibers),17 result in a larger impairment of LV 
torsion. Previous experimental studies in an occlusion-reperfusion model 
provide evidence for this hypothesis by showing that LV torsion was 
impaired in the presence of transmural ischemia, whereas LV torsion was 
preserved in the presence of subendocardial ischemia only.22,23 In addition, 
LV myofibers have a typical spiral architecture that is also extremely 
important in determining the LV systolic wringing motion. Large infarcts 
may be associated with extensive distortion of the typical architecture of 
LV myofibers, altering their obliquity and eventually impairing LV 
torsion.24 
 
Role of LV Torsion in Predicting LV Remodeling 
Besides being strictly related to the myocardial damage after AMI, LV 
torsion at baseline was found to be a strong predictor of LV remodeling at 
6-month follow-up; interestingly, this relation remained even after 
adjustment for other univariate predictors of LV remodeling, including 
infarct size (expressed as MPI). Peculiar properties of the LV systolic 
twisting motion may explain this finding. 
LV torsion indeed is not simply an index of global LV systolic function; 
previous mathematical models revealed the essential role of LV torsion in 
optimizing LV oxygen demand and the efficiency of LV systolic thickening 
by uniformly distributing myofiber stress across the myocardial wall.25 A 
significant impairment of LV torsion after AMI will therefore result in 
increased myofiber stress and oxygen demand of the remaining 
noninfarcted myocardium. This low-efficiency state would further impair 
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myocardial contractility, possibly representing the initial step of a vicious 
circle of progressive LV dilatation and decline in LV systolic function.18,24 
 
Clinical Implications 
The present evaluation underscores the value of LV torsion as a sensitive 
global parameter of LV systolic myocardial performance. Its impairment 
early after AMI is strictly related to the extent of myocardial damage and 
possibly plays an important role in the development of LV remodeling. 
Indeed, peak LV torsion provided modest but significant incremental value 
over clinical, echocardiographic, and MCE variables in predicting LV 
remodeling. Accordingly, this parameter may be used in clinical practice 
as an early marker for risk stratification. Early assessment of LV torsion 
after AMI by speckle tracking echocardiography could identify patients 
(with reduced LV torsion) who may benefit from aggressive medical 
therapy to prevent LV remodeling, heart failure, and poor outcome. 
 
Limitations 
Some limitations should be acknowledged. First, only patients with ST-
segment elevation AMI were included; consequently, the results cannot be 
extrapolated to patients with non–ST-segment elevation AMI. Another 
important limitation concerns the acquisition of short-axis images. The 
acquisition of true LV apical short-axis images is indeed dependent on the 
acoustic window (more than the basal short-axis view) and may be 
technically difficult to acquire in some patients. In addition, transducer 
position has a strong impact on the assessment of apical rotation by 
speckle-tracking echocardiography. It should, however, be emphasized 
that the most caudal transducer position was used to acquire the 
parasternal short-axis apical view; moreover, all patients without true LV 
apical short-axis images were not included in the present evaluation. 
Furthermore, motion throughout the planes at the basal level may reduce 
the accuracy of measurement of LV basal rotation. Finally, the impairment 
of LV torsion observed early after AMI may be partially related to the 
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presence of myocardial stunning; further studies are needed to assess the 




LV torsion is significantly impaired early after AMI. The amount of 
impairment of LV torsion is related to infarct size. In addition, LV torsion 
at baseline predicts the occurrence of LV remodeling at 6-month follow-
up, with modest but significant incremental value over clinical, 
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The impact of left ventricular (LV) dyssynchrony after acute myocardial 
infarction (AMI) on LV ejection fraction (EF) is unknown. One hundred 
twenty-nine patients with a first ST-elevation AMI (58±11 years, 78% 
men) and QRS duration <120 ms were included. All patients underwent 
primary percutaneous coronary intervention. Real-time 3-dimensional 
echocardiography and myocardial contrast echocardiography were 
performed to assess LV function, LV dyssynchrony, and infarct size. LV 
dyssynchrony was defined as the SD of the time to reach the minimum 
systolic volume for 16 LV segments, expressed in percent cardiac cycle 
(systolic dyssynchrony index [SDI]). Myocardial perfusion at myocardial 
contrast echocardiography was scored (1 = normal/homogenous; 2 = 
decreased/patchy; 3 = minimal/absent) using a 16-segment model; a 
myocardial perfusion index, expressing infarct size, was derived by 
summing segmental contrast scores and dividing by the number of 
segments. SDI in patients with AMI was 5.24±2.23% compared to 
2.02±0.70% of controls (p <0.001). Patients with AMI and LVEF <45% 
had significantly higher SDI compared to patients with LVEF ≥45% 
(4.29±1.44 vs 6.95±2.40, p <0.001). At multivariate analysis, SDI was 
independently related to LVEF; in addition, the impact of SDI on LV 
systolic function was incremental to infarct size and anterior location of 
AMI (F change 16.9, p <0.001). In conclusion, LV synchronicity is 
significantly impaired soon after AMI. LV dyssynchrony is related to LVEF 
and has an additional detrimental effect on LV function, beyond infarct 
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Advances in echocardiographic techniques, i.e., tissue Doppler 
echocardiography, speckle-tracking echocardiography, and real-time 3-
dimensional echocardiography (RT3DE) have recently demonstrated an 
impaired left ventricular (LV) synchronicity in patients with acute 
myocardial infarction (AMI).1-3 In the setting of chronic heart failure, LV 
dyssynchrony is a phenomenon extensively described and related to 
impaired LV systolic function and poor prognosis.4-8 In the setting of AMI, 
however, it is unclear whether LV dyssynchrony is independently 
associated with LV ejection fraction (EF). Moreover, the detrimental 
effect of LV dyssynchrony on LV systolic function in addition to other 
variables remains unknown. Accordingly, the aim of the present study was 
twofold: (1) to assess the decrease in LV synchronicity after AMI 
(compared to normal values) and (2) to explore the relation between this 
decrease in LV synchronicity and LV systolic function. In particular, the 





The population consisted of 159 consecutive patients admitted to the 
coronary care unit because of a first ST-segment elevation AMI. Patients 
with a QRS complex duration >120 ms were excluded from the study. 
The diagnosis of AMI was made based on typical electrocardiographic 
changes and/or ischemic chest pain associated with increased cardiac 
biomarkers.9 All patients underwent immediate coronary angiography and 
primary percutaneous coronary intervention (PCI). The infarct-related 
artery was identified by the site of coronary occlusion during coronary 
angiography and electrocardiographic criteria. During PCI, the final 
Thrombolysis In Myocardial Infarction flow was assessed. In addition, time 
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from onset of symptoms to first balloon dilatation (symptoms-to-balloon 
time) was determined. 
Using the electrocardiograms acquired on admission and 1 hour after PCI, 
the ST-segment resolution was assessed, as previously described.10 The 
sum of ST-segment elevations was measured 60 ms after the J point in 
leads I, aVL, and V1 to V6 for anterior AMI and leads II, III, aVF, V5, and V6 
for nonanterior AMI. Percent resolution of ST-segment elevation from 
before to after PCI was then calculated. 
RT3DE was performed 48 hours after PCI to assess global LV systolic 
function and LV dyssynchrony; immediately after RT3DE, myocardial 
contrast echocardiography was performed to assess infarct size. These 
echocardiographic examinations are part of the routine, comprehensive 
assessment of patients presenting with AMI in our clinics. 
In addition, 30 subjects without evidence of structural heart disease and 
without known risk factors for coronary artery disease, matched for age, 
gender, and body surface area, who underwent RT3DE, were included as a 
control group. These subjects were derived from the echocardiographic 
database and were clinically referred for echocardiographic evaluation 
because of atypical chest pain, palpitations, or syncope without murmur. 
To determine impairment of LV synchronicity after AMI, patient data were 
compared to data from controls. In addition, the relation between LV 
systolic function and other clinical and echocardiographic variables 
(including LV dyssynchrony, infarct size, and infarct location) was 
evaluated. 
Patients underwent imaging in the left lateral decubitus position with a 
commercially available system (Vivid 7, GE Healthcare, Horten, Norway) 
equipped with a 3V phased array transducer (2.5 MHz). Apical full volume 
3D datasets were acquired in harmonic mode, integrating, during a brief 
breath-hold, 8 R-wave–triggered subvolumes into a larger pyramidal 
volume (90° by 90°) with a complete capture of the left ventricle. The 
3D datasets were digitally stored for off-line analysis. 
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Off-line analysis was performed by an observer who had no knowledge of 
patients' identity and myocardial contrast echocardiographic results. 
Dedicated software (4D LV-Analysis; TomTec, Munich, Germany) was 
used. The algorithm used by the software to calculate LV end-diastolic 
volume, LV end-systolic volume, and LVEF is described in detail 
elsewhere.11 Briefly, a semiautomated method for the detection of the 
apical 4-chamber view and the 60° and 120° incremental views and for 
the tracing of the endocardial border in the entire 3D dataset (including 
LV trabeculations and papillary muscles within the LV volume) were used. 
Subsequently, a final reconstruction of the LV model was generated and 
LV volumes and LVEF were obtained. In addition, the same LV model was 
used for the assessment of LV dyssynchrony, as previously described.12 
Briefly, the LV model was automatically divided in 16 pyramidal 
subvolumes (6 basal segments, 6 mid segments, and 4 apical segments) 
based around a nonfixed central point. For each volumetric segment, the 
time–volume curve for the entire cardiac cycle was derived and the time 
taken to reach the minimum systolic volume was calculated. The SD of 
the time taken to reach the minimum systolic volume expressed as 
percent cardiac cycle (systolic dyssynchrony index [SDI]) was then 
calculated as a marker of global LV dyssynchrony.12 
Immediately after RT3DE, myocardial contrast echocardiography was 
performed to evaluate myocardial perfusion, to assess infarct size after 
AMI. The same ultrasound system equipped with a 3.5-MHz transducer 
was used. The 3 standard apical views were acquired using a low-power 
technique (mechanical index 0.10 to 0.26). Background gains were set so 
that minimal tissue signal was seen, and the focus was set at the level of 
the mitral valve. Luminity (Bristol-Myers Squibb Pharma, Brussels, 
Belgium) was used as contrast agent. Each patient received an infusion of 
1.3 ml of echocardiographic contrast diluted in 0.9% sodium chloride 
solution 50 ml through a 20-gauge intravenous catheter in a proximal 
forearm vein. Infusion rate was initially set at 4.0 ml/min and then titrated 
to achieve optimal myocardial enhancement without attenuation 
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artifacts.13 Machine settings were optimized to obtain the best possible 
myocardial opacification with minimal attenuation. At least 15 cardiac 
cycles after high mechanical index (1.7) microbubble destruction 14 were 
stored in cine-loop format. 
Analysis of myocardial contrast echocardiograms was performed off-line 
using EchoPAC 7.0.0 (GE Healthcare). To evaluate myocardial perfusion, 
the left ventricle was divided according to the 16-segment model of the 
American Society of Echocardiography.15 A semiquantitative scoring 
system was used to assess contrast intensity after microbubble 
destruction: (1) normal/homogenous opacification; (2) 
decreased/patchy opacification; (3) minimal or absent contrast 
opacification.14,16 A myocardial perfusion index, expressing infarct size, 
was derived by adding contrast scores of all segments and dividing by the 
total number of segments.14, 16 
Continuous variables are expressed as mean±SD, when normally 
distributed, and as median and interquartile range, when not normally 
distributed. Categorical data are presented as absolute numbers and 
percentages. 
Differences in continuous variables were assessed using Student's t test 
or Mann-Whitney U test, if appropriate. Chi-square test or Fisher's exact 
test, if appropriate, was computed to assess differences in categorical 
variables. 
Univariate and multivariate regression analyses were performed to 
evaluate the relation between LVEF in patients with AMI and the 
characteristics of age, gender, coronary risk factors, infarct location, 
multivessel disease, Thrombolysis In Myocardial Infarction flow grade 3 
after PCI, symptoms-to-balloon time, QRS duration, ST-segment 
resolution, peak troponin T, LV dyssynchrony (expressed as SDI), and 
infarct size (expressed as myocardial perfusion index). Only variables with 
a p value <0.1 at univariate analysis were entered as covariates in the 
multivariate model. To determine the potential incremental value of SDI 
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over the other variables, the R2 of the multivariate model was compared 
to the R2 of the same model without SDI. 
A p value <0.05 was considered statistically significant. Statistical 




Reliable real-time 3-dimensional echocardiographic and myocardial 
contrast echocardiographic data were obtained in 129 patients; 
consequently, 30 patients were excluded from further analysis. All control 
subjects had reliable real-time 3-dimensional echocardiographic data. 
Clinical and echocardiographic characteristics of patients with AMI are 
listed in Table 1. Sixty patients (46%) had an anterior AMI; obstructive 
multivessel disease (i.e., >1 vessel with luminal narrowing ≥70%) was 
present in 46 patients (36%). 
Compared to control subjects, patients with AMI had significantly lower 
LVEF (64±6% vs 46±9%, p <0.001) and significantly higher SDI 
(2.02±0.70% vs 5.24±2.23%, p <0.001). The observed impairment of 
LV synchronicity in patients with AMI is shown in Figure 1. 
Patients with AMI were subdivided into 2 groups according to LV systolic 
function (LVEF ≥45%, n = 83; LVEF <45%, n = 46). Clinical and 
echocardiographic characteristics of these 2 groups are presented in 
Table 2. Patients with LVEF <45% had more frequently multivessel 
disease (p = 0.032), less frequently Thrombolysis In Myocardial Infarction 
flow grade 3 after primary PCI (p = 0.049) and higher peak troponin T (p 
= 0.006) compared to patients with LVEF ≥45% (Table 2). 
Regarding LV synchronicity, patients with LVEF <45% had significantly 
higher SDI (p <0.001) compared to patients with LVEF ≥45% (Table 2). 
Figure 2 shows the impairment of LV synchronicity in patients with AMI 
and LVEF <45% compared to those with LVEF ≥45%. Indeed, a significant 
relation (r = 0.69, p <0.001) was noted between LVEF and SDI. 
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Table 1. Clinical and echocardiographic characteristics of control subjects and patients 
with acute myocardial infarction 
 Control subjects 
(n = 30) 
AMI patients 
(n = 129) 
p 
value 
Age (years) 57±11 58±11 0.53 
Men 23 (77%) 100 (78%) 0.92 
Body surface area (m²) 1.96±0.58 1.98±0.22 0.76 
Diabetes mellitus - 14 (11%) - 
Family history of coronary artery 
disease * 
- 49 (38%) - 
Hypercholesterolemia † - 19 (15%) - 
Hypertension ‡ - 47 (36%) - 
Current or previous smoker - 76 (59%) - 
Anterior wall acute myocardial 
infarction 
- 60 (46%) - 
Infarct-related coronary artery 
- left anterior descending 














Multi-vessel coronary disease - 46 (36%) - 
Thrombolysis In Myocardial 
Infarction flow grade 3 
 109 (85%) - 
Symptoms-to-balloon time 
(minutes) 
- 177 (134-219) - 
QRS duration (msec)  96±13  
ST-segment resolution (%) - 62±31 - 
Peak troponin T (µg/l) - 3.10 (1.52-6.89) - 
Left ventricular end-diastolic volume 
(ml) 
90±23 110±30 0.01 
Left ventricular end-systolic volume 
(ml) 
35±14 60±23 <0.001 
Left ventricular ejection fraction (%) 64±6 46±9 <0.001 
Systolic dyssynchrony index (%) 2.02±0.70 5.24±2.23 <0.001 
Myocardial perfusion index - 1.25 (1.09-1.50) - 
Data are expressed as mean±SD or median (interquartile range), and n (%). *. Defined when 
close relatives had premature coronary artery disease (men <55 years old and women <65 
years old). †: defined as total cholesterol ≥240 mg/dl. ‡: defined as systolic blood pressure 
≥140 mmHg and/or diastolic blood pressure ≥90 mmHg. 
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Figure 1. SDI in control subjects (white bar) and patients with AMI (black bar) (p 
<0.001). 
 
Table 3 presents the results of univariate and multivariate regression 
analyses performed to determine factors related to LV systolic function. 
At univariate analysis, several variables were significantly related to LVEF. 
However, at multivariate analysis, only anterior location of AMI (beta 
−0.16, p = 0.037), SDI (beta −0.52, p <0.001), and myocardial 
perfusion index (beta −0.28, p = 0.034) were independent factors 
associated with LVEF. Adding SDI to the multivariate model significantly 
increased R2 from 0.45 to 0.52 (F change 16.9, p <0.001). 
Figure 3 shows an example of a patient with severe impairment of LV 




The results of the present study show that LV synchronicity (assessed by 
RT3DE) is significantly impaired soon after AMI. The severity of this 
impairment is related to LV systolic function. In addition, the impact of 
SDI on LV systolic function was incremental to infarct size and anterior 
location of AMI. 
The presence and clinical relevance of LV dyssynchrony in the setting of 
chronic heart failure has been extensively investigated in the previous 
decade; in this group of patients, loss of LV synchronous contraction is 
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related to impaired LV systolic function and poor hemodynamic status 
and is a predictor of worse outcome.4-8 In addition, restoration of LV 
synchronicity, by cardiac resynchronization therapy, has been shown to 
reverse LV remodeling and to improve LV function and prognosis.17-19 
 
Table 2. Clinical and echocardiographic characteristics of patients with acute myocardial 
infarction in relation to left ventricular systolic function 
 LVEF ≥45% 
(n = 83) 
LVEF <45% 
(n = 46) 
p 
value 
Age (years) 57±11 60±11 0.090 
Men 60 (72%) 40 (87%) 0.056 
Diabetes mellitus 9 (11%) 5 (11%) 1.00 
Family history of coronary artery 
disease 
31 (37%) 18 (39%) 0.84 
Hypercholesterolemia 12 (15%) 7 (15%) 0.91 
Hypertension 35 (42%) 12 (26%) 0.069 
Current or previous smoker 47 (57%) 29 (63%) 0.48 
Anterior wall acute myocardial 
infarction 
34 (41%) 26 (57%) 0.090 
Multi-vessel coronary disease 24 (29%) 22 (48%) 0.032 
Thrombolysis In Myocardial Infarction 
flow grade 3 
74 (89%) 35 (76%) 0.049 
Symptoms-to-balloon time 
(minutes) 
170 (127-215) 184 (150-231) 0.16 
QRS duration (msec) 94±13 99±13 0.027 
ST-segment resolution (%) 65±31 56±30 0.13 
Peak troponin T (µg/l) 2.69 (1.23-5.39) 4.82 (1.85-11.02) 0.006 
Left ventricular end-diastolic volume 
(ml) 
105±25 118±38 0.042 
Left ventricular end-systolic volume 
(ml) 
51±14 75±28 <0.001 
Left ventricular ejection fraction (%) 51±5 37±6 <0.001 
Systolic dyssynchrony index (%) 4.29±1.44 6.95±2.40 <0.001 
Myocardial perfusion index 1.19 (1.00-1.38) 1.56 (1.23-1.81) <0.001 
Data are expressed as mean±SD, median (interquartile range), or number of subjects 
(percentage). 
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Figure 2. SDI in patients with AMI in relation to LV systolic function, namely LVEF 
≥45% (white bar) and LVEF <45% (black bar) (p <0.001). 
 
Table 3. Univariate and multivariate regression analyses to determine independent 
correlates of left ventricular systolic function in patients with acute myocardial infarction 
 Univariate Multivariate 
 β p 
value 
β p value 
Age -0.17 0.058 0.025 0.72 
Male gender -0.14 0.10 - - 
Diabetes mellitus 0.017 0.85 - - 
Family history of coronary artery disease 0.092 0.30 - - 
Hypercholesterolemia -0.031 0.73 - - 
Hypertension 0.051 0.57 - - 
Current or previous smoker -0.005 0.96 - - 
Anterior wall acute myocardial infarction -0.19 0.036 -0.16 0.037 
Multi-vessel coronary disease -0.19 0.032 -0.94 0.35 
Thrombolysis In Myocardial Infarction flow 
grade 3 
0.15 0.092 0.001 0.99 
Symptoms-to-balloon time -0.077 0.38 - - 
QRS duration -0.17 0.061 -0.079 0.24 
ST-segment resolution 0.21 0.015 0.028 0.69 
Peak troponin T -0.28 0.001 0.037 0.62 
Systolic dyssynchrony index -0.69 <0.001 -0.52 <0.001 
Myocardial perfusion index -0.65 <0.001 -0.28 0.034 
The R2 of the model selected at multivariate analysis was 0.52. 
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Figure 3. Example of a patient showing severe impairment of LV systolic function 
(LVEF 22%) and synchronicity (SDI 11.3%) after AMI. 
 
More recently, LV dyssynchrony has been described to occur also in 
patients with AMI.1-3, 20 However, the clinical meaning of this phenomenon 
has not been yet fully elucidated. In particular, it is unclear whether the 
presence of LV dyssynchrony after AMI independently influences LV 
function in these patients. Moreover, the detrimental effect of LV 
dyssynchrony in addition to other variables (e.g., infarct size and anterior 
location of AMI) on LV systolic function remains unknown. 
In the present study, RT3DE was used to assess LV systolic function and 
LV synchronicity after AMI. This approach has been documented to 
provide highly accurate measurements of LVEF;21 in addition, it is more 
robust than tissue Doppler echocardiography for the evaluation of LV 
dyssynchrony, being more reproducible and more consistent in 
differentiating healthy subjects from those affected by LV 
dyssynchrony.22 Moreover, myocardial contrast echocardiography was 
used to obtain information about myocardial perfusion abnormalities after 
AMI and, hence, infarct size.23 
In line with previous observations,1 impairment of LV synchronicity 
(expressed as SDI) was observed in patients with AMI compared to 
control subjects. In addition, LV dyssynchrony was significantly 
associated to LV systolic function. Importantly, this relation remained 
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after adjustment for infarct size and anterior location of AMI, being 
incremental over these variables in determining LVEF. 
LV dyssynchrony results in a nonhomogenous distribution of myocardial 
load and deformation and thus increases myocardial energy demand;24 
this may negatively influence the contractility of residual viable 
myocardium, thus further impairing LV function. 
The results of the present study suggest that LV dyssynchrony soon 
after AMI has an additional detrimental impact on LV performance, 
beyond the infarct size itself; moreover, it may potentially contribute to 
the vicious circle of progression of LV dysfunction.2 In this perspective, 
therapeutic approaches aiming to recover a more synchronous LV 
contraction (e.g., with cardiac resynchronization therapy) may be 
beneficial and improve LV systolic function, thus preventing LV 
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Aims. The relationship between temporal changes in left ventricular (LV) 
dyssynchrony and LV functional recovery after acute myocardial 
infarction (MI) remains unclear. Accordingly, the aim of the present study 
was to evaluate the temporal evolution of LV synchronicity after acute MI, 
and to explore the relationship between changes in LV systolic function 
and LV synchronicity. 
Methods and results. In 193 patients with a first acute MI, LV 
dyssynchrony (SDI) and global systolic function were evaluated with real-
time three-dimensional echocardiography 48 h after percutaneous 
coronary intervention and at 6 months follow-up. Changes in LV systolic 
function and synchronicity were evaluated at the follow-up and the 
relationship between these changes was explored. A total of 59 (40%) 
patients had an anterior acute MI. Median peak value of troponin T was 
2.97 µg/L (1.41–6.06 µg/L). Mean LVEF was 47±8% and mean SDI was 
5.01±2.10%, respectively. At 6 months follow-up, a significant 
improvement in LVEF (50±9 vs. 47±8%; p < 0.001) and SDI 
(4.52±1.97 vs. 5.01±2.10%; p = 0.003) was noted. A strong 
correlation was found between LVEF change and SDI change (β = −0.63; 
p <0.001). At multivariate analysis, SDI change was an independent 
factor associated with changes in LVEF. Importantly, an addition of SDI 
change to the multivariate model significantly increased the R2 from 0.41 
to 0.57 (F change 49.0, p <0.001). 
Conclusion. A temporal evolution of LV synchronicity was observed 
after a first, mechanically reperfused, acute MI. The reduction in LV 
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Recently, impairment of the synchronicity of left ventricular (LV) 
contraction has been described in the acute phase of myocardial 
infarction (MI);1–4 in this setting, the presence of LV dyssynchrony has 
been shown to have a detrimental effect on haemodynamic function, mid-
term LV remodelling, and long-term prognosis.1–4 However, scarce data 
are available regarding the temporal evolution of LV dyssynchrony during 
the follow-up. In addition, the relationship between temporal changes in 
LV dyssynchrony and LV functional recovery remains unclear. 
Accordingly, the aim of the present study was two-fold: first, to assess 
the temporal evolution of LV synchronicity after acute MI, and second, to 






One-hundred ninety-three consecutive patients admitted with a first ST-
segment elevation acute MI were selected from an ongoing registry.2 
Patients with a QRS complex duration >120 ms were excluded from the 
study. 
The diagnosis of acute MI was made on the basis of typical 
electrocardiographic changes and/or ischaemic chest pain associated 
with increased plasma levels of cardiac biomarkers.5 Immediate coronary 
angiography and primary percutaneous coronary intervention (PCI) of 
infarct-related artery were performed in all the patients. The infarct-
related artery was identified by the site of coronary occlusion during 
coronary angiography and electrocardiographic criteria. Troponin T levels 
were determined at admission and at 6, 12, and 18 h of admission. Real-
time three-dimensional echocardiography (RT3DE) was performed 48 h 
after PCI to assess global LV systolic function and LV dyssynchrony; in 
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addition, the presence and grade of mitral regurgitation and diastolic 
dysfunction were evaluated with two-dimensional colour, pulsed, and 
continuous wave Doppler echocardiography. At 6 months follow-up, 
RT3DE was repeated and global LV systolic function and LV dyssynchrony 
were re-assessed. Accordingly, changes in LV systolic function and 
synchronicity were evaluated at follow-up and the relationship between 
these changes was explored. These echocardiographic examinations were 
performed as part of the routine, comprehensive assessment of patients 
presenting with acute MI in our clinic, and not purely for study purposes. 
Clinical, angiographic, and echocardiographic data were prospectively 
collected in the departmental cardiology information system (EPD-
Vision®) and retrospectively analysed. 
 
Real-time three-dimensional echocardiography 
Patients were imaged in the left lateral decubitus position with a 
commercially available system (Vivid 7, GE Healthcare, Horten, Norway) 
equipped with a 3V-phased array transducer (2.5 MHz). Apical full-volume 
three-dimensional data sets were acquired in harmonic mode, integrating, 
during a brief breath-hold, eight R-wave-triggered sub-volumes into a 
larger pyramidal volume (90° by 90°) with a complete capture of the 
LV. The 3D data sets were digitally stored and a dedicated software (4D 
LV-Analysis©; TomTec, Munich, Germany) was used for the offline 
analysis. The algorithm used by the software to calculate LV end-diastolic 
volume (EDV), LV end-systolic volume (ESV), and LVEF is described in 
detail elsewhere.6,7 Briefly, a semi-automated method for the detection of 
the apical four-chamber view and the 60° and 120° incremental views 
and for the tracing of the endocardial border in the entire 3D data set 
(including LV trabeculations and papillary muscles within the LV volume) 
is used. Subsequently, a final reconstruction of the LV model is generated 
and LV volumes and LVEF are obtained. Qualitative assessment of 
regional wall motion was performed according to the 16-segment model 
of the American Society of Echocardiography and the global wall motion 
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score index (WMSI) was calculated for each patient.8 In addition, the same 
LV model was used for the assessment of LV dyssynchrony, as previously 
described.9 Briefly, the LV model was automatically divided in 16 
pyramidal sub-volumes (six basal segments, six mid segments, and four 
apical segments) based around a non-fixed central point. For each 
volumetric segment, the time–volume curve for the entire cardiac cycle is 
derived and the time to minimum systolic volume (Tmsv) is calculated. 
The standard deviation (SD) of the 16 segments Tmsv expressed in 
percentage of cardiac cycle (the systolic dyssynchrony index, SDI) was 
then calculated as a marker of global LV dyssynchrony.9 
As previously reported,2 a normal control group value of SDI was 
2.02±0.70%; significant mechanical dyssynchrony was defined as an SDI 
> 3 SD above the mean for normal subjects (4.12%). 
 
Two-dimensional echocardiography 
Two-dimensional echocardiography was performed with the same 
commercially available system (Vivid 7 Dimension, GE Healthcare) 
equipped with a 3.5 MHz transducer. Standard Doppler and colour-Doppler 
data were acquired from parasternal and apical views (four-, two-, and 
three-chamber) and digitally stored in cine-loop format; analyses were 
subsequently performed offline using EchoPAC version 7.0.0 (GE 
Healthcare, Horten, Norway). 
The severity of MR was quantitatively determined by integrating different 
echocardiographic parameters such as vena contracta width and 
regurgitant volume measured with the proximal isovelocity surface area 
method, as recommended.10 As previously described,11 transmitral and 
pulmonary vein pulsed-wave Doppler tracings were used to classify 
diastolic function as (i) normal; (ii) diastolic dysfunction grade 1 (mild); 
(iii) diastolic dysfunction grade 2 (moderate); (iv) diastolic dysfunction 
grade 3 (severe). 
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Statistical analysis 
Continuous variables are expressed as mean and standard deviation, when 
normally distributed, and as median and interquartile range, when not 
normally distributed. Categorical data are presented as absolute numbers 
and percentages. Differences in continuous variables between baseline 
and 6 months follow-up were assessed using the paired t test or the 
Wilcoxon singed rank test, if appropriate. Differences in continuous 
variables between two different groups were assessed using the Student 
t-test or the Mann–Whitney U-test, if appropriate. 
The relationship between the changes in LVEF (ΔLVEF) and in LVESV 
(ΔLVESV) and the change in LV dyssynchrony (ΔSDI) after 6 months 
follow-up was evaluated with the linear regression analysis. 
To evaluate the independent determinants of ΔLVEF at follow-up, 
univariate and multivariate linear regression analyses were performed. The 
following clinical and echocardiographic characteristics were included in 
the univariate model: age, gender, coronary risk factors, infarct location, 
multi-vessel disease, peak troponin T, symptoms onset to balloon time, 
baseline LVESV, baseline LVEF, baseline WMSI, presence of mitral 
regurgitation at baseline, presence of diastolic dysfunction at baseline, 
baseline SDI, and ΔSDI. Only significant variables at univariate analysis 
were entered as covariates in the multivariate model. Finally, in order to 
determine the potential incremental value of ΔSDI over the other 
variables, the R2 of the multivariate model was compared with the R2 of 
the same model without ΔSDI. 
A two-tailed p value < 0.05 was considered statistically significant. 
Statistical analysis was performed using the SPSS software package 




A total of 36 patients were excluded from the analysis because of 
suboptimal RT3DE image quality data; in addition, 10 patients were lost at 
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follow-up. Consequently, a total of 147 patients were included in the final 
analysis. 
 
Characteristics of the patient population 
Baseline characteristics of the study population are summarized in Table 
1. A total of 59 (40%) patients had an anterior acute MI; obstructive 
multi-vessel disease (i.e. more than 1 vessel with a luminal narrowing 
≥70%) was present in 52 (35%) patients. The median peak value of 
troponin T was 2.97 µg/L (1.41–6.06 µg/L). Mean LVEF was 47±8% and 
mean SDI was 5.01±2.10%, respectively. A total of 87 (59%) AMI 
patients had an SDI higher than 4.12%, therefore having significant 
mechanical dyssynchrony. 
Of note, anterior AMI patients had significantly worse SDI when compared 
with non-anterior AMI patients (6.06±2.58 vs. 4.31±1.32%; p <0.001). 
Conversely, no difference in SDI was observed between single-vessel and 
multi-vessel disease patients (4.83±1.87 vs. 5.35±2.46%; p = 0.19). 
 
Evolution of LV volumes, systolic function, and LV 
dyssynchrony 
At follow-up, a slight increase in LVEDV was observed (105±27 vs. 
109±32 ml; p = 0.094), whereas LVESV remained unchanged (56±18 
vs. 55±24 ml; p = 0.48); however, a total of 34 (23%) patients showed 
adverse LV remodelling (defined as an increase ≥15% of LVESV) 12,13 at 6 
months follow-up. 
A significant improvement in LVEF (47±8 vs. 50±9%; p <0.001) and SDI 
(5.01±2.10 vs. 4.52±1.97%; p = 0.003) was also noted (Figure 1). A 
total of 72 (49%) AMI patients remained with an SDI higher than 4.12%, 
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Table 1. Baseline characteristics of acute MI patients 
Variable n = 147 
Age (years) 58±11 
Male gender 116 (79%) 
Diabetes 15 (10%) 
Family history of CAD 59 (40%) 
Hypercholesterolemia 23 (16%) 
Hypertension 50 (34%) 
Current or previous smoking 87 (59%) 
Anterior myocardial infarction 59 (40%) 
Infarct-related artery 
- left anterior descending coronary artery 
- left circumflex coronary artery 





Multi-vessel disease 52 (35%) 
Peak troponin T (µg/l) 2.97 (1.41-6.06) 
Symptom onset to balloon time (minutes) 192±100 
Medical therapy at discharge 
- Antiplatelets 








LVEDV (ml) 105±27 
LVESV (ml) 56±18 





100 (68%)/43 (29%)/3 (2%)/1 (1%) 
Diastolic dysfunction 
- absent/grade 1/grade 2/grade 3 
 
59 (40%)/79 (54%)/7 (5%)/2 (1%) 
SDI (%) 5.01±2.10 
ACE: angiotensin-converting enzyme; ARBs:, angiotensin receptor blockers; CAD: coronary 
artery disease; EF: ejection fraction; EDV: end-diastolic volume; ESV: end-systolic volume; 
LV: left ventricular; MI: myocardial infarction; SDI: systolic dyssynchrony index; WMSI: wall 
motion score index. 
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Figure 1. Changes in left ventricular ejection fraction (LVEF) and systolic 
dyssynchrony index (SDI) at 6-month follow-up. (Panel A) A significant increase 




Figure 2. Relation between the change in left ventricular ejection fraction 
(∆LVEF) and the change in systolic dyssynchrony index (∆SDI) after 6 months 
follow-up in the study population. In patients with a decrease in SDI (restoration of 
LV synchronicity), LVEF improved. In contrast, in patients with an increase in SDI 
(impairment in LV dyssynchrony), LVEF decreased. 
 
Of note, patients with anterior AMI improved in SDI to a larger extent 
when compared with non-anterior AMI patients (ΔSDI: −1.30±2.32 vs. 
0.53±1.55%; p <0.001). Conversely, no difference in ΔSDI was 
observed between patients with single-vessel and multi-vessel disease 
(−0.55±1.85 vs. −0.39±2.27%; p = 0.66). 
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A strong correlation was found between ΔLVEF and ΔSDI (β = −0.63; p 
<0.001); importantly, patients having an improvement in LV 
synchronicity showed also an improvement in LVEF, while worsening in SDI 
was associated to a further decline in LVEF (Figure 2). A significant but 
weak correlation was observed also between ΔLVESV and ΔSDI (β = 
0.33; p <0.001). 
 
Table 2. Univariate and multivariate regression analyses to determine the independent 
correlates of change in LVEF at 6 months follow-up 
 Univariate Multivariate 
 β p value β p value 
Age 0.070 0.40 - - 
Female gender 0.081 0.33 - - 
Diabetes -0.053 0.52 - - 
Family history of CAD 0.059 0.48 - - 
Hypercholesterolemia -0.26 0.002 -0.12 0.038 
Hypertension -0.24 0.003 -0.11 0.057 
Current or previous smoker 0.14 0.089 - - 
Anterior acute MI 0.16 0.047 0.017 0.78 
Multi-vessel coronary disease -0.048 0.56 - - 
Peak troponin T -0.29 0.001 -0.35 <0.001 
Symptom onset to balloon time -0.017 0.84 - - 
Baseline LVESV -0.031 0.71 - - 
Baseline LVEF -0.39 <0.001 -0.30 <0.001 
Baseline WMSI -0.039 0.64 - - 
Presence of mitral regurgitation at baseline -0.16 0.062 - - 
Presence of diastolic dysfunction at 
baseline 
0.088 0.29 - - 
Baseline SDI 0.11 0.18 - - 
ΔSDI -0.63 <0.001 -0.46 <0.001 
The R2 of the model selected at multivariate analysis was 0.57. Abbreviations as in Table 1. 
 
Correlates of change in LV systolic function (LVEF) at 6 
months follow-up 
Table 2 shows the results of the univariate and multivariate regression 
analysis performed to determine the factors related to ΔLVEF between 
baseline and 6 months follow-up. At univariate analysis, several variables 
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were significantly related to ΔLVEF: hypercholesterolaemia, 
hypertension, anterior location of acute MI, peak troponin T, baseline 
LVEF, and ΔSDI. At multivariate analysis, hypercholesterolaemia, peak 
troponin T, baseline LVEF, and ΔSDI were independent factors associated 
with ΔLVEF. More importantly, the addition of ΔSDI to the multivariate 
model significantly increased the R2 from 0.41 to 0.57 (F change 49.0, p 
<0.001). This underscores the strong and independent relationship 





The present study demonstrates that after a first-reperfused acute MI, an 
improvement in LV global performance occurs with an improvement of LV 
systolic function (LVEF) and of LV synchronicty. Changes in LV 
synchronicity at 6 months follow-up are significantly and independently 
related to changes in LV systolic function. 
 
Temporal evolution of LV systolic function and LV 
dyssynchrony after acute myocardial infarction 
In the present study, an improvement in LVEF was shown at 6 months 
follow-up in patients with a first acute MI successfully reperfused. Of note, 
LV functional recovery (expressed as positive ΔLVEF) was significantly 
and inversely related to peak value of troponin T (reflecting myocardial 
damage) and baseline LVEF. In addition, the inverse relationship between 
baseline LVEF and improvement in LV systolic function during follow-up is 
likely related to functional recovery of stunned myocardium.14–16 
Furthermore, LV dyssynchrony early after acute MI has been related to 
LVEF and LV remodelling at follow-up.1,2 Besides infarct size as quantified 
with levels of Troponin or extent of wall motion abnormalities, LV 
dyssynchrony has shown to be an independent determinant of LV 
remodelling after acute MI.1 However, the relationship between changes in 
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LV dyssynchrony and LV systolic function over time after reperfused 
acute MI remained unknown. The present study shows that restoration of 
LV synchronicity was associated with improved LV systolic function after 
6 months; conversely, in the subset of patients experiencing worsening of 
LV dyssynchrony, a further decline in LVEF was observed. Of note, the 
impact of change in LV synchronicity on the change in LV systolic 
function was independent and incremental to other baseline variables 
(including baseline peak troponin T and baseline LVEF). Previous 
experimental and clinical reports partially explained these observations;17–
20 the detrimental effects of LV dyssynchrony on LV performance may be 
incremental to the effects of LV structural changes. After acute MI, LV 
remodelling is characterized by hypertrophy and fibrosis of the non-
infarcted regions and expansion and thinning of the infarct core.21 These 
changes determine a redistribution of myocardial fibre strain with 
increasing myocardial work and energy demand.17–19 The addition of LV 
dyssynchrony may impact negatively on myocardial fibre strain further 
impairing LV global performance and favouring LV remodelling. 
 
Clinical perspective 
The present study demonstrates that the impairment in LV synchronicity 
observed early after acute MI is not a permanent phenomenon. In the 
overall study population, restoration of LV synchronicity was observed, 
which was related to LV functional recovery. Conversely, progressive 
worsening of LV dyssynchrony during the follow-up appeared to be an 
ominous mechanism, which independently contributed to progression of 
LV dysfunction. Accordingly, beside the essential role of timely and 
effective revascularization of the culprit vessel, therapeutic strategies to 
restore a more synchronous LV contraction could potentially be useful in 
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Limitations 
Some limitations should be acknowledged. First, only patients with ST-
segment elevation AMI who underwent PCI were included; consequently, 
the results cannot be extrapolated to patients with non-ST-elevation AMI 
or patients who did not undergo reperfusion therapy. In addition, RT3DE 
image quality is highly dependent on the acoustic window; consequently, 
analysable 3D LV model may be technically difficult to acquire in some 
patients.7 Peak troponin T levels measured within the first 18 h of 
admission may not accurately reflect the infarct size.22 However, these 
peak levels are clinically relevant as they predict major cardiac events at 





A temporal evolution of LV synchronicity was observed after a first, 
mechanically reperfused, acute MI. The reduction in LV dyssynchrony 
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SUMMARY AND CONCLUSIONS 
 
The general introduction of the thesis outlines the value of non-invasive 
imaging modalities (including coronary artery calcium scoring and multi-
slice computed tomography [MSCT] coronary angiography, conventional 
echocardiography, myocardial deformation imaging, real-time three-
dimensional echocardiography [RT3DE] and contrast-echocardiography) 
in the diagnostic process. The main applications are described in patients 
with suspected coronary artery disease and in patients with acute 
myocardial infarction (AMI). 
 
Part I  
The first part of the thesis discusses the clinical utility of non-invasive 
imaging modalities for diagnosis and risk stratification of patients with 
suspected coronary artery disease. In Chapter 2, an overview of the 
literature regarding the prognostic value of CACS assessment is provided; 
in addition, potential other applications of CACS assessment as well as the 
limitations of the technique are discussed. In Chapter 3, the prevalence 
of coronary artery disease across the Framingham Risk Score categories 
using CACS and MSCT coronary angiography was evaluated; a strong 
positive relationship was observed between Framingham Risk Score and 
the prevalence and extent of atherosclerosis. Especially in intermediate 
Framingham Risk Score patients, CACS and MSCT coronary angiography 
provided useful information on the presence of subclinical atherosclerosis. 
In these patients, who represent a substantial part of the population, 
clinical management is frequently uncertain and refinement of risk using 
atherosclerosis imaging may allow more appropriate targeting of 
preventive measures.  
CACS and MSCT coronary angiography, despite providing meaningful 
information about the presence and extent of coronary atherosclerosis, 
do not provide information about the functional relevance of the observed 
coronary lesions. In Chapter 4, a better understanding of the 
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complementary information provided by these non-invasive methods 
(imaging of coronary atherosclerosis versus evidence of inducible 
ischemia), especially in relation to traditional risk assessment, is provided 
and a flow chart describing the proposed integration of non-invasive 
imaging of coronary arteries and stress testing into the traditional risk 
assessment of coronary artery disease events is presented. 
In Chapters 5 and 6 the prevalence of coronary artery disease, by 
means of MSCT, and of abnormal stress testing were evaluated among 
patients with paroxysmal or persistent atrial fibrillation and compared 
with patients without a history of AF. Interestingly, a higher prevalence of 
obstructive coronary artery disease was observed among patients with 
AF, while the prevalence of functionally-relevant coronary lesions was 
similar to non-AF patients. The higher burden of subclinical coronary 
atherosclerosis observed in patients with AF may explain the previously 
observed higher long-term risk of coronary artery disease event in this 
group; accordingly, more aggressive medical therapy and risk factor 
modification may be justified in AF patients. 
The presence of cardiac and aortic calcium shares many risk factors and a 
similar cause with both systemic and coronary atherosclerosis; as shown 
in Chapter 7, a simple echocardiography-derived calcium score, obtained 
through the comprehensive assessment of the burden of cardiac and 
ascending aorta calcium, is able to predict CACS and the presence of 
obstructive coronary artery disease, assessed using MSCT coronary 
angiography. Accordingly, recognition of cardiac and ascending aorta 
calcium using transthoracic echocardiography, a simple, low-cost, 
radiation-free and widely available technique, may be used to optimize the 
identification of patients with obstructive coronary artery disease in 
clinical practice. 
As previously observed by the Multiethnic Study of Atherosclerosis 
(MESA) study, a progressive impairment of myocardial contraction 
(despite normal left ventricular ejection fraction) is associated with an 
increasing severity of coronary atherosclerosis (detected by MSCT or 
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EBCT) in patients without known coronary artery disease. In Chapter 8, 
the relation between obstructive coronary artery disease (assessed by 
MSCT coronary angiography), left ventricular diastolic dysfunction, and 
subclinical left ventricular systolic dysfunction (assessed by speckle-
tracking echocardiography) and the potential incremental value of left 
ventricular diastolic dysfunction and subclinical left ventricular systolic 
dysfunction over the initial estimate of pretest likelihood of obstructive 
coronary artery disease were investigated. Of note, both left ventricular 
diastolic dysfunction and subclinical left ventricular systolic dysfunction 
were independently related to obstructive coronary artery disease and 
the presence of subclinical left ventricular systolic dysfunction provided 
significant incremental value over the Duke Clinical Score for the 
identification of patients having obstructive coronary artery disease. 
Especially among the patients with low or intermediate Duke Clinical 
Score, the presence of subclinical left ventricular systolic dysfunction 
significantly increased the likelihood of having obstructive coronary artery 
disease. Accordingly, routine screening for subclinical left ventricular 
systolic dysfunction among patients without known coronary artery 
disease may possibly refine the traditional clinical assessment and may be 
useful for selection of further diagnostic tests. 
 
Part I I  
In this part of the thesis the clinical value of novel echocardiographic 
techniques is evaluated in patients with AMI. At present, transthoracic 
echocardiography is a frequently used imaging modality in the 
management of patients with AMI. Echocardiography is a low-cost and 
safe modality, which can be easily applied at the bedside and is valuable 
for patient follow-up. The accuracy of RT3DE acquisitions with and 
without contrast early after AMI was investigated in Chapter 9; of note, 
the administration of contrast agents in these patients was of incremental 
value, improving endocardial border visualization and reproducibility of 
left ventricular function assessment. As shown in Chapter 10, the use of 
Summary	  and	  Conclusions	   265	  
	  
echocardiographic contrast agents permits also the assessment of left 
ventricular fluid dynamics, which are related to the remodelling and 
deformation properties of the left ventricle. The assessment of vortex 
formation with contrast echocardiography represents indeed a novel 
measurement of left ventricular diastology; vortex formation time and 
morphology were indeed good correlated with infarct size and with left 
ventricular untwisting rate. 
This technique also allows for the evaluation of myocardial perfusion and 
therefore of myocardial infarction extension, which is an important 
parameter to take into account in the evaluation of cardiac mechanics at 
short- and long-term follow-up after AMI. In fact, left ventricular function 
immediately after AMI was demonstrated to be independently associated 
with infarct size and left ventricular twist (Chapter 11). Of note, the 
impairment of left ventricular twist early after AMI was significantly and 
independently related to the occurrence of left ventricular remodelling at 
6 months follow-up, representing a sensitive global parameter of left 
ventricular systolic performance after infarction. 
Advances in echocardiographic techniques (i.e., tissue Doppler 
echocardiography, speckle-tracking echocardiography, and RT3DE) have 
demonstrated an impaired left ventricular synchronicity in patients with 
AMI; in Chapters 12 and 13, the relation between this decrease in left 
ventricular synchronicity and left ventricular systolic function at baseline 
and at 6 months follow-up was investigated. Early after AMI, the severity 
of impairment of left ventricular synchronicity had an additional 
detrimental impact on left ventricular performance, beyond the infarct 
size itself. The impairment in left ventricular synchronicity observed early 
after AMI is not however a permanent phenomenon in all patients; in 
patients having restoration of left ventricular synchronicity at 6 months 
follow-up, left ventricular functional recovery was also observed. 
Conversely, progressive worsening of left ventricular dyssynchrony during 
the follow-up appeared to be an ominous mechanism, which 
independently contributed to progression of left ventricular dysfunction. 
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Accordingly, beside the essential role of timely and effective 
revascularization of the culprit vessel, therapeutic strategies to restore a 
more synchronous left ventricular contraction could potentially be useful 




Non-invasive cardiac imaging modalities play a crucial role in the 
diagnostic process and clinical management of patients without known 
coronary artery disease and patients with AMI.  
Non-invasive coronary angiography with MSCT has witnessed an 
enormous development in the last decade allowing accurate detection of 
significant coronary stenosis; its implementation in clinical practice helps 
to refine traditional patients’ risk stratification. 
Conventional two-dimensional echocardiography, the use of echo-
contrast agents, myocardial deformation imaging, and RT3DE have been 
demonstrated to be useful techniques for the identification of patients 
with obstructive coronary artery disease and for the risk stratification of 
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SAMENVATTING EN CONCLUSIES 
 
De inleiding van dit proefschrift beschrijft de waarde van niet-invasieve 
beeldvormende technieken (coronair calcium score scan, multi-slice CT 
(MSCT) coronair angiografie, myocard deformatie imaging, real-time 3D 
echocardiografie (RT3DE) en contrast-echocardiografie) voor het 
diagnostisch proces. De belangrijkste toepassingen hiervan worden 
beschreven in patiënten met verdenking op coronairlijden en in patiënten 
met een acuut hartinfarct. 
 
Deel I  
In het eerste deel van dit proefschrift wordt de waarde van niet-invasieve 
beeldvorming voor de diagnostiek en risico-stratificatie van patiënten met 
verdenking op coronairlijden besproken. Hoofdstuk 2 verstrekt een 
overzicht van de literatuur over de prognostische waarde van een coronair 
calcium score scan; er wordt tevens ingegaan op eventueel andere 
toepassingen van deze calcium scan en er wordt beschreven wat de 
beperkingen aan deze techniek zijn. In Hoofdstuk 3 werd in de 
verschillende Framinghame Risk Score categorieën de prevalentie van 
coronairlijden bestudeerd met behulp van de calcium score scan en MSCT 
coronair angiografie.  Er bleek een sterk positieve relatie te zijn tussen de 
Framingham Risk Score en de prevalentie en ernst van de atherosclerose.  
Met name in patiënten met een intermediaire Framingham Risk score werd 
er met de coronair calcium score scan en de MSCT coronair angiografie 
nuttige informatie verschaft over de aanwezigheid van subklinische 
atherosclerose.  
Het klinisch beleid is in deze patiënten, die een substantieel deel van de 
populatie vertegenwoordigen, nog vaak onzeker en met verfijning van het 
risico met behulp van beeldvorming van de atherosclerose zouden er meer 
geschiktere preventieve maatregelen genomen kunnen worden. Hoewel 
de coronair calcium scan en MSCT coronair angiografie zeer waardevolle 
informatie verschaffen over de aanwezigheid en uitgebreidheid van de 
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atherosclerose in de kransslagaders, wordt er geen informatie verkregen 
over de functionele relevantie van de geobserveerde coronair laesies. Een 
beter begrip van de aanvullende informatie die deze niet-invasieve 
beeldvorming verschaft ten opzichte van traditionele risico evaluatie en 
hoe afgebeelde coronair atherosclerose zich verhoudt tot induceerbare 
ischemie, wordt verstrekt in Hoofdstuk 4. Tevens wordt er aan de hand 
van een flow chart een voorstel gepresenteerd voor de integratie van 
niet-invasieve beeldvorming van de kransslagaders met stress-testing in 
de traditionele risico evaluatie voor ischemisch hartlijden. In Hoofdstuk 
5 en 6 werd de prevalentie van coronairlijden (op MSCT) en een 
abnormale stress-test bestudeerd in patiënten met paroxysmaal of 
persisterend atriumfibrilleren (AF) en vergeleken met patiënten zonder 
AF. Er bleek een hogere prevalentie te zijn van obstructief coronairlijden in 
de patiënten met AF ten opzichte van diegene zonder AF terwijl de 
prevalentie van functioneel relevante coronair laesies tussen beide 
groepen hetzelfde was. De grotere burden van subklinische coronair 
atherosclerose in de patiënten met AF verklaart wellicht het hogere risico 
dat deze patiënten hebben op hart- en vaatziekten gerelateerde events. 
Op basis hiervan zou agressievere medische behandeling en het strenger 
beperken van de risicofactoren in AF patiënten rechtvaardig zijn.  
 In Hoofdstuk 7 wordt getoond dat veel van de risicofactoren voor 
cardiaal calcium hetzelfde zijn als die voor calcium in de aorta hetgeen 
zich uit in zowel systemische als coronair atherosclerose. Een op 
echocardiografie gebaseerde calcium score, verkregen bij grondige 
analyse van de cardiale en aorta calcium burden, bleek in staat te zijn de 
coronair calcium score en de aanwezigheid van obstructief coronairlijden 
op MSCT te kunnen voorspellen. Op deze manier kan het bij transthoracale 
echocardiografie herkennen van cardiaal calcium en calcium in de 
ascenderende aorta een eenvoudige, weinig-kostende en stralingsvrije 
techniek zijn die in de dagelijkse praktijk gebruikt kan worden voor het 
optimaliseren van de identificatie van patiënten met obstructief 
coronairlijden. Zoals eerder al werd geobserveerd in de Multiethnic Study 
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of Atherosclerosis (MESA) studie, is een progressieve verslechtering van 
de myocardiale contractie (ondanks een normale linker kamer ejectie 
fractie) geassocieerd met een toenemende ernst van coronair 
atherosclerose op multi-slice of electron-beam CT. In Hoofdstuk 8 werd 
de relatie tussen obstructief coronairlijden (op MSCT coronair angiografie) 
en diastolische linker kamer dysfunctie en subklinische, systolische linker 
kamer dysfunctie (beoordeeld met speckle-tracking echocardiografie) 
onderzocht en werd er bekeken of het evalueren van hiervan een 
incrementele waarde had boven een initiële, pretest likelihood schatting 
op coronairlijden. Zowel diastolische linker kamer dysfunctie als 
subklinische, systolische linker kamer dysfunctie bleken onafhankelijk 
gerelateerd te zijn aan obstructief coronairlijden. Daarnaast verschafte de 
aanwezigheid van subklinische, systolische linker kamer dysfunctie een 
incrementele waarde voor het identificeren van patiënten met obstructief 
coronairlijden boven de Duke Clinical Score.  
Met name bij patiënten met een lage of intermediaire Duke Clinical Score, 
verhoogde de aanwezigheid van subklinische, systolische linker kamer 
dysfunctie de kans op obstructief coronairlijden. Routine screening voor 
subklinische, systolische linker kamer dysfunctie in patiënten zonder 
bekend coronairlijden zou mogelijk de traditionele klinische benadering 
kunnen verfijnen en zou wellicht bruikbaar kunnen zijn voor het selecteren 
van andere diagnostische testen.  
 
Deel I I  
In dit deel van het proefschrift werd de klinische waarde van nieuwe 
echocardiografische technieken in patiënten met een acuut hartinfarct 
bestudeerd. Op dit moment is transthoracale echocardiografie de meest 
gebruikte beeldvormingstechniek in het management van patiënten met 
een acuut hartinfarct. Echocardiografie is een weinig kostende en veilige 
techniek die gemakkelijk ook aan bed gebruikt kan worden en waardevol is 
voor de follow-up. De accuraatheid van RT3DE acquisities met en zonder 
contrast vroeg na het acute infarct werd onderzocht in Hoofdstuk 9. 
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Het toedienen van contrastmiddelen in deze patiënten bleek van 
toegevoegde waarde daar het de visualiteit van de endocardiale border 
verbeterde en de linker kamer functie reproduceerbaarder kon worden 
bepaald. Zoals laten zien in Hoofdstuk 10, maakt het gebruik van 
echocardiografische contrastmiddelen het mogelijk de linker kamer 
vloeistof dynamiek te kunnen bepalen; deze zijn gerelateerd aan 
remodelling en aan de deformerings eigenschappen van de linker kamer.  
Het evalueren van de vortex formatie met contrast-echocardiografie is 
een nieuwe maat voor linker kamer diastologie. De vortex formatie tijd en 
morfologie bleken goed gerelateerd te zijn aan de infarct grootte en aan 
de linker kamer untwisting rate. Deze techniek maakt het verder ook 
mogelijk om de myocardiale perfusie te evalueren en daarmee dus ook de 
myocardiale infarct extensie. Dit is een belangrijke parameter in de 
evaluatie van de cardiale mechaniek op zowel korte als lange termijn 
follow up na het acute hartinfarct.  
De linker kamer functie onmiddellijk na het acute hartinfarct bleek 
onafhankelijk te zijn gerelateerd aan infarct grootte en linker kamer twist 
(Hoofdstuk 11). 
De vermindering van linker kamer twist vroeg na het acute hartinfarct was 
significant en onafhankelijk gerelateerd aan het ontstaan van linker kamer 
remodelling na 6 maanden follow-up en is dus een gevoelige, globale 
parameter van de systolische linker kamer performance na het infarct. 
Ontwikkelingen in echocardiografische technieken (waaronder tissue 
Doppler echocardiografie, speckle-tracking echocardiografie en RT3DE) 
hebben een verminderde linker kamer synchroniciteit aangetoond in 
patiënten met een acuut hartinfarct. In Hoofdstuk 12 en 13 werd de 
relatie tussen de vermindering in linker kamer synchronie en systolische 
linker kamer functie op baseline en na 6 maanden follow-up bestudeerd. 
Vroeg na het infarct heeft de ernst van vermindering in linker kamer 
synchroniciteit een extra schadelijke impact op de linker kamer 
performance, verder dan de infarct grootte an sich.  
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De vermindering in linker kamer synchroniciteit welke vroeg na het infarct 
gezien werd bleek echter niet een permanent fenomeen te zijn in alle 
patiënten. In patiënten waarbij na 6 maanden follow-up herstel van de 
linker kamer synchroniciteit gezien werd,  was er ook herstel van de linker 
kamer functie. Omgekeerd bleek een toename van de linker kamer 
dissynchronie een omineus mechanisme te zijn, welke onafhankelijk 
bijdroeg aan de progressie van linker kamer dysfunctie.  Naast een snelle 
en effectieve revascularisatie van de culprit laesie, zouden therapeutische 
strategieën die een meer synchrone linker kamer contractie nastreven, 




Niet-invasieve cardiale beeldvormingstechnieken spelen een cruciale rol in 
het diagnostisch proces en klinisch management van patiënten zonder 
bekend coronairlijden en in patiënten met een acuut hartinfarct.  
Niet-invasieve coronair angiografie door middel van MSCT heeft het 
laatste decennium een enorme ontwikkeling doorgemaakt waardoor er nu 
een accurate detectie van significante coronair stenosen mogelijk is. De 
implementatie hiervan in de dagelijkse klinische praktijk helpt de 
traditionele risico-stratificatie te verfijnen. Van conventionele 2D 
echocardiografie, het gebruik van echografische contrastmiddelen, 
myocardiale deformatie beeldvorming en van RT3DE is aangetoond dat dit 
waardevolle technieken zijn voor de identificatie van patiënten met 
obstructief coronairlijden en voor de risico-stratificatie van patiënten na 
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